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Abstract
Comparative functional analysis of the atypical Notch lig-
ands DLK1 and DLK2 in vertebrate development
Alexandra Svarrer Ashcroft
DLK1 and DLK2 are vertebrate specific non-canonical Notch ligands. Dlk1 is imprinted
throughout murine development [76] but selectively loses its imprint in the postnatal neu-
rogenic niche by an unknown mechanism [78]. Possessing both secreted and membrane-
tethered isoforms[212, 211], DLK1 plays critical roles in a wide range of developmental
processes and is implicated in several diseases, including obesity and cancer[35, 241].Apart
from a few exceptions[78], in the majority of processes, the precise roles and relative contri-
butions of membrane-bound and secreted DLK1 are unknown . DLK2 is a related gene with
homology to DLK1 [108, 49]; however virtually nothing is known about it. Preliminary data
from the Ferguson-Smith lab suggests that it is involved in neurogenesis in the Zebrafish.
This project investigates the role that DLK2 plays in wild-type mice and compares the gene
to DLK1.
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1.1 Protein structures of DLK1 and DLK2
Protein delta-like homolog 1 (Dlk1) was discovered three independent times in 1993 [106,
129, 213] and is a vertebrate-specific member of the Jagged/Delta/Serrate family of NOTCH
ligands [129]. Less is known about protein delta-like homolog 2 (Dlk2), first sequenced in
1998 [108], despite relatively high (protein) sequence conservation between the genes across
multiple species.
The overall folded structure of both genes is still unknown; no structural studies have
been carried out on DLK2 and despite a preliminary analysis of the structure of DLK1 [127],
it has yet to be purified. Although the protein model portal provides homology models for
both genes, the models are based on experimentally verified structures with less than 60%
sequence homology [91]. These probably unreliable structures compound the challenge
of elucidating the genes’ already complicated signalling mechanisms (section 1.6). Never-
theless, key domains can be inferred from the gene sequences (table 1.1), emphasising the
similarity between the two proteins.
Structural component DLK1 DLK2 References
Chromosome 12 17 [113]
Protein length (aa) 385 382 [227]
Mass (Da) 41320 40404 [227]
Protein type SPTMP SPTMP [227]
EGF domains 6 6 [207, 212, 211,
247]
Cleavage domain Exc. isoforms C, C2, D &
D2
e.u. [113, 207]
Calcium binding domains n.p. 2 [207, 227]
Motifs Asn-Xaa-Cys n.p. [127, 227]
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Table 1.1 (continued)
Structural component DLK1 DLK2 References
N-linked glycoslyation (at) 100, 165 (p), 174 (a), 295
(pd)
157 [127]
O-linked glycosylation 94, 126, 224, 258, 267 (p),
271
n.p. [227]
Predicted phosphorylation (at
aa)
262, 264, 357 47,
316
[25]
Disulphide bonds 18 17 [207, 227]
Table 1.1 Comparison of structural domains present in DLK1 and DLK2 in mice
Acronyms used: a — atypical, aa — amino acid, EGF — epidermal groth factor like
repeat, e.u. — experimentally unvalidated, Exc. — excluding, n.p. — none predicted, p —
partial, pd — predicted, SPTMP — single pass type I membrane protein
DLK1 and DLK2 are transmembrane proteins. As is typical of proteins in the Delta
family, they contain a series of Epidermal Growth Factor (EGF)-like repeats (figure 1.1).
Although both DLK1 and DLK2 contain six of these tandemly repeated EGF-like motifs in
mice, they lack the conserved residues thought to be required for binding to EGF receptors
[129]. Instead, the two most N-terminal EGF-like repeats of the DLK genes are a conserved
DOS Delta and OSM-11 motif, shared by classical Notch ligands [122]. Crucially both genes
also have short intracellular domains and lack Delta/Serrate/LAG-2 (DSL) domains, present
in canonical Notch ligands [122]. Notch ligands are believed to activate Notch through the
DSL domain [65]. The absence of a DSL domain suggests that DLK genes interact with
Notch in an atypical manner (section 1.6).
Both DLK1 and DLK2 contain a juxtamembrane motif (figure 1.1), in all species except
zebrafish that lacks the cleavage domain in Dlk1. Experiments on cell lines demonstrated
that tumour necrosis factor-alpha converting enzyme (TACE) can cleave the juxtamembrane
domain of DLK1 to produce a soluble protein (S-DLK1) [247]. Reports of S-DLK1 in vivo
[95] suggest that cleavage of DLK1, probably by TACE, is a real, physiologically relevant
phenomenon. However, there is no experimental evidence to support or refute cleavage of
DLK2. Indeed, whether the cleavage domain is contained in the final mRNA transcript of
any species is still unverified. Immunohistological experiments in zebrafish, the only model
organism in which DLK2 protein has been characterised, cannot determine whether a soluble
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Fig. 1.1 Structures of murine DLK1, DLK2, and DLL1 compared to the structure of
Drosophila melanganster DELTA Not to scale
DLK1 and DLK2 are single pass transmembrane proteins with short intracellular domains
significantly shorter than those of their homologues DLL1 and DELTA. All proteins contain
various numbers of epidermal growth factor repeats, with DLK1 and DLK2 each possessing
6 in mice. Both genes retain the complete suite of EGF repeats in all species studied thus far.
DLK1 and DLK2 do not have Delta/Serrate/LAG-2 (DSL) domains. DLK1 makes isoforms
possessing and lacking the extracellular cleavage domain in mice but nothing is known
about DLK2 isoforms and whether they retain or excise the cleavage domain. All studied
vertebrate species with DLK1 possess the cleavage domain in their amino acid sequence,
except zebrafish. Zebrafish do however possess the cleavage domain sequence for DLK2.
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isoform of DLK2 (S-DLK2) exists (PhD thesis, Dr. Ben Shaw, University of Cambridge
(2017)).
Information on Dlk1 transcripts is much more robust. Alternative splicing creates tran-
scripts encoding at least six different DLK1 isoforms, producing membrane-bound (M-DLK1)
and soluble forms of the protein [212, 211] in eutherian mammals. Isoforms A and B, encod-
ing S-DLK1, contain the protein cleavage domain whereas spliceoforms C, C2, D and D2,
encoding M-DLK1, lack the juxtamembrane domain, are not cleaved and remain tethered to
the cell membrane [211]. Both isoforms have been reported to play distinct developmental
roles in mice [78, 150]. The number of alternative Dlk1 spliceoforms varies between species;
expression of various Dlk1 isoforms has been detected in pigs [57], cows [242], sheep [54],
chickens [205], quails [205], turkeys [205], and even opossums [250]. Full-length Dlk1
is believed to be the dominant isoform expressed in humans but this is difficult to verify
experimentally as most publications appear to ignore isoforms when investigating DLK1 in
humans.
1.2 Evolution of DLK1 and DLK2
Duplication events of the prototypical Notch ligand Delta ultimately resulted in the DLK
genes (figure 1.2). Delta-like originally arose from the duplication of Delta at some point be-
fore the divergence of Ciona intestinalis from the rest of the chordate lineages. A subsequent
duplication, early on in the vertebrate lineage, produced DLK1 and DLK2 (pers. comm. Dr.
Carol Edwards). Although it is unclear when such duplication event occurred, it most likely
happened during one of the vertebrate genome duplication events [56].
1.2.1 Imprinting of DLK1
Supporting the hypothesis that Dlk1 is more evolutionarily dynamic than Dlk2, is the unique
behaviour of Dlk1 in eutherian mammals: genomic imprinting [119, 223]. Imprinted genes
are expressed in a parental-origin specific manner, and many map in clusters [187]. Some
imprinted genes may therefore be expressed exclusively from the paternally-inherited chro-
mosome and others from the maternally inherited chromosome [77]. All work to date on
Dlk2 indicates that it is not imprinted in mice; for example, no study has identified it in any
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(a) Duplication of DLK1 and DLK2 (b) Vertebrate specific whole genome duplication
events
Fig. 1.2Duplication of atypical Notch ligands DLK1 and DLK2 (Delta-like homologues
1 and 2) from canonical Notch ligand DL (Delta).
Duplication likely occurred during one of the early vertebrate specific whole genome du-
plication events (coloured dots in b) although it is difficult to give an exact time. Figure a
shows that vertebrate specific canonical notch ligands DLL1-3 (Delta like 1-3) also arose
from duplication events of Delta. Both figures adapted from Carol Edwards.
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screen for imprinted genes [21, 155, 174, 220].
Dlk1 resides within the imprinted delta-like homolog 1 and type III iodothyronine deiodi-
nase (Dlk1-Dio3) cluster in mammals (figure 1.3), spanning 1.3Mb on mouse chromosome
12. Dlk1 is not imprinted in avian species [205], fish and non-eutherian mammals [68]
although expression of the gene has been observed in all vertebrates in which experimental
analysis of Dlk1 expression has been performed.
Fig. 1.3 Schematic of the imprinted Dlk1-Dio3 cluster on mouse chromosome 12
Dlk1, Rtl1 and Dio3 are protein coding genes that are expressed only from the paternally
inherited chromosome (PAT). Multiple noncoding RNA (ncRNA) genes, including microR-
NAs (miRNAs) and small nucleolar RNAs (snoRNAs), are expressed exclusively from the
maternally inherited chromosome (MAT). This imprinting is regulated by the intergenic DMR
(IG-DMR), an intergenic element betweenDlk1 andGtl2 that causes the protein-coding genes
to be repressed on the maternal chromosome and the ncRNAs to be active. The Dlk1-Dio3
cluster is only methylated at the IG-DMR (intergenic differentially methylated region) on
the paternal chromosome (PAT) under normal conditions. In the postnatal neurogenic niche,
there is methylation of the IG-DMR on the maternal chromosome and maternal expression
of Dlk1. Arrows indicate the direction of transcription. The cluster is syntenic to human
chromosome 14. Figure adapted from Prof. Anne Ferguson-Smith.
In mammals, Dlk1 is expressed predominantly from the paternally inherited allele. The
intergenic differentially methylated region (IG-DMR) regulates gene expression within this
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cluster. The IG-DMR is methylated on the paternal chromosome allowing expression of
protein coding genes Dlk1, Rtl1 and Dio3 [67, 140]. Absence of methylation at the IG-DMR,
on the maternal chromosome, leads to repression of these genes and expression of a plethora
of non-coding RNAs [34, 199, 201].
Consistent with other clusters, the Dlk1-Dio3 cluster acquires its imprint in the germ-line
[187] and Dlk1 is imprinted throughout embryogenesis at the gross level. After fertilisation,
ZFP57, initially maternally derived, binds to the methylated IG-DMR [139, 220] in the zy-
gote, protecting it from the global reprogramming of epigenetic marks that occurs very early
in embryogenesis. KAP1/TRIM28 is also important for this process [13]. The importance of
imprinting at this cluster in development is epitomised by the severe phenotypes associated
with alterations of dosage of these genes [45, 187].
In addition to cluster level regulation of Dlk1 expression, it is emerging that there is gene
specific regulation of imprinting and expression, at least in mice. The postnatal neurogenic
niche selectively loses imprinting solely of Dlk1shortly after birth, giving rise to bi-allelic
gene expression [78] (figure 1.3). The consequential increase dosage of protein product is
necessary for niche maintenance [78]. Selective loss of imprinting of one gene within a given
cluster has been observed in additional clusters [79]. The mechanisms responsible for this
remain poorly understood but are likely epigenetically regulated. Nevertheless increased
dosage of a given gene, through selective absence of imprinting of it but not other genes
gives further evidence into the importance of dosage regulation of imprinted genes.
1.3 Expression patterns of DLK genes
Dlk1: In situ hybridisations (ISHs) generally suggest that Dlk1 is widely expressed in par-
ticular lineages throughout the developing embryo and may, amongst many other things,
mark sites of branching morphogenesis [52, 69, 256]. With the exception of the postnatal
neurogenic niche [78], quantitative isoform-specific, tissue-specific expression analysis has
not been performed. In general, Dlk1 RNA-seq data, which can be more sensitive but has
lower resolution at the cellular level, is consistent with the expression patterns observed by
ISHs. However, there is some variability within the public transcriptomes, consistent with
their automated production and absence of validation. Overall, the protein localization for
DLK1 is consistent with the mRNA expression studies [52, 256].
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Dlk2: There is no reliable expression data, mRNA or protein, for DLK2, in part, due to
the absence of a DLK2 antibody. For example, Eurexpress, a high-throughput ISH database,
detected Dlk2 in the brain and spinal-cord at embryonic-day 14.5 (e14.5) with high back-
ground staining [61]. However, the Allen Brain Atlas did not detect any Dlk2 expression in
the brain at any embryonic stage but did detect expression in the adult mouse brain [221].
Reverse-transcriptase polymerase-chain-reaction (rt-PCR) detected expression in a wide
range of adult and foetal tissues, although the study did not state the age of the developing
tissues [186]. Dlk2 expression is extremely ’noisy’ in RNA-seq databases, such as ENCODE
[48] and FANTOM5 [142]. Collectively these datasets highlight the unreliability of high
throughput databases for accurate expression information and the difficulty in determining
where Dlk2 is expressed without robust independent experimental analysis.
1.4 Functions of DLK1
It is challenging to elucidate the role of DLK1 for several reasons. Firstly, insights into DLK1
protein function come from a series of different cell lines and organisms. Evidence suggests
that DLK1 is more evolutionarily dynamic than DLK2 (section 1.2); which means that DLK1
may have been co-opted to play different roles in different organisms. The imprinting of
Dlk1 in eutherian mammals is particularly supportive of this hypothesis as many imprinted
genes have functions co-opted to help mammals transition to independent life, a significant
challenge that is unique to mammalian organisms [36].
In addition, DLK1 can behave as a paracrine, endocrine and autocrine factor in most
organisms. The potential interactions between these behaviours are perhaps the most chal-
lenging barrier to revealing the function of the gene. Consideration of DLK1 isoforms, and
their potential signalling mechanisms, is especially important as work on neurospheres has
demonstrated that S-DLK1 and M-DLK1 can interact with each other [78]. Furthermore,
S-DLK1 can be detected in mouse serum and is likely produced by a variety of sources. How
then can one be sure that circulating S-DLK1 is not acting on a tissue in which DLK1 has
been selectively knocked out? There is evidence of this occurring when Dlk1 is selectively
removed in skeletal muscle in mice [243]. Additional weak phenotypes observed in a series
of tissue specific DLK1 knock-out experiments [18, 243] may also have arisen because of
S-DLK1 acting in an endocrine manner to mitigate a severe phenotype.
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Elucidating the relationship between M-DLK1 and S-DLK1, receptor-ligand interactions,
and the signalling pathways of different isoforms is thus essential to developing a robust
understanding of DLK1 function. This will be difficult. Although a well-designed cell
line experiment can take account of DLK1 isoforms, cell lines may not sufficiently model
the in vivo context. However, deciphering the isoform specific functions in vivo in mouse
models is difficult as it is challenging to modulate the different isoforms separately as they
are expressed from the same gene locus.
Despite the described caveats, significant strides towards understanding the role of DLK1
have been made, particularly in mammals. The gene is implicated in many prenatal and
postnatal processes, such as wound healing [64, 191, 188] and metabolism [35, 44]. It is
also very clear that DLK1 plays a role as a stem cell regulator (discussed in section 1.4.1);
it is likely that this is the ancestral function of the gene and is shared across all species.
Mammalian (section 1.4.3) and avian (section 1.4.2) specific roles are also emerging. Al-
though the precise contributions of the different isoforms remain mainly uncharacterised, our
understanding of mammalian DLK1 function is the most comprehensive.
1.4.1 DLK1 as a stem cell regulator
A significant number of, predominantly mammalian, studies suggest that DLK1 functions as a
stem cell regulator. Overall, DLK1 is believed to maintain progenitor cell pluripotency until it
is appropriate for their differentiation. In vivo and in vitro studies found that DLK1 negatively
regulates the switch from proliferating cells to a mature differentiated state in ameloblasts
[178], DPCs [177], adult neural stem cells [78], immature chondrocytes [41, 248], osteoblasts
[7, 6], hematopoietic-stem-cells [138, 152, 160, 168], hepatoblasts [153, 225], myoblasts
[206], and preadipocytes [4, 18, 116, 158, 162, 213] in various mammals. A comprehensive
analysis of all niches is beyond the scope of this thesis. However, some informative niches
will be discussed below.
Where studied, the same stem cell regulatory behaviour has been observed in birds [204]
and zebrafish [188]. In addition, where investigated Dlk1 gains selective biallelic expression
in adult mammalian stem cell pools [78, 217], suggesting that normal biallelic expression
of DLK1 is necessary for the function of this gene as a stem cell regulator. Dlk1 is not
imprinted in birds [205] or fish [68]; in non-eutherian vertebrate species the gene will always
show biallelic dosage when expressed. It is likely therefore that maintenance of progenitor
pluripotency might be the ancestral function of DLK1, requiring biallelic gene dosage. The
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breadth of mammalian tissues in which DLK1 functions as a stem cell regulator is further
circumstantial evidence that supports this argument. However, investigation into the function
of DLK1 in other non-eutherian vertebrates and imprinting patterns of Dlk1 in other stem
cell pools in mice will be necessary to probe this hypothesis.
Adipogenesis
No review of Dlk1 is complete without discussing its role in adipogenesis. Its role in adipo-
genesis is perhaps the best characterised of any of its behaviours. Indeed, the gene is also
known as preadipocyte factor 1 (Pref-1). Most research suggests that DLK1 inhibits adipoge-
nesis of white [4, 18, 116, 158, 162, 213] and brown fat [19, 96, 37]. DLK1 expression is
high in preadipocytes and abolished in adipocytes in both white [213] and brown adipose
[209]. Furthermore overexpression of retinoic acid by preadipocytes inhibits adipogenesis
in mice through upregulation of DLK1 [26]. In addition, endothelial stromal cells, located
in adipose tissue, also have markedly high DLK1 levels [15], and there is some evidence
that expression of DLK1 by stromal cells may also inhibit adipogenesis [8, 24, 248]. The
accepted interpretation of this data is that DLK1 inhibits differentiation of pre-adipocytes.
This is consistent with the behaviour of the gene in other progenitor cells (section 1.4.1) and
fits the hypothesis that stem cell regulation is the ancestral function. However, this data could
be interpreted another way.
Recent work suggests DLK1 may drive lipid metabolism, and that increased lipolysis is
misinterpreted as inhibition of adipogenesis [35]. Given the number of tissues in which DLK1
seems to function as a stem cell regulator, this other hypothesis is sometimes ignored in
support of the original conventional hypothesis of DLK1 function in adipogenesis. However,
the two hypotheses are not mutually exclusive. DLK1 does probably function as a stem cell
regulator in pre-adipocytes. Since stem cell regulation is likely the ancestral function of the
gene, it is doubtful that this behaviour would have been lost in only one stem cell niche.
Nevertheless, DLK1 displays autocrine, paracrine, and endocrine behaviours (section 1.6);
with the latter most likely involved in the mammalian specific metabolic roles ofDlk1 (section
1.4.3). Adipose tissue is tightly regulated and an integral part of whole body metabolism. It
is unsurprising that additional mammalian specific endocrine gene functions might also be
detected when studying this tissue, especially as it almost exclusively studied in mammalian
models.
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Neurogenesis
DLK1 also plays a role in adult neurogenesis but is dispensable for embryonic neurogenesis
[78]. Interestingly Dlk1 is not imprinted postnatally in adult murine neurogenic niches
suggesting that DLK1 dosage is critical in this process [78]. This is the only study that
investigates the function and imprinting status of this gene together. Other studies have
detected biallelic expression ofDlk1 in stem cell niches [217], or observed its role in stem cell
regulation [7, 4, 6, 18, 41, 116, 138, 152, 153, 158, 160, 162, 168, 177, 206, 213, 225, 248].
This study also provides interesting insights into Dlk1 signalling (section 1.6) S-DLK1
is secreted by niche astrocytes and M-DLK1 is present in neural stem-cells. Both the
soluble and membrane-bound forms of DLK1 are necessary for neural stem-cell self-renewal:
S-DLK1 induces renewal via membrane-bound DLK1 [78].
1.4.2 DLK1 avian neofunctionalism
Only a very small portion of the work on Dlk1 has been performed on birds. Most of it
focuses on sequencing different isoforms [205], confirming expression [205] and identifying
the stem cell regulatory in behaviour in avian myoblasts [204] (discussed in section 1.4.1).
None of which is specific to birds, nor particularly novel. Nevertheless, this research does
contribute to our overarching understanding of Dlk1 as it supports the hypothesis that the role
Dlk1 plays in stem cell regulation is an ancestral one. A recent study, however, has identified
that Dlk1 may play a role in the adaptive radiation of beak size in Darwin’s finches [40].
During adaptive radiation organisms rapidly diversify from a single common ancestral
species into a plethora of new forms [195]. Adaptive radiation often occurs when changes in
the environment create new evolutionary challenges or make new resources available [195].
The speciation of Darwin’s finches, of the genus Geospiza, is considered the prototypical
example of adaptive radiation [195]. Currently 23 branches, consisting of 14 distinct species
living in various Galapagos islands, are recognised for finch speciation [130].
The study looked three sympatric species of ground finches located on the same island as
investigating on-going speciation will generate greater insights into adaptive radiation than
studying well established lineages. They found that a single nucleotide polymorphism (SNP),
located near Dlk1, was strongly associated with beak size and, to a lesser extent, body size
[40]. Another studying investigating beak size across the entire clade also predicted Dlk1 as
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playing a role [130].
The observation that different Dlk1 variants or alleles are predictive of different pheno-
typic outcomes in finches is exciting. The role of the gene in beak size may be an example of
avian neofunctionalism – beaks are a trait specific to the avian clade. However, this may also
simply be a reflection of the its role as a stem cell regulator. Different Dlk1 variants have
different activity levels that dictate its ability to modulate differentiation of stem cells, which,
in turn, affects the gross phenotypic outcome of a given organ. The latter hypothesis may be
the more likely as a mild association was also observed between Dlk1 and body size [40].
Modulations to Dlk1 dosage, in mice, also affect body size (section 1.4.3).
1.4.3 DLK1 neofunctionalism in eutherian mammals
Dlk1 evolved its imprinting in eutherian mammals [68], suggesting that dosage of this gene
is highly important for its function. Although biallelic gene expression may be necessary
for Dlk1 to function as a stem cell regulator (section 1.4.1), alterations to Dlk1 dosage at
the gross level, in mice, result in severe phenotypes (section 1.4.3). This may suggest that
phenotypes resulting from altering monoallelic gene dosage, may be due to functions that
co-evolved with imprinting and are thus specific to eutherian mammals. Such functions are
likely to be related to mammalian specific phenomena such as placentation (section 1.4.3)
and puberty (section 1.4.3). Furthermore, metabolism is highly important in mammals: a key
process in the transition of a mammalian organism to independent life is shift from lipolytic
to lipogenic metabolism [? ]. This shift allows the digestion of solid food and the storing of
excess energy as fat [? ].
Insights from Dlk1 mutant mice
Given the wide expression of Dlk1 throughout development (section 1.3) and its function
as a stem cell regulator (section 1.4.1), it is worth noting that knocking out Dlk1 causes a
partially penetrant neonatal lethality on some genetic backgrounds but not on others. Deletion
of exons 2-3 caused approximately 50% neonatal lethality on the C57BL/6J and genetic
backgrounds [158]. The mutant generated by the Schmidt group lacks exons 5-6 and displays
25% lethality on a C57BL/6J background [18]. The Bauer group removed the promoter and
exons one to three; their mice show minimal lethality in the C57BL/6J mouse strain [181].
Dlk1 therefore, is clearly not an essential gene. Given the high sequence homology between
Dlk1 and Dlk2 (section 1.1), Dlk2 may be playing a compensatory role in the Dlk1 mutants.
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Only the study of mice carrying deletions of both genes would resolve this.
The surviving Dlk1-null mice have mild phenotypes. All mutants are growth retarded
[18, 42, 158, 181]. Comparison of mutant and wild-type embryo weights, demonstrated that
the Dlk1-null growth phenotype does not arise until late gestation at e18.5 [18, 42]. Overall,
however, the gross morphological effects of losing Dlk1 are not as dramatic as might be
expected.
Overexpressing DLK1 seems to be more detrimental than deleting the gene. Tripling
DLK1 dosage is lethal from e16 and despite an initial prenatal growth advantage [51]. These
mice have oedema, and lung and skeletal defects [51]. Simply doubling DLK1 dosage causes
developmental overgrowth and is lethal in the perinatal period in some but not all offspring
[51].
The role of Dlk1 in placentation
DLK1 likely plays a key role in placenta function. It is expressed in the endothelial cells of the
foetal capillaries labyrinth zone and a subset of trophoblast cells [27, 256]. Labyrinth zone
vasculature production of DLK1 is thought to regulate embryonic growth through paracrine
signalling [18]. Loss of expression of Dlk1 leads to a reduction in labyrinth zone size from
late gestation [18, 158]. Placenta composition in Dlk1 knock-out mice is also altered; the
junctional zone has a decreased number of glycogen cells [18], which is surprising given
that Dlk1 expression has not been detected in junctional zone glycogen cells [52]. Abnormal
glycogen cell migration occurs in uniparental disomies of chromosome 12 in mice [87].
Some researchers postulate that DLK1 is also responsible for glycogen cell migration [100]
however this cannot be assessed without a placental Dlk1 overexpression model.
The role of DLK1 in metabolism
The precise roles DLK1 plays in metabolism are unclear but are likely related to the endocrine
function of the gene. Mice with alterations in DLK1 gene dosage display metabolic pheno-
types [35, 158]. Since DLK1 is a tightly regulated imprinted gene and simply doubling the
gene dosage to normal biallelic gene expression produces severe phenotypes [35], it is likely
that the metabolic functions co-evolved with imprinting and are possibly mammalian specific.
Mice with increased gene dosage, fed a high fat diet, are leaner than wild type controls
despite being hyperphagic [35]. Metabolic phenotypes are complex and difficult to resolve
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but DLK1 may regulate whole body metabolism by modulating the IGF1 and growth hor-
mone (GH) pathways. Additionally, recent work has shown that DLK1, secreted from the
foetus, regulates maternal metabolic partitioning in mice [44].
Work in [explants from] mice over-expressing Dlk1 shows that S- and M-DLK1 can
inhibit insulin like growth factor 1 (IGF1) signalling in the pituitary gland [35]. In addition,
over- or forced Dlk1 expression in murine cell-lines reduces Igf1 expression [260] but cell
lines lacking insulin and IGF1 receptors show almost ablated Dlk1 expression [28], suggest-
ing a negative feedback loop between IGF1 and DLK1.
DLK1 is also likely involved in GH signalling. Interestingly, both mice overexpressing
Dlk1 display increased GH levels [35] and mice lacking Dlk1 have reduced GH levels
[42, 35], whereas mice with increased GH have reduced S-DLK1 levels [3]. The interaction
between GH and DLK1 is clearly more complex but important as GH regulates whole body
metabolism [156].
The role of DLK1 in puberty
Puberty is an essential mammalian process that marks the transition from childhood to
adulthood, where individuals are capable of reproducing [10]. In humans, activation of the
hypothalamic-pituitary-gonadal axis marks the onset of puberty [10]. The axis is charac-
terised by increases in pulsatile gonadotropin-releasing hormone (GnRH) release, which, in
turn, leads to secretion of luteinizing hormone (LH) and follicle stimulating hormone (FSH)
from the pituitary gland [10]. Mutations in another imprinted gene, makorin RING-finger
protein 3, cause central precocious puberty in humans [9], suggesting a role for imprinted
genes in regulating the timing of human puberty. This is perhaps unsurprising given the over-
representation of imprinted genes in processes necessary for the transition to independent
life in mammals [36].
Work on humans demonstrates that DLK1 plays an important role in the age of puberty
onset, although the exact nature of its role remains unclear. Genome wide association studies
(GWAS) link low frequency variants of Dlk1 with large effect sizes at age at menarche (first
menstrual cycle) in females [53, 55, 70, 173], some delaying puberty by 6-9 months [55]
and/or with an intriguing parent-of-origin bias [55, 173]. In addition, a male patient with an
imprinting mutation in the IG-DMR, causing a predicted but experimentally unvalidated re-
duction in DLK1 expression, presented with precocious puberty among other clinical features
[226]. Epimutations causing loss of methylation at the IG-DMR, effectively "maternalising
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the paternal chromosome", and deletions of the full Dlk1-Gtl2 imprinted gene cluster also
result in early on set of puberty in humans [30]. Furthermore, maternal uniparental disomy
of chromosome 14 (mUPD14) is thought to be caused by aberrant expression of genes,
including DLK1, within the imprinted domain at 14q32 [109, 226]. Precocious puberty,
a well documented phenotype in rare patients with mUPD14 [81, 99, 125, 224, 229], is
conserved across the majority (>86% at the time of writing) of all studied cases of mUPD14
in humans [193, 105]. Perhaps the most compelling evidence for a role of DLK1 in puberty is
the recent work by the Latronico group [53]. In this study they found that paternally inherited
rare deletions covering the 5’ UTS and first exon of Dlk1 cause central precocious puberty
[53]. The only other trait described in these patients was increased fat mass, suggesting that
the other phenotypic traits observed in patients with mUPD or IG-DMR epimutations arise
from aberrant expression of other genes. Together these data suggest that deletion of DLK1
is sufficient to cause early onset of puberty in humans.
Despite the compelling evidence suggesting that DLK1 helps determine puberty onset
in humans, there is no mechanistic link between DLK1 function and pubertal development
in any mammalian species. However, circumstantial evidence enables speculation that al-
ternations in DLK1 levels may modulate the hypothalamic-pituitary-gonadal axis, which
is essential for puberty [10]. Dlk1 is expressed in the adult hypothalamus [53, 240]. qPCR
detected Dlk1 expression in the same hypothalamic substructure from which GnRH, an
important player in puberty onset [10], is also expressed [53]. Dlk1-/- mice have fewer
FSH-immunoreactive cells in the adult pituitary [176]. A subsequent radioimmunoassay of
adult WT and Dlk1-/- pituitaries showed that Dlk1-/- pituitaries have reduced levels of all
pituitary hormones, including FSH and LH [42]. Taken together, these data suggest that Dlk1
may indirectly influence the hypothalamic-pituitary-gonadal axis and thus the age of puberty
onset.
Although the supporting evidence for a mechanism by which DLK1 influences puberty
onset comes from mice, no phenotypic reports of the Dlk1 mouse models actually describe
aberrant puberty onset. Perhaps a more targeted analysis of puberty is needed on the Dlk1
mouse models to determine if DLK1 also influences the age of puberty onset in mice.
Alternatively, should the link between DLK1 and the hypothalamic-pituitary-gonadal axis
in mice prove unsubstantiated, it might be worth considering that the role that DLK1 plays
in puberty may be human, or at least primate, specific. Puberty is a more dramatic event
in the human/primate life spans compared to [66]: it lasts longer and may need to be more
tightly regulated. Perhaps imprinted genes, such as DLK1, were co-opted to dynamically
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regulate the process in primates, in the same way imprinted genes were co-opted to assist in
the transition to independent life in mammals [68]. There is also some evidence to support
this hypothesis; detailed MRIs on humans with central precocious puberty, caused by Dlk1
deletions, show normal hypothalamic-pituitary regions [53]. DLK1 may be influencing
puberty age onset in humans independently of the canonical hypothalamic-pituitary-gonadal
axis.
The role of Dlk1 in postnatal bone remodelling
Although Dlk1 has been demonstrated to function in stem cell regulation (section 1.4.1)
during embryonic chondrogenesis [41, 248], it may play a more interesting role in the
postnatal skeleton. DLK1 may drive osteoclast differentiation. DLK1 activity in stromal
cells activates NF-κB signaling [4, 233], ultimately increasing production of a number of
pro-inflammatory osteoclast-activating cytokines [4, 170, 233, 251]. DLK1 activity has
also been implicated in bone remodelling, a process that occurs throughout adulthood to
maintain skeletal integrity [180]. Increasing serum DLK1 levels reduces bone mass in mice
[4]. Similarly, reduction of bone-mineral density and body weight was observed in mice
overexpressing Dlk1 specifically in their osteoblasts [2]. In addition, soluble DLK1 levels
and bone-mineral-density are negatively correlated in patients with anorexia nervosa [74, 75].
Furthermore, antibody based inhibition of circulating S-DLK1 prevented estrogen deficiency
induced bone loss in mice [80]. Such results suggest that DLK1 enhances osteoclast activity,
in an endocrine/autocrine manner, and thus drives bone reabsorption.
1.5 Functions of DLK2
Very little is known about the function and signaling of DLK2 despite high similarity to
DLK1 (table 1.1). Electrical annotation by InterPro, suggests that it binds calcium ions [227],
although this has yet be verified experimentally. Reliable investigation into Dlk2 signalling
pathways has yet to be performed. Some work suggests that Dlk2 is a transcriptional target
of KLF4 in preadipocytes [185], interacts with NOTCH [167, 192], and may modulate
adipogenesis [166]. However such studies are conducted in cell lines and, as described in
section 1.6.2, their physiological relevance is limited.
The most promising work into DLK2 gene function was carried out recently on ATDC5
cells which are typically used to investigate chondrogenesis [254]. The group found that Dlk2
overexpression inhibited differentiation and promoted proliferation [254]. Silencing DLK2
produced the reverse phenotype [254]. Similar stem cell regulation has been observed for
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Dlk1 across numerous cell types (section 1.4.1), and is thought to be the ancestral function of
the gene. Given the high homology between both genes (section 1.1), it is plausible that Dlk2
might also possess a similar function. Further in vivo and in vitro studies across many more
lineages will be necessary to ascertain whether the behaviour of Dlk2 is conserved across
multiple niches or if it is an artefact of the ATDC5 cell line.
1.6 Known mechanisms of DLK1 and DLK2 function
How DLK1 and DLK2 function at the molecular level is perhaps the most poorly understood
aspect of these genes. They are atypical NOTCH interactors, lacking the DSL domain
present on canonical NOTCH ligands [65]. The absence of the crucial DSL domain has led
to speculation that the DLK genes interact in an inhibitory manner with NOTCH (section
1.6.1), or function independently of NOTCH (section 1.6.2). However, some studies argue
that DLK genes actually activate NOTCH (section 1.6.1). This quandary has been probed
experimentally but, as discussed further in sections 1.6.1 and 1.6.2, the data can be confusing.
The majority of information is inferred indirectly, by looking at RNA and/or pro-
tein expression of Dlk1 and Dlk2, and genes involved in key signalling pathways in vivo
[2, 6, 18, 42, 133, 154, 181, 182, 198, 232, 262], and in vitro [3]. Another common strategy
is to study the expression levels of genes responsive to the major signalling pathways, in-
cluding NOTCH, in cell lines, following Dlk1/2 knockdown [262], transfection of Dlk1/2
constructs [3, 16, 41, 177, 198, 232, 260], external administration of S-DLK1 [3, 18, 41, 78,
92, 116, 182, 248], and pharmacological modulation [18, 41, 177, 182, 189, 248]. Another
approach is to generate interactomes computationally; such as those generated in figure
1.4. However, these are subject to some of the same flaws present in most experimentally
generated interactomes. Although the two proteins may interact in vitro, their interaction
may not occur in vivo. The proteins may localise to distinct subcellular compartments or
may not even be expressed in the same cells. They may also miss interactions that depend on
specific post-translational modifications. Furthermore, most studies focus on DLK1 and the
behaviour of DLK2 is subsequently extrapolated. Not all of the data is, therefore, reflective
of the in vivo context. Nevertheless, it is highly likely that both NOTCH dependent and
independent signalling mechanisms exist in vivo.
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(a) DLK1
(b) DLK2
Fig. 1.4 Putative interactomes of DLK1 and DLK2 in mice
Putative murine DLK2 and DLK1 binding partners found using STRING (v10) [222]. All
active prediction methods were considered. Only medium confidence interactors (>0.400)
shown. Interactions found (from/by): experimentally – pink, databases – blue, text-mining –
green, purple – homology.
1.6.1 Notch dependent DLK gene function
Given their homology with other Delta-like NOTCH ligands one might expect DLK1 or
DLK2 to activate NOTCH signalling, in trans [84], but experimental evidence is conflicting.
Direct binding of either DLK1 or DLK2 to a NOTCH protein, of which most vertebrates
have four [148], has yet to be reported in vivo. Immunoprecipitation performed on COS-7
cells, transfected with both Dlk1 and Notch1, found no binding between the two genes [249].
However, Mammalian [232] and yeast [23] two hybrid systems show binding of DLK1 to
NOTCH1. Furthermore, unbiased screening approaches identified DLK1 as interacting only
with IRAK1 [169, 171], fibronectin [249], or CFR [154], with only the latter two validated
by immunoprecipitation [154, 249]. Such discrepancies highlight the limited physiological
relevance of artificial systems when extrapolating to in vivo contexts.
The relationship between DLK1 and DLK2, and NOTCH must thus be inferred indirectly,
and correlative [120, 123, 203, 232, 238] and antagonistic [23, 29, 89, 165, 198] relationships
have been reported. The strongest support for NOTCH agonism, and indeed antagonism,
comes from systems such as Drosophila where neither DLK gene is endogenously expressed,
limiting the physiological relevance of these studies. Although both genes lack the canonical
DSL domain that interacts with NOTCH in vertebrates [65], they retain the OSM-11 motif,
which has been shown to activate NOTCH in Caenorhabditis elegans, a non vertebrate species
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[120, 123]. There is also strong evidence that DLK1, at least, inhibits NOTCH signalling.
NOTCH signalling is increased in Dlk1-/- mice [89], and DLK1 mediated cis-inhibition of
NOTCH has been observed in murine cell-lines [23, 165] and when expressed in flies [29].
Alternatively, the DLK genes might simply block the interaction between NOTCH and a
canonical ligand and thus, in a dominant negative fashion, prevent activation of NOTCH
signalling. However, this phenomena has, thus far, only been demonstrated in non-NOTCH
contexts [154].
A neat resolution to the controversy surrounding DLK signalling is that the different
DLK isoforms interact differently with various NOTCH genes, especially in different cellular
contexts. The work in the heterologous systems provides some preliminary evidence that
this might occur. Only M-DLK1 possessed inhibitory behaviour when expressed in flies [29]
and S-DLK1 was able to rescue the phenotype in C. elegans lacking osm-11, the agonist of
NOTCH in worms [120]. Although promising, this hypothesis needs to be properly probed,
in vivo, in a physiologically relevant setting. This will be challenging since it is likely that
the DLK genes activate additional pathways to NOTCH (section 1.6.2), which may confound
the results.
1.6.2 Notch independent DLK gene function
DLK1 and DLK2 likely interact with more proteins and signalling pathways than just NOTCH.
Numerous studies have implicated non-NOTCH signalling in DLK gene function. DLK2 is
associated with KLF4 signalling [185] whereas DLK1 is linked to AKT [35, 41], CFR [154],
cytokine [3, 6], ERK1/2 [116, 177, 189, 248], FGF18 [154], fribronectin [41, 249], growth
hormone [4, 14, 16, 18, 33, 35, 133, 181], miR-126-5p [198], NFκB [3, 6], oestrogen [2, 6],
SOX9 [248], and WNT10b [262] signalling. Nearly all of the studies try to understand the
molecular mechanism utilised by DLK1 to negatively regulate the switch from immature
stem cells to mature differentiated cells, in various different lineages. Despite this broadly
conserved function, multiple different systems have been implicated and not always consis-
tently. Dlk1 has been shown to upregulate GH levels [18, 35, 181] and repress it GH in GH3
cells (derived from rats) [16]. Both the ERK [116, 189, 248] and cytokine [3] signalling
pathways were identified when studying the role DLK1 plays as a negative regulator of
adipogenesis, in mouse and human models, respectively. Other work identified Sox9 as being
key in regulating chondrocytic differentiation [248], but a later study, using a different cell
line, found no evidence of Sox9 expression modulation by DLK1 during chondrogenesis
despite specifically testing for it [41]. Such contradictions highlight the limitations of using
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cell lines to model in vivo phenomena.
It is plausible that DLK1 interacts with different signalling pathways at the cellular level
to achieve the same gross output (e.g. negative regulation of cell fate in stem cell niches).
Since an ancestral role in stem cell regulation is inferred, it might therefore be evolutionarily
expensive and unlikely for DLK1 to behave, on a molecular level, differently between niches
and across species, especially as core stemness genes are so broadly conserved. It is much
more probable that there is a core, conserved, signalling mechanism that DLK1 implements
when regulating stem cells. However, currently the collective data is insufficient to determine
which of these signalling pathways are physiologically relevant, and which may be cell
culture artefacts. Further in vivo studies will be necessary to resolve this issue.
DLK1 can act in autocrine, endocrine and paracrine manner, and it is possible these
different signalling modes interact. Such interactions could obfuscate the data, making
it challenging to work out what the gene is doing in each specific situation. Indeed, this
is potentially one of the causes of the contradictions the literature, and especially in the
cell line work, as most studies seem to ignore the different DLK1 isoforms. Most, but not
[18, 78, 182] all, studies only look at the full-length gene and/or add S-DLK1 (often in the
form of Dlk1-Fc) to culture media. Such strategies essentially ignore M-DLK1. Given the
preliminary data on DLK1 and NOTCH (section 1.6.1) that there is some evidence that
different isoforms may behave in opposing manners, this is perhaps short sighted. Arguably
only one study properly accounted for the different isoforms, performing co-cultures between
the target cell and cells expressing M-DLK1 or S-DLK1 [78]. Supported by in vivo work,
these experiments showed that the different DLK1 isoforms actually interact with one another
to negatively regulate neurogenesis in the murine adult neurogenic niche [78].
Interestingly, at the time of writing, no reports of NOTCH independent signalling have
been identified for the canonical NOTCH ligands. This suggests that the NOTCH independent
signalling of the DLK genes may be a vertebrate specific phenomenon.
1.7 DLK1 and disease
DLK1 has been implicated in numerous diseases perhaps due to its far-reaching role as
a stem cell regulator. Indeed, its roles in cancer (section 1.7.2), autoimmune and liver
diseases (sections 1.7.1 and 1.7.4, respectively), and diabetes (section 1.7.3) may all be
attributable to malignant adaptation of Dlk1 stem cell function. Well-studied diseases will
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be discussed in detail below. It is less clear what Dlk1 might be doing in other disorders.
It is downregulated in Parkinson’s disease [137] and decreased in the placenta of mothers
with prenatal depression and/or anxiety/obsessive compulsive disorder/panic [141]. It is also
implicated in atherosclerosis [198] and imprinting disorders: Kagami-Ogata [100], Silver
Russell [86], and Temple [88], syndromes. The involvement of DLK1 in such a wide variety
of diseases makes it an excellent therapeutic target. Although, at the time of writing, no
clinical or pre-clinical studies modulating DLK1 as a treatment have been announced, patents
for Dlk1 modulators have been filed [47].
1.7.1 Autoimmune diseases and DLK1
Multiple sclerosis (MS) is an autoimmune disease that ultimate demyelinates and damages the
central nervous system [164]. Although the cause of MS is unknown [163], it is a somewhat
heritable disease [253]. Interestingly experimental autoimmune encephalomyelitis, the
murine model of MS, demonstrated that lower Dlk1 expression enhances disease progression
and severity and modulates adaptive immune reactions [219]. As with liver diseases (section
1.7.4), the role of the gene in disease progression may simply be reflective of its core function
as a stem cell regulator (section 1.4.1). Reductions in DLK1 activity will enhance cellular
differentiation at a given niche. Should this niche be responsible for the production of rogue
immune cells that self recognize, then it is logical that individuals with more active DLK1
levels would be better protected against the condition. This work is exciting as it may explain
the partial heritability of the condition and set the stage for potential therapies. Patients with
paternal Dlk1 variants with lower activity may have more severe disease progression, though
this still needs to be clinically investigated.
1.7.2 DLK1 and cancer
Dlk1 has long been implicated in cancer; indeed it was originally cloned as a tumour
protein [129]. With few exceptions [72, 93, 144], Dlk1 expression has since been found
to be increased in various cancer types including acute myeloid leukemia [190], alveo-
lar rhabdomyosarcomas [197], erthroleukemia [190], ganglioneuroma [101], glioma [257],
hepatoblastoma [32, 59, 73, 143, 145], hepatocellular carcinoma [255], megakaryocytic
leukemia [190], myelodysplastic syndromes [190], nephroblastoma [83], neuroblastoma
[101, 104, 236, 255], neurofibromatosis [93], pancreatic tumours [231], pituitary adenoma
[14, 43], pheochromocytoma [14], small cell lung cancer [93], and testicular adrenal rest
tumours [144].
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Identifying whether a gene implicated in cancer is the driver or a consequence of the
disease is challenging. Increased Dlk1 levels may be a response to the disease phenotype.
Dlk1 is a stem cell regulator, preventing progenitor cells from differentiating and promoting
self-renewal (section 1.4.1). Promotion of self-renewal and differentiation inhibition is,
in general, a cancer hallmark; perhaps Dlk1 is activated early during cancer evolution to
promote stem cell like behaviour. Increased expression of DLK1 resulted in increase in
clonogenic growth in cell lines modelling cancer [117], while knockdown of DLK1 limited
in vivo tumour generation from mice injected with carcinogenic cells [202].
However, our understanding of Dlk1 is incomplete and it is possible that Dlk1 plays
another role. Morpholino mediated knockdown of Dlk1, promoted tumour induced angio-
genesis in xenograph assays in zebrafish [188] . This phenotype of was reversed when the
morpholino was co-injected with human Dlk1 mRNA [188]. This experiment suggests that
Dlk1 may prevent angiogenesis during tumourgenesis. Vascularisation is a limiting factor on
tumour size and is considered a therapeutic target in cancer treatment (reviewed in [12]). In
contrast work on cultured endothelial cells suggests that DLK1 promotes angiogenesis [104].
However, this work was performed with recombinant protein of only the extracellular portion
of DLK1 [104] and the gene may behave differently in normal endothelial cells as opposed
to endothelial cells within a tumour. If Dlk1 does limit angiogenesis perhaps the organism
increases Dlk1 expression to limit tumour growth. DLK1 has an endocrine signalling isoform
and it is plausible for the whole organism to produce S-DLK1 from an alternate source to
regulate tumourgenesis. Indeed some of the early characterisations of DLK1 were performed
on S-DLK1 identified in the serum of cancer patients [93].
This hypothesis does not explain the increased gene expression observed within actual
tumours. However, DLK1 may be playing opposing roles in the different contexts. Dlk1
might be activated during tumourgenesis to enhance stem cell self-renewal whereas whole
organisms could drive S-DLK1 expression to prevent angiogenesis and limit tumour size.
Interestingly, hypoxia is sufficient to increase Dlk1 expression in cancer cells in vitro [117].
Perhaps tumour survival or destruction results from conflict between these two processes.
Functional experiments, investigating the role of DLK1 within a tumour and within a diseased
animal, would be needed to test this hypothesis and probe the role of the gene.
1.7.3 DLK1 and diabetes
Given that Dlk1 is highly expressed in pancreatic-β-cells [5, 33, 110], including those of
embryonic [230, 231] and adult [63], humans, it is fairly unsurprising that it is implicated in
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diabetes mellitus. A recent GWAS found a paternally inherited risk of type 1 diabetes of a
variant in a region known to alter expression of DLK1 [245]. Furthermore, Dlk1 seems to
be repressed in islets of patients with type-2-diabetes [110] and a recent nested population
based case-control study, looking at the incidence of diabetes over a four year period, found
that the disease occurred threefold more frequently in women with low DLK1 levels [135].
A positive correlation between S-DLK1 levels and serum insulin levels was also observed in
231 Spanish children [95]. In addition, selective overexpression of Dlk1 in pancreatic-β-cells,
in mice, leads to increased insulin production, pancreatic-islet hypertrophy and hyperinsu-
linemia in fasting and fed conditions, and Dlk1-/- mice have smaller islets [246]. These
results suggest DLK1 might be a positive regulator of insulin release and high DLK1 levels
may protect against diabetes. However there might be an alternative explanation for the
correlation between Dlk1 and diabetes.
Rather than protecting against diabetes, Dlk1 might be involved in the response of
an organism to the disease. Dlk1 is a stem cell regulator and maintains pluripotency of
progenitor cells. Perhaps Dlk1 expression is increased as a result diabetes and is part of
a response that dedifferentiates ductal or alpha cells into a progenitor like state, whereby
they are subsequently differentiated into beta cells. Exogenous administration of S-DLK1 to
PANC1 cells, a human pancreatic ductal cell line, ultimately resulted in differentiation into
insulin secreting cells [183]. In addition, high levels of DLK1 were seen in the acinar cells
surrounding pancreatic islets, a tissue not previously shown to express DLK1, in wild type
mice [18]. Furthermore, pancreatectomised rats treated with DLK1 show improved pancreas
regeneration compared to rats not receiving treatment [183].
1.7.4 Liver diseases
Non-alcoholic fatty and alcoholic liver disease refer to a broad spectrum of liver diseases with
hepatosteatosis in the absence [228] and presence [234] of 20g/day alcohol consumption,
respectively. Remarkably, Dlk1-overexpressing adult mice, with an obesogenic genetic
background, had reduced hepatosteatosis [35]. This is thought to be due to a reduction in
circulating growth-hormone [35]; as the hormone, in conjunction to others, regulates liver
fatty acid metabolism [156]. This may also be a consequence of the its function as a stem
cell regulator. DLK1 limits differentiation in stem cell niches; thus higher DLK1 levels
may limit differentiation into adipocytes in the liver and, in turn, reduce hepatosteatosis. In
addition, DLK1 also seems to reprogram hepatic lipid metabolism in alcoholic liver disease
[234]. Such findings may have implications for disease susceptibility in humans; for example
individuals with low activity Dlk1 variants may be more likely to develop hepatosteatosis
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and individuals that produce more DLK1 may be protected against the conditions. Although
such a hypothesis will need to be verified with clinical population studies, investigations into
the clinical potential of this have already begun. Exogenous administration of S-DLK1 wad
found to ameliorate hepatic steatosis in mice [136].
1.7.5 The role of DLK1 in obesity
Given that Dlk1 is a stem cell regulator of preadipocytes (section 1.4.1) and plays a role in
whole body metabolism in mammals (section 1.4.3), including driving lipolysis [35], it is
unsurprising that Dlk1 has been implicated in obesity in mice [35, 134, 158, 241] and humans
[252]. Placental Dlk1 levels mildly correlate with birth weight in humans [159] and serum
S-DLK1 levels are significantly lower in pregnant women who go on to deliver offspring
that are small for their gestational age [44]. Mice lacking Dlk1 are obese [158]; whereas
those overexpressing the gene are leaner [35, 134, 241] even if the strain is fed on a high fat
diet [241] or possesses an obesogenic genetic background [35]. Interestingly, Dlk1 levels
are increased in the adipose of rats whose mothers were fed high fat diets 21 days before
mating, throughout pregnancy and during lactation [200]. Such rats have abnormal metabolic
programmes and were heavier than the offspring of mothers fed normal diets [200]. Perhaps
Dlk1 expression is increased in response to the disease to restrain adipogenesis. Further
studies will be needed to probe this hypothesis. However, attempts to modulate DLK1 levels
for clinical treatment of obesity will likely need to increase expression of both isoforms as
exogenous administration of S-DLK1 to mice had no effect on adipose deposits compared to
vehicle treated controls [136].
1.8 DLK2 and disease
Given the paucity of information regarding Dlk2, it is unsurprising that almost nothing is
known about the gene in the context of disease. Only one study has specifically investigated
the involvement of Dlk2 in any disease: when looking at the role of NOTCH ligands in
suicide, Monsalve and colleges found no difference in DLK2 expression in studied brain
regions between normal individuals and victims of suicide [157]. To the author’s knowledge,
no genome wide association studies or other such screens have identified significant misregu-
lation of Dlk2 in any disease context.
The absence of any data concerning Dlk2 and disease might be informative. The im-
portance of Dlk1 in some diseases (section 1.7) such as diabetes (section 1.7.3) and obesity
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(section 1.7.5) was initially identified through unbiased and agnostic GWASs and expression
analyses, such as RNAseq or microarray, between healthy and diseased tissues. Importantly
the involvement of Dlk1 in many of its associated diseases is likely related to its function as
a stem cell regulator (section 1.7). Given that Dlk2 may also, tentatively, function as a stem
cell regulator under certain contexts, such as chondrogenesis (section 1.5), it is surprising
that no disease is associated with the gene. Perhaps Dlk2 contributes weakly to stem cell
regulation and so the effect size is too small to be detected in current projects. Alternatively,
Dlk2 might be an essential gene and alterations to its activity could be lethal. Finally, it
is possible the Dlk1 can act redundantly with Dlk2 in particular contexts and rescue any
phenotypic anomalies associated with Dlk2 mutation. Until a detailed understanding of the
basic function of the gene is achieved, it is difficult to favour either hypothesis.
1.9 Project aims
This research project aimed to characterise DLK2, and compare it to DLK1. Although the
evolutionary relationship between the two genes was assessed across various vertebrates, their
expression and function was studied in mice. Classical expression studies were performed
on both genes and a DLK2 mutant was generated to investigate the function of the gene.

2 Investigating the evolutionary relation-
ship between DLK1 and DLK2
DLK1 and DLK2 are vertebrate specific NOTCH ligands. Preliminary evolutionary analysis
of both genes has only covered a subset of vertebrate species (section 1.2). Investigating the
evolution of both genes across a selection of species covering the entire vertebrate phylum
would yield greater insights into their relationship.
2.1 DLK2 is ancestral to DLK1
Protein and DNA sequences (appendix A.1) for DLK1 and DLK2 were identified in represen-
tative species of all vertebrate clades (table 2.1). Mammalian clades were over-represented
because Dlk1 is an imprinted gene and evolved to imprint during the eutherian lineage [68].
Sequences for DLK1 and DLK2 were found for all investigated species except representatives
of petromyzontiformes, leptocardii, and ascidiacea: lamprey, amphioxus and C. intestinalis,
respectively. Dlk1 is not found in any of these species but a truncated version of Dlk2 is
present in the lamprey genome (data not shown). The Dlk orthologue found in C. intestinalis
is most similar to Dlk2 (see section 2.3) and for subsequent analysis (sections 2.3, 2.4, and
2.5) Dlk2 is considered to be the version present in C. intestinalis.
Phy. class Phy.
order/clade
Representative
species
Common name Genes
present
Mammalia Euarchontoglires Homo sapiens Human Both
Mammalia Euarchontoglires Mus musculus Mouse Both
Mammalia Laurasiatheria Bos taurus Cow Both
Mammalia Laurasiatheria Canis lupus
familiaris
Dog Both
28 Investigating the evolutionary relationship between DLK1 and DLK2
Table 2.1 (continued)
Phy. class Phy.
order/clade
Representative
species
Common name Genes
present
Mammalia Afrotheria Loxodonta africana Elephant Both*
Mammalia Afrotheria Elephantulus
edwadii
Elephant shrew Both+
Mammalia Xenarthra Dasypus
novemcinctus
Nine banded
armadillo
Both+
Mammalia American
marsupialia
Monodelphis
domestica
Opossum Both
Mammalia Australian
marsupialia
Macropus eugenii Tammar wallaby Both+
Mammalia Australian
marsupialia
Sarcophilus harrisii Tasmanian devil Both
Mammalia Monotremes Ornithorhynchus
anatinus
Platypus Both+
Aves Gallus gallus Chicken Both
Reptilia Lepidosauria Anolis carolinesis Anole lizard Both
Reptilia Pantestudines Pelodiscus sinensis Chinese soft shell
turtle
Both
Amphibia Xenopus tropicalis Western clawed
frog
Both+
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Table 2.1 (continued)
Phy. class Phy.
order/clade
Representative
species
Common name Genes
present
Sarcoptery-
gii
Latimeria
chalumnae
Ceolacanth Both
Actinoptery-
gii
Danio rerio Zebrafish Both
Actinoptery-
gii
Oryzias latipes Medaka Both
Chon-
drichthyes
Callorhinchus milii Australian ghost
shark
Both
Hyperoartia& Petromyzon
marinus
Lamprey Truncated
DLK2
Leptocardii& Branchiostoma
floridae
Lancelet/am-
phioxus
Neither
Ascidiacea Ciona intestinalis Ciona DLK2
Table 2.1 Identification of DLK1 and DLK2 gene sequences in representative species of
major vertebrate clades
DLK1 and DLK2 were studied in phylogenetic classes and order/clades of vertebrates
with at least one species investigated per clade. Neither DLK1 nor DLK2 were found in
leptocardii, and only truncated DLK2 was found in the chondrichthyes. Some clades had
more than one species investigated if a gene protein or DNA sequence was of insufficient
quality to use in subsequent analyses. + and * denote species that possessed only sequences
of sufficient quality for DLK1 and DLK2, respectively. & Convention holds that of the
three chordate groups, cephalochordates, which includes leptocardii and thus lancelets, are
closer to vertebrates than ascidiacea or tunicates. This convention is still utilised by many
databases, such as UCSC genomes [113]. However, recent phylogenomic data suggests that
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tunicates, including ascidiacea, may be more closely related to vertebrates [58]. This will
have implications on interpreting these results. Acronyms used: Phy. — phylogenetic.
Dlk2 is present in two representative species of the three earliest clades (petromyzontif-
ormes, leptocardii, and ascidiacea), including what is conventionally considered the most
ancestral clade: ascidiacea. Although unlikely Dlk2, could have been lost in the amphioxus
genome but the poor quality annotation and high number of gaps in that reference genome
means that it is much more likely that Dlk2 is present ascidiacea but is not represented in the
available sequence.
The poor quality of the genomes also raises the possibility that Dlk1 is present but unde-
tectable in lamprey, amphioxus and C. intestinalis. However, early vertebrate whole genome
duplications occurred between the divergence of amphioxus and lamprey, and lamprey and
the early tetrapod (fish) lineages [56]. It is most likely that duplication of a Dlk precursor
gene to generate Dlk1 and Dlk2 occurred during a whole genome duplication event and thus
the orthologue present in ascidiacea (of Dlk2) is the ancestral version of the gene. Overall,
this suggests that Dlk2 is ancestral and that Dlk1 arose from a subsequent genome duplication
event.
The absence of a Dlk1 sequence from the petromyzontiformes clade (lamprey) could
be due to a poor-quality reference genome. However, it may also be reflective of actual
biology. If this is the case, then duplication of Dlk1 from Dlk2 likely occurred during the
whole genome duplication event occurring between the petromyzontiformes and tetrapod
clades [56].
There is an alternative interpretation. Historically, the overall scientific consensus has
been that the ascidiacea is phylogenitically older than the leptocardii clade. This conclusion
was drawn primarily because of morphological similarities (and differences) at the adult
stage of representative organisms from the ascidiacea and leptocardii clades, and early true
vertebrates, such as lamprey. Many organisations and databases, such as UCSC genomes
[113], still adhere to this. However, a recent phylogenomic study of 28 species, including
four types of tunicate (and including C. intestinalis), eight vertebrates, and one species of
lancelet, has concluded that lancelets are older than ascidiacea. If this were the case, it
provide a far stronger argument that Dlk2 is the more ancient gene. No Dlk2 sequence is
present in the lancelet genome however Dlk2 sequences are present in the genomes of C.
intestinalis and lamphrey. In this scenario, Dlk2 would have arisen between a duplication
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event occurring between the leptocardii and ascidiea lineages. Dlk1 would still have likely
arisen during the whole genome duplication event occurring between the petromyzontiformes
and tetrapod clades [56]. Nevertheless, whether leptocardii or ascidicea is the most ancient
clade, it is clear that Dlk2 is the most ancient gene.
It is also worth noting that single copies of Dlk1 and Dlk2 are present in coelacanths
and all ray-finned fish studied (including zebrafish, medaka, stickleback, and the tatraodon
and fugu genuses of pufferfish — data not shown). A further fish-specific round of genome
duplication occurred after they diverged from the common ancestor shared with coelacanths
[56]. This means both Dlk1 and Dlk2 were duplicated again in fish but the second copies were
rapidly lost. This suggests that dosage of both genes is highly important to their functions.
2.2 DLK1 and DLK2 are highly conserved genes
Percentage similarity (figure 2.2) and identity (figure 2.1) were calculated across all species
for both DLK1 and DLK2 (section 8.6.3). The closer two species are in evolution, the
higher the percentage identity and similarity between their protein sequences; and percentage
similarity is always higher then percentage identity.
In general, the percentage similarity or identity between two species is higher for DLK2
than DLK1. This provides further support that DLK2 is the ancestral form of the gene and
suggests that DLK1 may be undergoing further evolution. This would not be surprising
given the number of functions for the gene that are hypothesised to be mammalian specific
(section 1.4.3). Notably, DLK1 in zebrafish (figure 2.1) shares a particularly low percentage
identity with other species; indeed it never rises above 33%. Zebrafish DLK1 lacks the
juxtamembrane cleavage domain (section 2.3) suggesting that it may be more evolutionary
dynamic. The poor conservation between species could be reflective of this.
The percentage similarities and identities of the C. intestinalis DLK orthologue were
determined against all species for DLK1 and DLK2. The percentage similarities are higher
between DLK2 and the C. intestinalis DLK orthologue across all species. This is consis-
tent with what one might expect, given the identity of the DLK genes present in ancient
vertebrates relative to known whole genome duplication events (section 2.1). The higher
conservation of the C. intestinalis DLK orthologue to DLK2 lends support to the hypothesis
that DLK2 is the ancestral gene variant. It also suggests that it is appropriate to call the
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Fig. 2.1 Percentage identities of DLK1 and DLK2 shared between various vertebrate
species
Protein sequences, obtained as described in section 8.6.5, were aligned using ClustalO
(V1.2.4) [132] (section 8.6.1). Percentage identity of the sequences between species were
obtained using ’Ident & Sim’ tool in the sequence manipulation suite [218] using default
settings. Hs – human, Mm – mouse, Bt – cow, Cf – dog, Ee – elephant shrew, La — elephant,
Dn – nine banded armadillo, Md – opossum, Me – tammar wallaby, Sh – Tasmanian devil,
Oa – platypus, Gg – chicken, Ac – anole lizard, Ps – Chinese soft shell turtle, Xt – western
clawed frog, Lc – coelacanth, Dr – zebrafish, Ol – medaka, Cm – Australian ghost shark,
and Ci — C. intestinalis.
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Fig. 2.2 Percentage similarities of DLK1 and DLK2 shared between various vertebrate
species
Protein sequences, obtained as described in section 8.6.5, were aligned using ClustalO
(V1.2.4) [132] (section 8.6.1). Percentage similarity of the sequences between species were
obtained using ’Ident & Sim’ tool in the sequence manipulation suite [218] using default
settings. Hs – human, Mm – mouse, Bt – cow, Cf – dog, Ee – elephant shrew, La — elephant,
Dn – nine banded armadillo, Md – opossum, Me – tammar wallaby, Sh – Tasmanian devil,
Oa – platypus, Gg – chicken, Ac – anole lizard, Ps – Chinese soft shell turtle, Xt – western
clawed frog, Lc – coelacanth, Dr – zebrafish, Ol – medaka, Cm – Australian ghost shark,
and Ci — C. intestinalis.
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orthologue present in C. intestinalis DLK2.
2.3 Key functional domains are conserved in most verte-
brates for DLK1 and DLK2
Although assessing the conservation of a given protein across various species is useful at
the gross whole protein level, it yields little insight into the conservation of the functional
domains of the protein. Investigating the conservation of specific protein regions is useful
as it can create awareness about which domains are essential or dispensable for gene function.
Good quality protein sequences for DLK1 (figure 2.3) and DLK2 (figure 2.4), found
in the species studied in section 2.1, were aligned (section 8.6.1). Key protein domains
were annotated using Interpro (section 8.6.1). Each protein sequence was independently
annotated; no region was found using homology. This approach ensures that the striking
domain conservation was determined in an unbiased fashion.
The annotated alignments suggest that DLK1 and DLK2 are highly conserved across
vertebrates. DLK2 domains are generally much better conserved than DLK1 domains, but
this is expected given that it is more strongly conserved (section 2.2), and is likely to be the
ancestral version of the gene (section 2.1). However, this strong consensus makes it challeng-
ing to infer if any of the 6 EGF repeats are vital for DLK2 function. One interpretation is that
all of them are extremely important for DLK2 function. DLK1 EGFs are less well conserved.
The majority of species possess 6 EGF repeats in DLK1, except zebrafish and platypus
which both lack EGF 6. This suggests that EGF 6 is not essential for gene function. It is
much more likely that EGFs 2 or 3 that are functionally relevant in gene signalling as they
are perfectly conserved across all vertebrates. This is inconsistent with a recent study that
concluded that EGFs 5 and 6, of DLK1, interact with NOTCH [232]; however this work was
conducted using a mammalian yeast-2-hyrid system and so may not be reflective of the in
vivo context.
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Fig. 2.3 Alignments of DLK1 protein sequences across various vertebrates
Orange — EGF1, Red — EGF2, Pink — EGF3, Green — EGF4, Turquoise — EGF5,
Yellow— EGF6, Aubergine — juxtamembrane domain, and Blue — transmembrane domain.
Sequences obtained as described in section 8.6.5 were aligned using ClustalO (V1.2.4) [132]
and annotated as described in section 8.6.1. Identified regions were then manually highlighted
in the alignment at correct coordinates. Hs – human, Mm – mouse, Bt – cow, Cf – dog, Ee
– elephant shrew, Dn – nine banded armadillo, Md – opossum, Me – tammar wallaby, Sh
– Tasmanian devil, Oa – platypus, Gg – chicken, Ac – anole lizard, Ps – Chinese soft shell
turtle, Xt – western clawed frog, Lc – coelacanth, Dr – zebrafish, Ol – medaka, and Cm –
Australian ghost shark. Larger views of the same annotations are located in the appendix
A.1.5.
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Fig. 2.4 Alignments of DLK2 protein sequences across various vertebrates
Orange — EGF1, Red — EGF2, Pink — EGF3, Green — EGF4, Turquoise — EGF5,
Yellow— EGF6, Aubergine — juxtamembrane domain, and Blue — transmembrane domain.
Sequences obtained as described in section 8.6.5 were aligned using ClustalO (V1.2.4) [132]
and annotated as described in section 8.6.1. Hs — human, Mm — mouse, Bt – cow, Cf – dog,
La – elephant, Md – opossum, Sh – Tasmanian devil, Gg – chicken, Ac – anole lizard, Ps
– Chinese soft shell turtle, Dr – zebrafish, Ol – Medaka, Lc – coelacanth, Cm – Australian
ghost shark, and Ci – ciona. Larger views of the same annotations are located in the appendix
A.1.6.
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2.3.1 The juxtamembrane domain may be less evolutionarily dynamic
than expected
The assessment of domains across various vertebrates for DLK1 and DLK2, may confirm
earlier findings that zebrafish lack the juxtamembrane cleavage domain in DLK1 (pers.
comm. Dr. Carol Edwards). No true vertebrate that has been investigated has been found
to lack the cleavage domain in DLK2, perhaps reflective of the its stronger conservation.
The conventional interpretation of the lack of an obvious cleavage domain in only zebrafish
DLK1 is that this particular gene is highly divergent; this hypothesis is generally supported
with various measures of its gene conservation (sections 2.2, 2.4, 2.5) where zebrafish DLK1
is generally the most poorly conserved gene. However, there may be another interpretation.
Nonetheless, because of the absence of the juxtamembrane cleavage domain, zebrafish is a
good model to investigate isoform specific gene function.
Motif recognition of the TACE enzyme, which cleaves at the juxtamembrane site, is
poorly understood and sites are generally identified experimentally rather than through
sequence identification based approaches [31]. Perhaps the sequence coding for the jux-
tamembrane domain has altered sufficiently to possess amino acids that are difficult to align
bioinformatically but are still recognised by the TACE enzyme. There may be some circum-
stantial evidence to support this hypothesis. Delta, from which the DLK gene ultimately
evolved, does possess an extracellular cleavage domain targeted by the same TACE enzyme
[258]; but C. intestinalis does not possess a convincing cleavage domain sequence. However
the canonical NOTCH ligand Delta like 1 (Dll1), which also arose from duplication of Delta
(figure 1.2), possesses a juxtamembrane domain that is cleaved by ADAM10, a protein in
the same family as the TACE enzyme [210]. These data might suggest that the juxtamem-
brane domain region may have been subject to some dynamic evolution during the genome
duplications and was lost during the duplication of Delta to the C. intestinalis Dlk2. It may
have then subsequently been regained in later vertebrates and the domain then again lost
in Dlk1 throughout the speciation of zebrafish. Alternatively, primitive C. intestinalis may
have retained the cleavage domain but then lost it after the separation of other evolutionary
clades, with the domain also being lost in zebrafish Dlk1. A final explanation is that both C.
intestinalis Dlk2 and zebrafish Dlk1 possess experimentally unvalidated cleavage domains
that are recognisable by the TACE enzyme or ADAM10 but that are sufficiently different to
be missed in bioinformatics analysis.
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2.3.2 The intracellular portions of DLK1 andDLK2 are well conserved
Another interesting observation in the annotated alignments is the high conservation of
the intracellular portions of both proteins. DLK1, in particular, possesses residues that are
identical across all species. There is also very high conservation in this region within DLK2,
however the expanded intracellular domain in C. intestinalis somewhat obscures this in
the alignments. Conservation in this region could be vestigial, or it may reflect hitherto
unconsidered residues that are important for DLK gene function. The conserved residues
and/or regions may be important for intracellular protein-protein interactions. Proteins are
known to associate with the internal domain of Delta and are thought to play functionally
important roles [131]. The intracellular domains have been largely ignored because they are
so short (pers. comm. Dr. Ben Shaw), but perhaps it would be worth considering them in
future investigations into gene signalling.
2.4 DLK1 is more evolutionarily dynamic than DLK2
A maximum likelihood tree (figure 2.5) assessed the phylogenetic relationship between both
DLK1 and DLK2 across the same vertebrate species. The branch lengths of the tree represent
evolutionary distance – the longer the branches the further the two sequences have diverged.
The natural grouping of DLK1 and DLK2 sequences is expected.
The phylogenetic tree provides insights that further support the hypothesis that DLK2
is ancestral to DLK1. The branch lengths of DLK2 between the different species are dra-
matically shorter than the DLK1 branch lengths. This suggests that DLK2 is more tightly
conserved between species. The branching pattern is broadly consistent with the evolutionary
history of the species. Notably, species from afrotheria and laurasiatheria cluster together on
the same node. This is perhaps further evidence of just how highly conserved DLK2 is.
The phylogenetic analysis also provides evidence that DLK1 is more evolutionarily
dynamic than DLK2. The branch lengths are much longer, especially within the mammalian
clade. It is somewhat surprising that DLK1 has longer branch lengths within the mammalian
clade given that DLK1 evolved imprinting within eutherian mammals [68]. Representative
species of monotremes and marsupialia cluster together separately from the eutherian mam-
mals. Within the eutherian node, xenarthra, afrotheria, laurasiatheria, and euarchotoglires
form distinct subnodes. The branch lengths between these nodes are perhaps unexpectedly
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Fig. 2.5 Evolutionary tree of DLK1 and DLK2 across various vertebrates
Maximum likelihood tree drawn from ClustalO (V1.2.4) alignments (section 8.6.1) of DLK1
and DLK2 by Dr. Carol Edwards. The tree was drawn using PhyML [90] as described in
section 8.6.4. Hs – human, Mm – mouse, Bt – cow, Cf – dog, La – elephant, Ee – elephant
shrew, Dn – nine banded armadillo, Md – opossum, Me – tammar wallaby, Sh – Tasmanian
devil, Oa – platypus, Gg – chicken, Ac – anole lizard, Ps – Chinese soft shell turtle, Xt –
western clawed frog, Lc – coelacanth, Dr – zebrafish, Ol – medaka, Cm – Australian ghost
shark, and Ci – C. intestinalis.
long given how short they are for DLK2. This could be reflective solely of the evolution of
imprinting. However, it might also reflect the novel functions that are evolving perhaps as a
consequence of dosage control by genomic imprinting (as discussed in section 1.4).
Although the evolution of imprinting is the strongest candidate to explain the dynamic
phylogenetic behaviour of DLK1, it cannot be the only one. Zebrafish DLK1 is a clear
phylogenetic out-group. This is perhaps unsurprising given that it probably lacks a cleavage
domain (section 2.3) and shares low percentage identities and similarities with other species
(figures 2.1 and 2.2). DLK1 is not imprinted in zebrafish and so the pressures driving its
diversification must be imprinting independent. Furthermore, branch lengths between other
vertebrate clades are much longer for DLK1 than DLK2, suggesting that DLK1 is generally
more evolutionarily dynamic across all species than DLK2.
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Fig. 2.6 Ka/Ks values for DLK1 across various vertebrates
The Ka/Ks values of DLK1 were calculated, by Dr. Carol Edwards, as described in section
8.6.2. The redder the Ka/Ks value the greater the purifying evolutionary selection. Colour
scale is the same as in figure 2.7. Hs – human, Mm – mouse, Bt – cow, Cf – dog, Ee – elephant
shrew, Dn – nine banded armadillo, Md – opossum, Me – tammar wallaby, Sh – Tasmanian
devil, Oa – platypus, Gg – chicken, Ac – anole lizard, Ps – Chinese soft shell turtle, Xt –
western clawed frog, Lc – coelacanth, Dr – zebrafish, Ol – medaka, and Cm – Australian
ghost shark.
2.5 Both DLK1 and DLK2 are under purifying evolution-
ary selection
Calculating the Ka/Ks values of a given gene between various species is another effective way
to determine its evolutionary status [244]. Ka/Ks values less than one, between two given
species, indicate that a gene is under purifying evolutionary selection: more non-synonymous
mutations were eliminated compared to silent mutations, indicating that some amino-acid
changes had deleterious effects [244]. Genes with Ka/Ks values greater than one have change
selected for and are considered to be under positive evolutionary selection [244].
Ka/Ks values were calculated (section 8.6.2) for DLK1 and DLK2 across the suitable
vertebrate species identified in section 2.1. The Ka/Ks values are less than one for DLK1
(figure 2.6) and DLK2 (figure 2.7) between all studied species, suggesting that both genes
are under purifying evolutionary selection. This is consistent with genome-wide studies
investigating the evolution of duplicated genes and shows that duplicated genes are generally
under purifying evolutionary selection [121, 147, 235].
The Ka/Ks values support the findings of all the other evolutionary analyses (sections
2.1, 2.3, and 2.4). The Ka/Ks values are more consistent for DLK2 than DLK1, supporting
the phylogenetic analysis that indicates that DLK2 is better conserved between species and
probably the ancestral form of the gene. DLK1 is likely under more dynamic evolution,
reflective of becoming imprinted (section 1.2.1) and developing some neofunctionalism (sec-
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Fig. 2.7 Ka/Ks values for DLK2 across various vertebrates
The Ka/Ks values of DLK2 were calculated, by Dr. Carol Edwards, as described in section
8.6.2. The redder the Ka/Ks value the greater the purifying evolutionary selection. Colour
scale is the same as in figure 2.6. Hs – human, Mm – mouse, Bt – cow, Cf – dog, La – elephant,
Md – opossum, Sh – Tasmanian devil, Gg – chicken, Ac – anole lizard, Ps – Chinese soft
shell turtle, Dr – zebrafish, Ol – Medaka, Lc – coelacanth, Cm – Australian ghost shark, and
Ci – ciona.
tion 1.4). Zebrafish DLK1 perhaps epitomises this evolutionary dynamism. It is interesting
that this on-going evolution for DLK1, for which there seems to be substantial evidence, is
constrained within the parameters of purifying evolutionary selection. This is likely due to
the its function as a stem cell regulator (section 1.4.1), which may indicate just how important
the role DLK1 plays in stem cell regulation is.

3 Qualitative analysis of Dlk1 and Dlk2
embryonic expression
The comparative analysis of the expression ofDlk1 andDlk2 not only provides an opportunity
to consider their relative roles in development but also could provide insight into possible
functional redundancy between the two proteins. Expression of Dlk1 and Dlk2 was compared
by in situ hybridisation (ISH). Relative expression patterns for the two genes could already
be inferred by examining RNA-seq databases, such as ENCODE [48] and FANTOM5 [142].
However, as discussed in section 1.3, these databases are fairly noisy for Dlk1 and Dlk2
expression and as such provided little insight into the true sites of expression for each gene.
Furthermore, they lack cellular resolution. ISHs can thus be a better way of investigating
gene expression. High through put ISH databases, such as Eurexpress [61] and the Allen
Brain Atlas [221], do exist but their findings are inconsistent, particularly for Dlk2. The
unreliability of the high throughput approaches for determining Dlk2 expression, suggests a
need for robust independent experimental analysis of Dlk2 expression both temporally and
spatially.
ISH expression data for Dlk1 is much more reliable, predominantly because independent
gene-focused experimental analysis has been performed by more than one group, including
ours [256, 52]. However, these datasets do not cover the entirety of embryogenesis. Further-
more, when comparing the expression of two genes, it is best to perform ISHs on adjacent
sections of the same biological samples. Thus ISH of both Dlk1 and Dlk2 were performed.
The original experimental plan was to investigate gene expression throughout embryoge-
nesis in two day intervals — e.g. embryonic day 18.5 (e18.5), e16.5, e14.5, e12.5, and so on.
However, I was unable to dissect embryos with sufficient integrity for histological analysis
below e12.5. Thus only e12.5, e14.5, e16.5, and e18.5 time-points were investigated. This
covers a large part of embryogenesis and includes the development of many organs. The
Dlk1 riboprobe plasmid described by da Rocha et al. [52] had already been generated in the
lab, whereas a Dlk2 riboprobe (section 3.1) was generated by myself.
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Fig. 3.1 Genomic location of in situ hybridisation probe designed for Dlk2
Screen-shot from UCSC [113].
3.1 Generation of Dlk2 in situ hybridisation probe
The ISH probe for Dlk2 was designed to span the final exon of Dlk2 (figure 3.1). Primer3
[124] was used to find good quality primers (section 8.2.3) within exon 6; this was chosen
because a full length transcript is the most likely candidate for functional protein generation.
Importantly, the Dlk2 probe spans the region including the cleavage domain. It is unlikely
that any isoforms splicing out the cleavage domain (as yet unverified) would be detected with
this probe. The Dlk1 probe used covers the full length mRNA [52], and has the same problem
in that shorter isoforms lacking the cleavage domain are unlikely to be detected. However, a
study using ISH probes designed to distinguish between the different Dlk1 isoforms found
that all isoforms are co-expressed at e8.5 and e10.5 [151]. Without experimental validation,
this trend cannot be assumed to occur throughout the entirety of embryogenesis for Dlk1,
and certainly not for Dlk2. However, the limitation regarding isoform detection is consistent
between both probes.
3.2 In situ hybridisations ofDlk1 andDlk2 during embryo-
genesis
ISH of Dlk1 and Dlk2 were performed (section 8.5.2) using previously described [52] and
novel (section 3.1) riboprobes. The experiments were conducted on paraffin wax sections of
whole embryos and placentae (figure 3.2) harvested at embryonic days 12.5, 14.5, 16.5, and
18.5 (e12.5, e14.5, e16.5, and e18.5, respectively). Sense controls are shown in the Appendix
A.2.
Overall, the sagittal sections used provide good representation of the majority of the
growing organ primordia and established tissues present at the given developmental stage.
However, some tissues are missing from some sections, such as the adrenal gland and pan-
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Fig. 3.2 In situ hybridizations of Dlk1 and Dlk2 in developing murine wild-type em-
bryos and placentae
Staining performed at embryonic day 18.5 (e18.5), e16.5, e14.5 and e12.5. Sense controls
shown in the Appendix A.2. N = 2, 3, 1, 2 for Dlk1 in situ hybridizations at e12.5, e14.5,
e16.5 and e18.5, respectively, for embryos and placentae. N=3, 4, 1, 3 for Dlk2 in situ
hybridizations at e12.5, e14.5, e16.5 and e18.5, respectively, for embryos. The same number
of biological replicates was used for Dlk2 in situ hybridizations on placentae except at e14.5
where only 2 biological replicates had successful sense and antisense staining.
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Fig. 3.3 Summary of Dlk1 and Dlk2 expression in embryonic development
Expression patterns were observed in the in situ hybridisations conducted on wild-type
embryos at various embryonic stages (figure 3.2). Cell types were identified using the
Kaufman Mouse Atlas [111]. N/A – tissue/organ is not yet present or has been lost. N/V
– structure not visible in all sections at embryonic stage. Acronyms used: ant. – anterior,
exp. – expression, MF. – myofibers, MR. – multiple regions, PLVB. – primordium of lumbar
vertebral body, post. – posterior, R. – right, tg. – tongue.
creas at e12.5. Staining was only performed in the regions displayed in figure 3.2. Although
investigating expression of both genes throughout entire embryos would be ideal, the ven-
tral sagittal sections used are sufficient to investigate the relationship betweenDlk1 andDlk2.
3.3 Dlk1 and Dlk2 have distinct but overlapping expres-
sion during embryogenesis
The ISHs show that Dlk1 and Dlk2 are expressed in all germ layers and have distinct ex-
pression patterns with some overlap in developing murine embryos and placentae (figure
3.3). As Dlk2 expression is increasingly restricted to the brain throughout embryogenesis
(figure 3.2), a more detailed analysis of Dlk2 and Dlk1 expression throughout development
was conducted on the brain alone (figure 3.4).
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Fig. 3.4 Summary of Dlk1 and Dlk2 expression in embryonic murine brains
Expression patterns were observed in the in situ hybridisations conducted on wild-type
embryos at various embryonic stages (figure 3.2). Rathke’s pouch develops into the anterior
pituitary. The infundibulum develops into the pars nervosa. Brain regions were identified
using the Kaufman Mouse Atlas [111]. N/A – structure has not formed yet. N/V – structure
not visible in all sections at embryonic stage. Acronyms used: ant. – anterior, dev. – develops,
diff. – differentiation, exp. – expression, jxn. – junction, post. – posterior, R. pch. – Rathke’s
pouch.
Dlk1 and Dlk2 are co-expressed in the choroid plexus, diencephalon, medulla oblongata,
mid-brain, neopallial cortex, and pituitary (figure 3.4) at e12.5. As the embryo ages Dlk1
expression is increasingly reduced in the brain, and expression of both genes is lost between
e16.5 and e18.5. As Dlk2 is likely the ancestral gene (section 2.1), it is most likely that the
functions Dlk1 carries out in the areas of co-expression are its more ancient ones. Dlk1 and
Dlk2 are also co-expressed at e12.5, in liver hepatoblasts, lung endothelial cells, intestinal
epithelia, and the somites and the heart.
Their roles in areas of overlapping expression are likely to be ancient. Given the evidence
that stem cell regulation is the ancestral function of Dlk1 (section 1.4.1), it is likely that they
are regulating cellular differentiation in these regions. Furthermore, unpublished work in
zebrafish suggests that Dlk2 limits differentiation of stem cells in a manner similar to Dlk1
during embryonic neurogenesis (pers. comm. Dr. Ben Shaw). Thus it is a fair hypothesis
that both genes are regulating stem cells in these tissues at given time points. However, more
interesting questions arise from this conclusion: for example, why does expression of these
genes overlap in the first place, and why is their co-expression lost?
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The evolution of imprinting may answer these questions. Dosage is thought to be highly
important for the functions of these genes. Not only do experimental alterations of dosage in
mice have extreme phenotypic consequences [45, 51], but all fish studied have only one copy
of each gene despite whole genome duplication events (section 2.1); the extra copies appear
to have been actively lost. Dlk2 is biallelically expressed and, although its dosage cannot
be altered in the same way as Dlk1 can be since it is not imprinted [78], its expression is
perhaps more robust. In scenarios where regulation of stem cell differentiation is potentially
more important, such as in brain development, Dlk2 expression would perhaps have been
more likely selected for. The early Dlk1 expression could be reflective of redundancy. This
hypothesis could only really be tested with ISH of Dlk1 on Dlk2-/- mice at the same stages
in the brain.
The restriction of Dlk1 to the other developing tissues could be consistent with this
hypothesis. Biallelic, but not monoallelic, expression of Dlk1 was sufficient to regulate
postnatal neurogenesis [78], and so it is possible that biallelic Dlk1 dosage is necessary for
stem cell regulation in other tissues – if that is indeed its function in the described developing
tissues. However, Dlk1 is imprinted and although there is some preliminary evidence that
suggests that Dlk1 imprinting is lost in some progenitor cells in the later stages of developing
intestines [217], this observation has not been replicated across other developing tissues.
Most studies look at the imprinting status of bulk tissues [21, 155, 174, 220], of which pro-
genitor cells form a tiny portion, and so subtle cellular specific loss of imprinting may have
been missed. If Dlk1 does gain biallelic expression in stem cell niches during development,
then it is reasonable for Dlk2 expression to have been lost from the sites of co-expression.
Nuanced study of Dlk1 imprinting status at the cellular level in developing, and indeed
postnatal, tissues would help resolve this hypothesis. The findings of this work would also
give further crucial insight into whether stem cell regulation is truly the ancestral function of
Dlk1. If Dlk1 is biallelicly expressed in most non-neural stem cells it is likely that stem cell
regulation is the ancestral function. However, if Dlk1 is not then this suggests that there is a
more recently evolved stem cell role for the imprinted Dlk1 in mammals.
The default state for Dlk1, if expressed, is to be imprinted; this state was established in
the germ-line [187]. It could take developmental time for Dlk1 to gain biallelic expression.
Dlk2might retain early expression patterns in these tissues to ensure that correct DLK dosage
is present. It would provide mirror image redundancy to the hypothesis outlined above for
the roles of Dlk1 and Dlk2 in the brain. As before, Dlk2 expression is lost at later stages
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of development in wild-type embryos. The redundancy hypothesis can only be properly
explored with expression analysis of Dlk2 in Dlk1-/- embryos.
Dlk1 is also exclusively expressed in some tissues: the adrenal glands, the pancreas,
and the thymus (figure 3.3). These are also endocrine tissues. Metabolic functions are
hypothesised as being eutherian specific (section 1.4.3). Imprinting is known to be eutherian
specific [68]. Perhaps expression in these tissues co-evolved with imprinting? There is
no ideal functional experiment to test this hypothesis, but its validity could be inferred by
looking at Dlk1 (and Dlk2) expression patterns in other vertebrates.
In conclusion, the distinct, but overlapping, expression patterns of Dlk1 and Dlk2 through-
out murine development are likely reflective of functions of the genes. The roles the genes
play in tissues with overlapping expression are more likely to be ancient ones. Dlk2 seems to
be more dominantly expressed in the developing brain. Its biallelic expression may provide a
more robust initiator of DLK gene signalling. Whereas imprinted expression of Dlk1 in this
tissue arises for redundancy and, perhaps, to fine tune the DLK gene activity levels. However,
it is also possible that the Dlk1 expression observed in the developing brain is biallelic in the
stem cell niches, which would alter the interpretation of this data. Further analysis of Dlk1
imprinting at the single cell level in these developing tissues will be necessary to probe these
hypotheses.
Analysis of Dlk1 and Dlk2 expression patterns in other vertebrates would give insights
into all the hypotheses that this ISH data generates. If expression of Dlk1 in endocrine organs
is restricted to eutherian mammalians, then its most likely that this expression co-evolved
with imprinting. If Dlk1 is expressed throughout vertebrates in these tissues perhaps the
function is more ancestral and related to the regulation of stem cells. Seeing where Dlk1 and
Dlk2 expression overlaps, and (or, if it) is lost during development of non-mammalian species,
would also be interesting. This would give insights into whether the proposed redundancy
is related to imprinting. Should the pattern of expression observed in mice be consistent
throughout vertebrates, then perhaps Dlk1 and Dlk2, sharing an ancient stem cell regulatory
function, have specialised into different tissues.

4 Quantitative analysis ofDlk1 andDlk2
expression
ISH of Dlk1 and Dlk2 is useful as it allows assessment of expression patterns with cellular
resolution. However, this approach is not quantitative and so gives little insight into which
gene is expressed predominantly in a given region of co-expression. Quantitative real-time
PCR (qPCR) is perhaps the gold standard test of gene expression. Assessing Dlk1 and Dlk2
expression using qPCR would thus generate useful insights into their relative expression
levels.
Dr. Lisa Hulsman and Billy Watkinson generated a large tissue panel for qPCR analysis
for a different project in our group. They kindly gifted me aliquots of excess samples to test
for DLK gene expression. These samples were derived from wild-type hybrid reciprocal
hybrid mice allowing quantification of imprinting and assessment of strain effects. However
my study focused on the relative quantification of the two genes. For each sample, three
biological replicates were taken from C57BL/6J X CAST/EiJ crosses, and three from the
reciprocal crosses. For the purposes for my analysis, I assumed that there was no strain
effect on either Dlk1 or Dlk2 expression and the samples were treated equally, regardless
of cross origin. Reassuringly, Billy Watkinson observed no strain effect for Dlk1 when he
performed pyrosequencing based analysis (of Dlk1) on the same panel. He did not perform
pyrosequencing on Dlk2.
The dataset consists of various tissues at three different developmental time points: e16.5,
postnatal day 7 (p7), and p60. There was an overrepresentation of different brain regions in
the postnatal stages. This is highly advantageous given that Dlk2 is highly expressed in the
embryonic brain. Although Dlk1 expression is lost at e18.5, mRNA expression returns in the
early postnatal period [78]. It would not be surprising therefore, to detect Dlk2 expression in
postnatal tissues. Another advantage of the panel is that there is overlap between the selected
e16.5 tissues and the ISH panel. This should allow for validation of the e16.5 embryonic
ISH data.
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Primers were designed to target late exons in Dlk2 and Dlk1. Although these regions
possess single nucleotide polymorphisms (SNPs) between the C57BL/6J and CAST/EiJ
genomes, they were largely ignored for the qPCR experiment, as the primers were desired
to target regions of homology between the two genomes. However, the PCR products were
chosen so that they included at least one SNP. This would enable the same samples to be
assessed by pyrosequencing after qPCR. Pyrosequencing is used to assess the imprinting
status of a gene. Although no imprinted gene screen has ever detected Dlk2 [21, 155, 174,
220], many of the screens do not sufficiently validate and independent validation attempts
suggest a high false positive rate. Confirmation of the imprinting status of Dlk2 by a targeted
experimental approach would thus be valuable. Although such an experiment was attempted
during this project, it failed due to technical reasons.
4.1 TBP was selected as the control
To ensure that differences in expression between two genes or tissues are genuine, qPCR data
are normally normalised to a housekeeping gene [118]. Theoretically housekeeping genes
are vital for cell function and are thus expressed at constant levels between tissues [118].
By normalising target genes to housekeeper genes technical variability between samples,
introduced for example through unequal efficiencies in RNA extraction or cDNA synthesis,is
theoretically accounted for [118]. Housekeeper gene expression profiles have been published
in response to this [126].
Some consider housekeeping gene normalisation to be an over-simplification of the
underlying biology: there may be tissue specific variances in housekeeping gene expression
and with housekeeping gene normalisation noise is unintentionally introduced [237]. New
approaches normalising to the geometric mean of several housekeeper genes have thus been
proposed [237]. However, members of our group have observed that geometric mean normal-
isation also introduces noise and may obscure subtle differences in relative gene expression.
It is therefore best to test the expression of several candidate housekeeping genes for each
experiment. TATA binding protein (Tbp), 18s ribosomal RNA (18s), and Actin were chosen
as candidate housekeeping genes based on colleague advice. In the group, Tbp displayed the
most consistent expression between the tissues of all three genes (figure 4.1). Furthermore,
it had the lowest expression. Normalising against highly expressed genes can sometimes
obscure differences in relative expression of lowly expressed genes, and Dlk1 and Dlk2 are
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Fig. 4.1 Expression levels of candidate housekeeper control genes in tissues investigated
in sections 4.2, 4.3, and 4.4
Expression (40-ct) of Tata binding protein (Tbp), 18s ribosomal RNA (18s), and Actin. ct
values are the raw read out of relative gene expression from the qPCR machine and were
processed as described in section 8.3.13. Expression tested on e16.5 brain, liver, and placenta;
p7 and p60 brainstem, cerrebellum, cortex, hippocampus, and hypothalamus; and p7 liver,
and muscle.
expected to be expressed in the low to intermediate range. Tbp was thus selected as the
housekeeper gene for qPCR normalisation.
4.2 Dlk2 is expressed more than Dlk1 in e16.5 brain
qPCR investigated Dlk1 and Dlk2 gene expression in e16.5 brain, liver and placenta. Expres-
sion of both genes was detected in all tissues (figure 4.2). Expression of both genes was also
detected in the brain and placenta of e16.5 embryos using ISH (section 3.3). This suggests
that the ISHs are accurate. However, no expression of either gene was observed in e16.5
livers by ISH.
There are several explanations for this discrepancy: there was a false detection in the
qPCR, or, more likely the qPCR is more sensitive than the ISH. This emphasises the value of
taking both approaches when conducting expression analyses. Other hypotheses explaining
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the lack of consistency between the ISHs and qPCR in e16.5 livers are biological in nature.
The ISH were performed on C57BL/6J embryos whereas the qPCR was performed on
samples derived from C57BL/6J X CAST/EiJ hybrids. Perhaps gene expression in the liver is
influenced by genetic background. However, this is unlikely given that the range of Dlk1 and
Dlk2 expression in the e16.5 livers is broadly consistent between C57BL/6J X CAST/EiJ and
CAST/EiJ X C57BL/6J derived samples. This similarity of Dlk1 and Dlk2 expression ranges
between the reciprocal crosses is also consistent across all tissues. Nevertheless, exploring
the data from the genetic background perspective reduces the sample size for each condition
and more subtle trends could emerge were this number of animals studied increased.
The unlikelihood that genetic background accounts for the presence of Dlk1 and Dlk2 is
detected in e16.5 livers by qPCR but not ISH, means that something else may be occuring.
Notably both Dlk1 and Dlk2 display high ranges of expression in the e16.5 livers (assessed
by qPCR). Perhaps expression of these genes is being dynamically lost during the e16.5
period, which would be unsurprising given thedynamic downregulation that is occurring
during the e16.5-e18.5 time-window (section 3.2). No dissections are carried out at identical
periods of embryogenesis due to precise differences in the times of fertilisation. Embryos
from different litters are thus be slightly older or younger than each other, even if they are
considered to be in the e16.5 range. If Dlk gene expression is being dynamically lost in
the e16.5 period, variance in embryo age might result in populations with retained or lost
Dlk gene expression.This hypothesis is supported by the fact that samples that express high
levels of Dlk1 also express high Dlk2. The same pattern of Dlk1 and Dlk2 expression levels
may also suggest coordinate regulation of these genes; indeed this may be responsible for
the widespread loss of Dlk1 and Dlk2 expression between e16.5 and e18.5. The absence of
any detected expression by ISH in the liver at e16.5 may be an artefact of only testing one
biological replicate. Although ISH was performed on other biological replicates at e16.5
it was not successful. However, if the ISHs were repeated they may reveal inter-individual
variation in absence or presence of Dlk1 and Dlk2 gene expression in the e16.5 liver.
The qPCR suggests that Dlk2 is expressed at a higher level in 16.5 brains than Dlk1
(figure 4.2). This is not surprising given that ISHs suggest Dlk2 is more widely expressed
than Dlk1 at this stage (section 3.3). At e16.5, Dlk1 is only expressed in the lateral extremity
of the pituitary and in the neopallial cortex. Whereas Dlk2 is expressed in the cerebellar
primordium, the corpus striatum, the thalamus, the posterior horn of the forth ventricle, the
right lateral wall of the midbrain, and the neopallial cortex. Given the widespread expression
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of Dlk2 (section 3.3) it is surprising how small its difference in level is compared to Dlk1
expression. This might suggest that Dlk2 is expressed at lower levels in more tissues, whereas
Dlk1 is highly expressed from just the lateral extremity of the pituitary and in the neopallial
cortex. It is also possible that a brain region not covered by the ISHs sections (section 3.2) is
responsible for relatively high Dlk1 expression at e16.5.
In an opposing expression pattern, Dlk1 is expressed much more strongly than Dlk2 in
the e16.5 placenta (figure 4.2). ISHs suggest that, at e16.5, Dlk1 is expressed in the labyrinth
zone, and Dlk2 in the Labyrinthine trophoblast . Interestingly, the labyrinth zone is the largest
placental zone at e16.5 [46]. The qPCR is performed at the level of the whole tissue and
hence may reflect this greater tissue representation at this stage. These findings suggest that
Dlk1 and Dlk2 are acting in different functional zones within the placenta and that they may
function independently of each other in that tissue. However, it is noteworthy that given
that the ISHs show dramatically stronger staining in their respective zones e12.5 and e14.5
placentas is likely a better initial use of resources. Given that the ISHs show dramatically
stronger staining at e12.5 and e14.5 compared to e16.5 it is most likely that both genes carry
out their main functions during these periods.
It is interesting to speculate on the function of both genes during placental development.
No other tissue has Dlk1 and Dlk2 expressed so clearly in adjacent cell types. Given that
Dlk2 is thought to be ancestral to Dlk1 (section 2.1) and that the oldest Dlk1 gene function
is probably stem cell regulation, it is reasonable to hypothesise that Dlk2 may also play
a regulatory role in stem cells. Perhaps both genes are carrying out this function in the
placenta but instead of different Dlk1 isoforms working together in adjacent (as in postnatal
neurogenesis [78]), the gene paralogs are signalling with each other to carry out their pla-
cental function. However, there are fewer ’stem cells in the labyrinthine zone than in the
spongiotrophoblast zone [46]. This might suggest that Dlk2 evolved an unknown additional
function, independent to stem cell regulation, for the spongiotrophoblast. In this scenario,
Dlk1 would likely still act as a stem cell regulator via traditional signalling methods, thought
to be independent of Dlk2. Further experiments will be necessary to probe these hypotheses.
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Fig. 4.2 Normalised expression of Dlk1 and Dlk2 in e16.5 brain, liver, and placenta
Expression was was calculated as: 40 - ct to ensure a positive integer. Each individual
expression value (40 - ct) of either Dlk1 and Dlk2 reflects the technical replicate mean
for the expression data of either Dlk1 or Dlk2 in a given tissue normalised against the
corresponding technical replicate mean of Tpb expression in the same tissue. ct values are
the raw read out of relative gene expression from the qPCR machine and were processed as
described in section 8.3.13. 6 biological replicates were examined for each tissue. Biological
replicates were discarded from the analysis if technical replicates were of insufficient quality
in either the target gene or Tbp: ct value differences less than 0.4 between technical replicates
were considered to be of sufficient quality to use the biological replicate in the analysis.
A minimum of 3 biological replicates were retained per tissue. Unpaired non-parametric
Mann-Whitney tests were performed (GraphPad Prism V7) for expression levels of Dlk1 and
Dlk2 in the brain (p=0.0238), liver (p=0.1429), and placenta (p=0.0095).
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4.3 Dlk2 is dominantly expressed in all tested P7 brain re-
gions
Dlk1 and Dlk2 mRNA expression were investigated in P7 brainstem, cerebellum, cortex,
hippocampus, hypothalamus, liver, and muscle. Expression of both genes was detected
in all tissues (figure 4.3), suggesting that Dlk1 and Dlk2 mRNA expression returns in the
early postnatal period despite being almost completely lost at e18.5 (section 3.3). This is
consistent with previous observations for Dlk1 [78]. Interestingly, Dlk2 expression levels are
broadly consistent between the e16.5 brain and the various brain regions tested at P7. Dlk1
expression, however, seems lower in the postnatal ages.
qPCR data is semi-quantitative and does not necessarily reflect the expression of the
same gene at the protein level. The half-life of the mRNA is not taken into account here and
the protein may or may not be translated in cell types analysed. The mRNA may have shorter
or longer half lives than expected, and so may be absent or more abundant than expected,
respectively. As proteins are generally responsible for gene function, qPCR data alone is not
sufficient to infer the quantitative function of a given gene. Further functional experiments,
of Dlk2 in particular, will thus be necessary.
Dlk2 is predominantly expressed in all studied brain regions, whereas the two genes are
expressed equally in the liver and muscle (figure 4.3). Dlk2 is probably ancestral to Dlk1
(section 2.1), and the most ancient function of Dlk1 is likely stem cell regulation (section
1.4.1). Therefore perhaps both genes are regulating stem cell niches in all tissues with Dlk2
playing a predominant role in the p7 brain. Unpublished characterisation of Dlk2-/- zebrafish
by Dr. Ben Shaw, suggest that Dlk2 does negatively regulate neurogenesis in fish (section
7.3), in a manner analogous to Dlk1 regulation of various stem cell niches in mice [78].
However, in the absence of expression data for a comprehensive range of additional
postnatal murine tissues, such as muscle, kidney, spleen, lung, and more, it is an assumption
to conclude, as above, that Dlk2 displays widespread expression throughout postnatal stem
cell niches. Perhaps Dlk2 is exclusively expressed in the brain, postnatally. In this scenario,
it would be likely that Dlk1 and Dlk2 both play key roles in neural stem cells (and that this is
the ancestral function of the genes). Throughout vertebrate, and in particular mammalian,
evolution, additional functions emerged and diverged, with Dlk1 still performing stem cell
regulation in a range of tissues (even as an imprinted gene) and Dlk2 gaining new and yet
unknown functions. Further experiments are necessary to identify where Dlk2 is expressed
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Fig. 4.3 Normalised expression of Dlk1 and Dlk2 in p7 brainstem, cerebellum, cortex,
hippocampus, hypothalamus, liver, and muscle
Expression was was calculated as: 40 - ct to ensure a positive integer. Each individual
expression value (40 - ct) of either Dlk1 and Dlk2 reflects the technical replicate mean
for the expression data of either Dlk1 or Dlk2 in a given tissue normalised against the
corresponding technical replicate mean of Tpb expression in the same tissue. ct values are
the raw read out of relative gene expression from the qPCR machine and were processed as
described in section 8.3.13. 6 biological replicates were examined for each tissue. Biological
replicates were discarded from the analysis if technical replicates were of insufficient quality
in either the target gene or Tbp: ct value differences less than 0.4 between technical replicates
were considered to be of sufficient quality to use the biological replicate in the analysis.
A minimum of 3 biological replicates were retained per tissue. Unpaired non-parametric
Mann-Whitney tests were performed (GraphPad Prism V7) for expression levels of Dlk1 and
Dlk2 in the brainstem (p=0.0357), cerebellum (p=0.0357), cortex (p=0.0238), hippocampus
(p=0.0159), hypothalamus (p=0.0357), liver (p=0.2500), and muscle (p=0.2500).
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postnatally and what its functions are.
If Dlk2 is found to regulate neurogenesis in mice, then this expression data still may not
be sufficient to fully interpret the interplay between Dlk1 and Dlk2. Dlk1 unequivocally
regulates postnatal neurogenesis in mice [78], however Dlk2 is predominantly expressed,
even in the brain regions containing the postnatal neurogenic niches (figure 4.3). Ferron et
al. showed that Dlk1 regulates postnatal neurogenesis via the interaction of two different
DLK1 isoforms [78]. They also demonstrated that the signalling takes place independently
of NOTCH, but were unable to fully determine the gene’s interacting partners [78]. Could
DLK2 be playing such a role? If so, are the observed expression patterns (figure 4.3) of both
genes at P7 reflective of tissues in which they cooperate to regulate differentiation of stem
cells, with each gene playing a cell type specific role within the niche? Alternatively, the
expression patterns may reflect redundancies. Perhaps Dlk2 functions predominantly in the
brain with weak Dlk1 expression as a ’back-up’; the situation being reversed in other co-
expressing somatic tissues such as muscle, where there is a slight statistically non-significant
bias towardsDlk1 expression.
4.4 Dlk1 and Dlk2 show similar expression levels in most
brain regions at P60
Despite significant preferential expression of Dlk2 throughout the P7 brain, expression levels
between Dlk1 and Dlk2 are more similar at P60. There is arguably a trend that Dlk2 is still
predominantly expressed in all tested brain regions but this is only statistically significant in
the cerebellum and the cortex (figure 4.4).
Interestingly the decrease in the difference of expression between the two genes seems to
come mostly from an increase in Dlk1 levels in the brainstem, hypothalamus, and hippocam-
pus. In addition, Dlk2 seems to be moderately less expressed within a given tissue at p60
(figure 4.4) compared to p7 (figure 4.3).
Testing gene expression at given time points only indicates how a given gene is behaving
at a particular moment in time; far more time points will need to be investigated to get an
accurate understanding dynamic relationship between the expression of the two genes. Thus,
the expression dynamics of Dlk1 and Dlk2 at e16.5 (figure 4.2), P7 (figure 4.3), and P60 (fig-
ure 4.4) may tentatively suggest dynamic gene behaviour meriting further investigation with
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Fig. 4.4 Normalised expression of Dlk1 and Dlk2 in p60 brainstem, cerebellum, cortex,
hippocampus, and hypothalamus
Expression was was calculated as: 40 - ct to ensure a positive integer. Each individual
expression value (40 - ct) of either Dlk1 and Dlk2 reflects the technical replicate mean
for the expression data of either Dlk1 or Dlk2 in a given tissue normalised against the
corresponding technical replicate mean of Tpb expression in the same tissue. ct values are
the raw read out of relative gene expression from the qPCR machine and were processed as
described in section 8.3.13. 6 biological replicates were examined for each tissue. Biological
replicates were discarded from the analysis if technical replicates were of insufficient quality
in either the target gene or Tbp: ct value differences less than 0.4 between technical replicates
were considered to be of sufficient quality to use the biological replicate in the analysis.
A minimum of 3 biological replicates were retained per tissue. Unpaired non-parametric
Mann-Whitney tests were performed (GraphPad Prism V7) for expression levels of Dlk1 and
Dlk2 in the brainstem (p=0.5476), cerebellum (p=0.0022), cortex (p=0.0159), hippocampus
(p=0.0238), and hypothalamus (p=0.9048).
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similar expression analysis at more time points, and, perhaps more importantly, functional
studies in Dlk2 mutant mice.
Dlk2 and Dlk1 may both regulate embryonic/early and adult neurogenesis, respectively.
Dlk2 expression is high in the embryonic brain and at P7 during periods of rapid brain expan-
sion. However at P60 its expression is generally decreasing, as Dlk1 expression generally
increases. Testing the expression of both genes at later adult stages, such as P90, P240,
and P365, would give insight into whether this trend continues and if the expression profile
switches, so that Dlk1 is the predominantly expressed gene. Dlk1 is known to regulate
adult neurogenesis. More primary neurospheres were derived from Dlk1-/- mice than wild
type at p7 [78]. However by P60 wild-type mice yielded far greater numbers of primary
neurospheres — this trend increased as the mice aged because the early expansion of the
neurogenic niche experienced by the Dlk1-/- ultimately depleted their neural stem cell pool
[78]. It would be interesting to perform similar experiments in Dlk2-/- mice. If Dlk2 regulates
embryonic neurogenesis then it would be likely that knocking out Dlk2 would deplete the
neurogenic niche very early in a murine life-cycle. In this scenario, mutant mice would
produce far more embryonically derived neurospheres compared to wild-type controls, a
phenotype expected to be reversed for neurospheres derived from stem cells harvested in the
early postnatal period.

5 Generation of a Dlk2-/- mouse using
CRISPR
A common approach to understanding the in vivo function of a gene is to knock it out, and
study the phenotypic consequences. Dlk2 was knocked-out in mice using the Clustered
Regular Interspaced Short Palindromic Repeats/Cas9 (CRISPR) system with microinjection
of guide RNAs and Cas9 protein into newly fertilised mouse zygotes. This was attempted
twice for Dlk2 with successful mutants being generated on the second attempt. The injections
were performed by the Cambridge Stem Cell Institute.
Exon mRNA/
Prot.
No. zyg.
trans.
No. mice
born
No.
muts.
Efficacy
(%)
Mut. sum.
2 Prot. 74 40 1 2.5 1*3bp del.
(in-frame)
5 mRNA 28 12 0 0 N/A
Table 5.1 Summary of the first CRISPR-Cas9 genome editing strategy
The gRNAs are described in section 8.7. Acronyms used: Del. — deletion, Muts. —
mutants, No. — number, N/A. — not applicable, Prot. — protein, Sum. — summary, Trans.
— transferred, Zyg. — zygotes
The first attempt at CRISPR mediated genome editing of Dlk2 was perhaps too ambitious.
Exons 2 and 5 were targets (section 8.7). Experimental design was based around information
presented at a genome editing course I attended run by CamBioScience with two guideRNAs
(gRNAs) injected per F1 x F1 (CBA x C57BL6/J) hybrid zygote per site to increase the like-
lihood of large deletions. In addition, we attempted to test the difference between injecting
Cas9 mRNA and Cas9 protein into the zygotes. Since the editing was unsuccessful in this
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Fig. 5.1 Locations of gRNA targets within Dlk2 for CRISPR-mediated genome editing
attempt 2
The gRNAs targeted exon 2, 3, and 5 (blue arrows), which are present in all Dlk2 isoforms.
Exons 2 and 5 were also targeted in attempt one, although different gRNAs were used.
round (table 5.1) this additional assessment could not be made. However, in parallel Dr Celia
Delahaye in the lab determined that the Cas9 protein gave higher frequency targeting than
injected Cas9 mRNA. This was consistent with other studies (reviewed in [208]), hence Cas9
protein was used in the subsequent CRISPR attempts. Only one mutant animal was generated
in the first attempt (table 5.1). The mutation was in-frame and so not followed up further. It is
recognised that the nature of the genetic sequence surrounding the on-target cleavage site can
promote undesirable in-frame mutations via microhomology-mediated end-joining [22, 179],
however accurately predicting how prone a given genomic region is to this process is limited.
The second attempt at CRISPR was more successful. New gRNAs were designed to target
exons 2, 3, and 5 (figure 5.1). The Stem Cell Institute performed pronuclear microinjection
of the gRNAs and spCas9 protein into (CBA x C57BL6/J) F1 x F1 hybrid zygotes (section
8.7). The strategy was successful and multiple mutant animals were generated from each
gRNA (table 5.2), with high efficiency.
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5.1 Genetic characterisation of mutant mice
The majority of founder animals generated were compound heterozygotes (table 5.2) and
were difficult to genotype accurately because of the poor signal-to-noise ratios in the DNA
sequence traces. However, this ambiguity made such mice excellent founders as they are able
to transmit both mutations to offspring. Thus the two most promising compound heterozygote
females were selected per exon for breeding. 11 distinct mutations (figure 5.2) were identified
in their offspring (table 5.3).
All but one of the mutations characterised in the F1 animals were out-of-frame. Many
also were nonsense mutations introducing premature stop codons. Non-sense mediated decay
generally targets and degrades transcripts that are prematurely translated [94, 114, 146],
a system regularly taken advantage of in CRISPR mediated genome editing (reviewed in
[175]). However, without experimental validation of tissues derived from homozygous
animals the consequences of these mutations can only be speculated upon. All F1 animals
were heterozygous and, depending on the number and genders of animals with each mutation,
would require 1-2 further generations of breeding to generate homozygous animals. Breeding
for further generations for 11 different mouse lines is highly time consuming and expensive.
Thus a subset of animals was selected for further characterisation.
ExonTotal no.
animals inv.
Mutation No. mice
5 24 13bp del
2bp del
INDEL
73bp del
12bp del
84bp del
WT
4
3
1
7
5
3
1
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Table 5.3 (continued)
ExonTotal no.
animals inv.
Mutation No. mice
3 14 16bp del
2G INS
1G INS
1C INS
WT
1
1
4
5
3
2 5 INDEL
70bp del
WT
1
3
1
Table 5.3 The number of animals identified for each mutation in the genotyped F1
animals
All animals were heterozygous for their given mutation. Acronyms used: del — deletion,
INDEL — insertion and deletion, INS — insertion, inv. — investigated, WT — wild-type
5 mutations (figure 5.3) were chosen to validate whether DLK2 protein expression was
ablated. Should all 5 lines successfully validate, only 2 will be taken forward for comprehen-
sive phenotypic validation. 2 lines will be analysed to compare consistency of phenotype and
as an additional control against off-target effects (section 5.2).
Initial selection of the 5 lines for validation was straightforward. Lines with in-frame mu-
tations were discarded. One exon 2 mutant caused intron retention and produced a premature
stop codon (figure 5.2). However, there was concern that exon 2 could simply be skipped
with transcription initiation beginning on exon 3, especially as all the major protein domains
are located from exon 3 onwards. This mutation was thus discarded.
From the remaining mutations, the 73bp deletion (DK73) in exon 5 was a very clear
choice. Three animals with this mutation had eye defects in the F1 generation. In addition,
one F1 animal, heterozygous for the DK73 mutation, was born large for its litter but failed to
thrive in the early postnatal period, and displayed an abnormally shaped skull. It was sacri-
ficed on postnatal day 14 (p14) in compliance with the Home Office regulations. To control
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Fig. 5.2 Summary of mutations identified in offspring of 6 founder Dlk2 CRISPR mu-
tants
Predicted gross effects of 11 CRISPR generated mutations in Dlk2 compared to the wild-type
protein. Wiggly lines indicate that the mutant sequence diverges from the wild-type. The
70bp deletion in exon 2 may result in exon skippage that might produce a functional protein
from exon 3 onwards. Exon 1 is not translated and so is not represented in this figure. Yellow
mutations were pursued for phenotypic characterisation. EGF – epidermal growth factor like
repeat, INDEL – insertion and deletion, TM – transmembrane.
Fig. 5.3 Alignment of the predicted amino acid sequences of the DLK2 mutants kept
for phenotypic analysis against the wild-type protein
Protein sequences were obtained by in silico translating the DNA sequences of the mutant
animals with Transeq [184]. The amino acid sequences selected for this analysis stopped
at the first premature stop codon as predicted by Transeq. Sequences were aligned using
ClustalO (V1.2.4) [132].
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for off-target effects, mutants without this defect were selected for colony establishment. A
13bp deletion in exon 5 (DK13) produced a truncated sequence of similar length (table 5.4)
and divergence from wild-type to DK73 (figure 5.2) but its F1 animals did not display any
abnormalities. This line was also selected.
The three remaining lines were selected from exon 3: DK1G, DK1C, and DK16. They
all introduced premature stop codons that, if translated, would produce short peptides (table
5.4). The lines chosen produced the shortest predicted peptides frommutations in exon 2 or 3.
Line name Exon Mutation Predicted protein length (aa)
DK13 5 13bp deletion 176
DK73 5 73bp deletion 154
DK16 3 16bp INDEL 55
DK1G 3 1G insertion 42
DK1C 3 1C insertion 42
Table 5.4 Summary of the 5 lines with CRISPR mediated mutations in Dlk2 kept for
experimental validation
Acronyms used: aa — amino acids, INDEL — insertion and deletion
5.2 In-silico analysis of predicted off-target effects
Arguably over-estimated [214, 239], off-target binding of gRNAs is a concern [82]; theoreti-
cally gRNAs may bind to other non-target regions of the genome, resulting in cleavage at
off-target sites. This is especially alarming since single or double mismatches are tolerated
[102], and off-target binding and cleavage has been observed experimentally in more sites
than predicted computationally for given gRNAs [128]. However three or more interspaced
mismatches eliminated detectable SpCas9 cleavage in the majority of loci studied in cell lines
[103]and a comprehensive analysis in cell lines indicates that off-target cleavage is much
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less efficient than on-target cleavage [128].
gRNA
target
Off-target binding
location
1 MM 2 MM 3 MM 4 MM
Exon 3 Exonic
Intronic
Intergenic
0
0
0
0
0
0
1
3
3
16
43
43
Exon 5 Exonic
Intronic
Intergenic
0
0
0
0
0
0
0
3
4
4
42
39
Table 5.5 Summary of off-target binding, relative to number of sequence mismatches,
for gRNAs targeting exon 3 and 5 of Dlk2
Off-target binding locations were found using the Wellcome Trust Sanger Institute
Genome Editing database [97]. Acronyms used: MM — mismatches
During gRNA selection period, the Wellcome Trust Sanger Institute Genome Editing
database [97] was used to identify off-target binding sites for the gRNAs that targeted exon
3 and exon 5 of Dlk2. 109 and 92 binding sites were predicted for exon 3 and exon 5,
respectively (table 5.5); the majority of sites possessed 3 or more mismatches suggesting
that SpCas9 off-target cleavage would be minimal [103]. Selected off-target sites in other
mice mutated by CRISPR by the group, using the same protocol, show no off-target mu-
tations (pers. comm. Dr. Celia Delahaye). However, there is still a risk that off-target
binding would occur in this model. The backcrossing protocol (section 5.3) was designed to
overcome this: off-target cleavage on other chromosomes can be segregated out via breeding.
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Another approach to assess for off-target effects was taken: the off-target binding in
exonic regions was investigated in detail. Only exonic off-target cleavage was studied since
it is likely to be more severe than intronic cleavage. The exonic off-target cleavage sites were
explored for the gRNAs targeting Dlk2 exon 3 (table 5.6) and exon 5 (table 5.7). Only one
off-target binding site is located on chromosome 17 for both exon 3 and 5, suggesting that
the majority of potential off-target alterations will be easily removed during the breeding
plan (section 5.3). Furthermore, the phenotypes associated with mutations in the genes with
the predicted off-target binding (obtained from the Mouse Genome Database [215] and the
International Mouse Phenotyping Consortium [60] where possible) are fairly severe, even
lethal in cases, and should be easily identified if present.
Gene
targeted
Chromo-
some
No.
MM
Phenotypes
SYNM 7 4 Abnormal behaviour and alterations in muscle.
TCT23 7 4 N/A
CAVIN2 1 4 Cardiovascular, adipose, and respiratory
problems.
NFASC 1 4 Abnormal aging, behaviour, and growth.
Table 5.7 The locations of predicted exonic off-target binding sites of the gRNA target-
ing Dlk2 exon 5, and associated phenotypes
Off-target binding locations were found using the Wellcome Trust Sanger Institute
Genome Editing database [97]. Where possible, the phenotypes associated with mutations in
the genes with predicted exonic off-target binding were obtained from the Mouse Genome
Database [215] and the International Mouse Phenotyping Consortium [60]. Acronyms used:
MM — mismatches, No. — number, N/A — not applicable because there was no phenotypic
information available.
5.3 Breeding strategy
As discussed in section 5.1, five Dlk2mutant lines were chosen for validation and preliminary
phenotypic analysis. Since maintaining five mutant mouse lines is very expensive, after
validation by Western blotting (not conducted in this thesis) two lines will be selected for
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comprehensive analysis. Since the mutations were generated in C57BL/6JXCBA hybrid
animals the animals will need to be backcrossed onto a pure C57BL6/J genome for the final
analysis. Nine generations of backcrossing (table 5.8) should be sufficient to transfer the
mutation onto a pure C57BL6/J genome. This approach also has the advantage that any
undesirable off-target effects, located on other chromosomes, should be segregated out at the
end of the breeding plan.
Backcrossed generation Percentage C57BL/6J (%)
N0 50
N1 75
N2 87.5
N3 93.75
N4 96.875
N5 98.4375
N6 99.21875
N7 99.609375
N8 99.8046875
N9 99.9023438
Table 5.8 Percentage of genome as C57BL/6J for each generation of backcrossed mu-
tant mice
Homozygous biological material will be needed for validation by Western blotting. Thus
the initial stages of the breeding plan (figure 5.2) will run concurrently for all 5 lines but the
complete breeding plan will only be conducted on two.
The breeding plan has two parts. Backcrossing of a line until generation 9 (N9) will
be maintained using heterozygous mutants. In addition, at generations 1 or 2 (N1 or N2,
respectively) heterozygous animals will be mated together to generate homozygous offspring
as material for molecular studies including Western blotting. These additional colonies
can also be used for preliminary phenotypic analyses such as breeding ratios and pre- and
post-natal weights. Together, these early generation analyses they will provide data that
should influence which two lines are retained for comprehensive analysis.
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Fig. 5.4 Breeding strategy for Dlk2 CRISPR mutants
Founder animals (backcross generation N0) are crossed with wild-type C57BL/6J mice.
Offspring from these crosses (N1/F1) are genotyped and 5 different mutations were selected
for colony generation (section 5.1). These heterozygotes will be backcrossed for 9 generations
until N9/F9 by crossing each generation with a pure C57BL/6J wild-type mice. Heterozygotes
from backcross generations N1, N2, N5, N9 will be breed together to generate N1, N2, N5,
N9 specific colonies respectively for each mutation. Mice from these separate colonies will
be used for molecular biology and phenotypic analysis. Acronyms used: Het — heterozygote.
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Similar heterozygous intercross sub-colonies will be generated at backcross generations
5 and 9 (N5 and N9, respectively). More detailed phenotypic analysis will be conducted on
the N5 colony, and comprehensive analysis on the N9 colony. Comprehensive analysis must
be conducted on the purest C57BL/6J genome as it the same reference genome on which the
Dlk1 line is maintained [181]. However, having preliminary phenotypic data from colonies
derived from other generations, such as N5, N2, or N1, is advantageous. It allows comparison
of phenotypes between generations, enabling assessment of genetic background effects.
Genetic background can dramatically influence phenotype and phenotypic interpretation; for
example the C57BL/6N strain possesses a Crb1 allele that causes retinal degeneration and
may confound other ocular phenotypes [149]. In addition, exploratory investigations can be
conducted on colonies derived from these earlier generations allowing the final experiments
to be hypothesis driven.
6 Preliminary phenotypic analysis ofDlk2-/-
mice
The five selected Dlk2 mutant lines will not be validated by Western blotting in this thesis as
initial attempts at Western Blotting, using DLK2 antibodies custom generated by Abcam were
unsuccessful in my hands. However, the biological materials necessary for such validation
were generated. As discussed in section 5.3, preliminary phenotypic observations can be
drawn secondary to the backcrossing and validation breeding protocols. Such observations
include litter sizes, pre- and post-natal body weights, and genotype ratios. Where possible
this information will be compared to similar data for the Dlk1 mutant line, maintained on
a pure C57BL/6J background. Given that genetic background effects are expected, it is
not ideal to compare the Dlk1 mutants (equivalent to N9) to N1 and N2 Dlk2 CRISPR
mutants. For similar reasons, pure C57BL/6J mice are imperfect wild-type control models.
Nonetheless, considerable insight into the value of the mutants can be generated from the
preliminary data I have generated on the early backcross generations.
6.1 There is no obvious difference in litter size between the
Dlk2 CRISPR lines
The litters from N2 heterozygous intercrosses have no significant size difference between
the five Dlk2 mutant lines, as assessed by a one-way ANOVA (figure 6.1). A similar trend is
seen for the offspring of crosses between N2 heterozygotes and pure C57BL/6J wild-type
animals (figure 6.1). This suggests that there is no off-target, on-target, or indeed any effect
that modulates litter size disproportionately for any mutation. However, the gross similarities
in litter size may belie significant alterations in genotype and sex ratios (assessed in sections
6.2 and 6.3, respectively).
In general, there is a trend for litters born from heterozygotes intercrosses to be of a
smaller size than the litters generated when mice with the same mutation are crossed with
pure C57BL/6J mice (table 6.1). This was observed when all the offspring are of an equiva-
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(a) Litter sizes from heterzygous intercrosses of N2
mutants
(b) Litter sizes from N1 heterozygous mutants
crossed with C57BL/6J WT animals
Fig. 6.1 Litter sizes (mean, standard deviation) of various Dlk2 mutant crosses gener-
ating N2 off-spring
There is no significant difference in the number of animals in each litter for (a) N2 mutants
crossed heterozygously, or (b) N1 heterzygotes crossed to wild-type animals (generatating
N2 offspring). p=0.3978 and 0.3939, respectively (Non-parametric Kruskal-Wallis test,
GraphPad Prism V7.0). Acronyms used: WT — wildtype.
lent backcrossed generation (N2). However, the standard deviations of the mean litter sizes
overlap dramatically between each cross, making it difficult to ascertain whether the trend
is an artefact or due to underlying biology. The Dlk1-/- mutants show reduced numbers of
homozygotes (PhD Thesis Mary Cleaton, University of Cambridge (2015)); given the homol-
ogy between Dlk1 and Dlk2 it would not be unexpected for litters from Dlk2 heterozygous
intercrosses to be smaller due to homozygous loss. This will be assessed with genotyping
(section 6.2).
Line Mean (SD) litter size hetXwt cross Mean (SD) litter size hetXhet cross
DK1G 7.10 (2.69) 8.00 (2.00)
DK1C 5.40 (3.13) 6.50(0.71)
DK16 8.20 (2.17) 5.86 (1.35)
DK73 6.67 (2.66) 6.22 (1.79)
DK13 7.89 (2.10) 6.00 (0.82)
Table 6.1 Mean (SD) litter sizes of N2 litters born from N2 heterozygous intercrosses
and from crosses between N1 heterozygotes and C57Bl/6J wils type mice
Acronyms used: het — heterozygote, SD — standard deviatio, wt — wild-type
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The number of litters assessed for each cross is fairly low (table 6.2) and is not consistent
between experimental groups. This, coupled with the high variability of litter size per cross
(figure 6.1), may suggest a trend that is not genuine. Furthermore, the mean litter size, from
21 litters, of the wild type C57BL/6J colony is 6.00 (+/- 2.28), which is also highly similar to
the values of the Dlk2 intercross litter sizes. The mean size of wild-type litters also possesses
a similarly high standard deviation, emphasising the inherent variability of animal work, at
least in the Combined animal facility where these mice are housed, and the need for large
sample sizes. It is worth noting however, that the Dlk2 mutants analysed are at the N2 stage
in backcrossing and possess only 87.5% of the C57BL/6J genome (table 5.8). Wild-type
C57BL/6JXCBA hybrid animals may display higher birth rates than pure C57BL/6J animals.
Line No. litters hetXwt cross No. litters hetXhet cross
DK1G 10 4
DK1C 5 2
DK16 5 7
DK73 6 9
DK13 8 7
Table 6.2 Number of litters analysed in table 6.1 and figure 6.1 for heterozygous inter-
crosses and heterzygote - wild-type crosses
Acronyms used: het — heterozygote, wt — wild-type
Elucidating whether different litter sizes are artefactual or not can only be completed
by comparing litter sizes across all backcrossed generations. This analysis will thus be
completed at the end of the backcrossing protocol at generation N9. However, some lines
were backcrossed to generation N3 (figure 6.2) and some mutants were bred together at N1
(figure 6.2). These preliminary data suggest that litter sizes are generally decreasing across
backcrossed generations. Further litters and generations will need to be assessed to ascertain
whether the trend is genuine.
Observing a reduction in litter size gives little insight into why mice may have smaller
litters. Only by analysing the sex and genotypic ratios will it become possible to answer that
question.
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(a) Litter sizes from N1 and N2 heterzygous inter-
crosses of DK73 and DK1C Dlk2 mutants
(b) Litter sizes from N1 and N2 heterozygous
DK1C and DK13 mutants crossed with C57/Bl6
WT animals
Fig. 6.2 Comparison of litter sizes (mean, standard deviation) of various Dlk2 mutant
crosses across N1, N2, and N3 generations
Litter sizes of heterozygous intercrosses were compared for DK73 and DK1C at backcross
generations N1 and N2 (a). There was no significant difference in litter size between
generations for DK1C (p=0.2485, unpaired non-parametric Mann-Whitney test; GraphPad
Prism V7). However, litters born at the N2 generation had significantly fewer offspring
compared to N1 litters of DK73 heterozygous intercrosses (p=0.0448, non-parametric Mann-
Whitney test; GraphPad Prism V7). Litter sizes were also assessed between backcross
generations N2 and N3 for DK1C and DK13 heterozygotes crossed with C57BL/6J wild-type
animals. There was no significant difference in litter size between generations for DK13
(p=0.2485, on-parametric Mann-Whitney test; GraphPad Prism V7). No statistical analysis
was performed on the DK1C line as the N3 generation possessed only 2 litters which was too
few for accurate statistical analysis.
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6.2 Dlk2mutant mice are generated at non-Mendelian fre-
quencies
Cross Percentage homs Percentage hets Percentage WTs
WTXHet 0 50 50
HetXHet 25 50 25
Table 6.3 Expected Mendelian ratios
Acronyms used: het — heterozygote, hom — homozygote, wt — wild type
The genotypes of offspring derived from heterozygous intercrosses and heterozygous by
wild type crosses were analysed. The lines behave differently from each other — especially
when observing the genotypes of offspring from heterozygous intercrosses. However, lit-
ter numbers are low and quite variable between lines, hence within line and between line
comparisons should be conducted with caution. Some of the differences may be due to
underlying biology: phenotypes are expected to alter and stabilise during the backcrossing
protocol (section 5.3), and some phenotypes may arise postnatally but not embryonically.
Characterisation of further litters will be needed to carry out to comprehensively determine
whether the offspring are being generated at Mendelian frequencies.
Wild type X N1 heterozygote crosses produce litters with a reduced number of wild-type
off-spring (table 6.4). However, the sample sizes are quite low for each litter and so the slight
biases observed may be artefacts of small sample sizes. On the other hand, if the data from
all lines is aggregated together to increase the sample size then there is still a slight bias
towards heterozygous births: specifically there are 85 heterozygous animals (57%) and 63
wild types (43%). However, due to potential variability between the five lines it would be
unwise to draw conclusions from aggregated data. Thus, the number of offspring born to
wild type X N1 heterozygote crosses will need to be increased, for all lines, to investigate
whether there is a heterozygous bias.
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Line Total no. litters Total no. pups No. het. pups (%) No. wt pups (%)
DK1G 2 15 8 (53.33%) 7 (46.67%)
DK1C 5 13 7 (53.86%) 6 (46.15%)
DK16 5 31 17 (54.84%) 14 (45.16%)
DK73 5 37 25 (67.57%) 12 (32.43%)
DK13 7 51 28 (54.90%) 24 (47.10%)
Table 6.4 Number of heterozygous and wild type N2 offspring resulting from N1 het-
erozygote x wild type crosses
Acronyms used: het — heterozygote, no. — number, wt — wild-type
If such further experiments did indicate a heterozygous bias, this might suggest that mice
lacking the paternal copy of Dlk2 have a survival advantage; perhaps due to unequal resource
allocation during embryogenesis.
Line Backcross
gen.
Total no.
pups
No. hom. pups
(%)
No. het. pups
(%)
No. wt pups
(%)
DK1G N2 7 3 (42.86%) 4 (57.14%) 0
DK1C N1 23 1 (4.34%) 18 (78.26%) 4 (17.39%)
DK16
DK73 N1 35 9 (25.71%) 17 (48.58%) 9 (25.71%)
DK73 N2 22 10 (45.45%) 5 (22.73%) 7 (31.82%)
DK13 N2 6 0 4 (66.67%) 2 (33.33%)
Table 6.5 Number of homozygous, heterozygous and wild type offspring resulting from
heterozygous intercrosses
Acronyms used: gen. — generation, het — heterozygote, hom. — homozygous, no. —
number, wt — wild-type
Small sample sizes also plague the heterozygous inter-crosses, making it challenging to
draw conclusions. Heterozygous inter-crosses for DK1G, DK13, and DK1C (generations
N2, N2, and N1, respectively) all show expansion in the proportion of heterozygous animals
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Fig. 6.3 Percentage of heterozygous and wild type N2 offspring born from N1 heterozy-
gote X C57Bl/6J wild type crosses for all Dlk2 mutant lines
Percentage of heterozygotes and wild-type N2 offspring born from crosses between C57Bl/6J
wild type animals and m N1 heterozygous mice from DK1C, DK1G, DK16, DK73, and
DK13 lines. Total number of animals per genotype for each line are located in table 6.4.
Unpaired parametric t-test with Welch’s correction performed between both experimental
groups (p=0.0076) using GraphPad Prism V7. Acronyms used: Het — heterozygotes, WT —
wild type.
(table 6.5) compared to the expected Mendelian ratios (table 6.3). This trend is also seen
in N2 embryos harvested from heterozygous intercrosses of DK16 (e14.5), DK73 (e16.5),
and DK13 (e14.5) (table 6.6). However, if the data from table 6.5 is aggregated then the
Mendelian ratios are normal: 48 heterozygotes, 22 wild types, and 23 homozygotes. This
suggests that the expansion of heterozygous animals observed for some litters postnatally
(table 6.5) and embryonically (table 6.6) may be artefacts of small sample sizes. However,
it is worth noting that it may be inappropriate to aggregate this data, especially as the inter-
crosses were performed on different backcross generations for different lines. In short, these
experiments must be repeated with far higher sample sizes to enable reliable interpretation.
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Line Back.
gen.
Em.
stage
Total
no.
No. homs.
(%)
No. hets.
(%)
No. WTs
(%)
DK1G
DK1C
DK16 N2 e14.5 14 1 (7.14%) 10 (71.43%) 3 (21.43%)
DK73 N1 e14.5 6 0 2 (33.33%) 4 (66.67%)
DK73 N2 e14.5 6 1 (16.67%) 3 (50.00%) 2 (33.33%)
DK73 N2 e16.5 9 2 (22.22%) 5 (55.56%) 2 (22.22%)
DK13 N2 e14.5 8 1(12.50%) 6 (75.00%) 1 (12.50%)
Table 6.6 Number of homozygous, heterozygous, and wild type embryos resulting from
heterozygous intercrosses
Acronyms used: Back. — backcross, Em. — embryonic, gen. — generation, het —
heterozygote, hom. — homozygous, no. — number, wt — wild-type
6.3 Dlk2 mutant may mice display abnormal sex ratios
Line Back. gen. pups Total no. pups No. fem. (%) No. male (%)
DK1G N2 11 7 (63.64%) 4 (36.36%)
DK1C N2 11 7 (63.64%) 4 (36.36%)
DK16 N2 28 16 (57.14%) 12 (42.86%)
DK73 N2 34 20 (58.82%) 14 (41.18%)
DK13 N2 49 21 (42.86%) 28 (57.14%)
Table 6.7 Number of female and male N2 offspring born to C57BL/6J wild type X N1
heterozygote crosses for all Dlk2 mutant lines
Acronyms used: Back. — backcross, fem. — female, gen. — generation, no. — number
Offspring of Dlk2 mutant mice may display abnormal sex ratios type (table 6.7). As
with the genotype data (section 6.2), the trend is more clear within the N1 heterozygote X
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C57BL/6J crosses (figure 6.4) where there may be a potential bias towards female offspring.
This trend is observed in all lines except DK13 for this cross type (table 6.7). However, the
DK13 line has the largest overall sample size so this data may be more reliable. Sex bias
is extremely difficult to assess without large sample sizes. For instance, the C57BL/6J and
Dlk1-/- colonies housed in the same facility (table 6.8) are known not to have sex biases. Yet,
their relatively small sizes produce sex biases comparable to those in table 6.7. It is therefore
likely that the observed sex bias in the heterozygote X C57BL/6J crosses may simply be an
artefact of insufficient numbers. Further experiments will be necessary to confirm this.
Line Total no. pups No. fem. (%) No. male (%)
WT 131 69 (52.67%) 62 (47.33%)
Dlk1-/- 67 36 (53.73%) 31 (46.29%)
Table 6.8 Number of female and male offspring born to intercrosses of C57BL/6J wild-
type and Dlk1-/- mice, housed in the same facility, in 2017
Acronyms used: fem. — female, no. — number, WT — wild type
Insufficient numbers of animals are also problematic when investigating the sex ratios of
offspring of heterozygous intercrosses (table 6.9). Collectively these crosses show dramatic
ranges of percentages female and male offspring per cross (figure 6.4). Nevertheless, DK1G,
DK1C, and DK13 lines show similar sex bias trends in the offspring from heterozygous
intercrosses (table 6.9) and heterozygote X C57BL6/J crosses (table 6.7). Although promis-
ing, the impact of the poor sample sizes on interpreting this data cannot be discounted. Sex
biases may occur when animals of a certain sex and genotype are depleted. However, as
the overall sample sizes are generally very low, often insufficient numbers of animals of a
given phenotype and sex are born to draw any conclusions (table 6.10). For example, no
homozygous females and heterozygous males were born to the DK1C line.
Line Back. gen. pups Total no. pups No. fem. (%) No. male (%)
DK1G N2 7 4 (57.14%) 3 (42.86%)
DK1C N1 11 9 (81.82%) 2 (18.18%)
DK16
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Table 6.9 (continued)
Line Back. gen. pups Total no. pups No. fem. (%) No. male (%)
DK73 N1 35 15 (42.86%) 20 (57.14%)
DK73 N2 14 5 (35.71%) 9 (64.29%)
DK13 N2 6 1 (16.67%) 5 (83.33%)
Table 6.9 Number of female and male offspring born to heterozygous intercrosses for
all Dlk2 mutant lines
Acronyms used: Back. — backcross, fem. — female, gen. — generation, no. — number
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Fig. 6.4 Percentage of female and male N2 offspring born from N2 heterozygous inter-
crosses and N1 heterozygote X C57Bl/6J wild type crosses for all Dlk2 mutant lines
Percentage of female and male N2 offspring born from crosses between C57Bl/6J wild type
animals and N1 heterozygous mice from DK1C, DK1G, DK16, DK73, and DK13 lines;
and from N2 heterozygous intercrosses from the same lines. Total number of animals per
genotype for each line are located in tables 6.7 and 6.9 for the heterozygote X WT and
heterozygote X heterozygote crosses, respectively. Unpaired non-parametric Mann-Whitney
tests were performed between both experimental groups for the wild type x heterozygote
crosses (p=0.0397) and the heterozgous intercrosses (p=0.6857), using GraphPad Prism V7.
Acronyms used: Het — heterozygotes, WT — wild type.
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6.4 There is no striking difference in postnatal weights be-
tween Dlk2 mutant and wild type mice
Postnatal weights can reflect several processes. These include developmental effects, the
influence of maternal care and, at post-weaning stages, metabolic phenotypes. Mice born to
N1 heterozygote x C57BL/6J wild type crosses (figure 6.5) and N2 heterozygote intercrosses
(figure 6.6) were weighed until they reached breeding age. Overall, there is no convincing
evidence of differences in postnatal weight between any of the genotypes for each line.
However, the sample sizes are generally too low (tables A.1 and A.2) to draw conclusions.
Increasing the sample sizes may reveal a subtle phenotype or confirm a current trend.
The mice were weighed for approximately 6 weeks for females, and 8 weeks for males.
However, since some postnatal weight phenotypes do not emerge until much later stages it is
typical to weigh each mouse for one year. Proper investigation of postnatal weights should
thus be conducted on a subset of mice from the two lines selected for extensive phenotypic
analysis.
DK73 Dlk2-/- females may have reduced mass compared to wild type littermate controls
(figure 6.6); although the sample size will need to be increased to verify this. This trend is
seen in offspring from both N1 and N2 heterozygous intercrosses (figure 6.7). If validated,
this would be an interesting phenotype since Dlk1-/- mice are heavier due to increased adi-
posity [158]. Further analysis, such as DEXA assessments, would be necessary to determine
why the Dlk2 mice have less mass.
6.5 There is no obvious difference in weight between wild-
types and Dlk2-/- mice for DK16, DK73, and DK13
lines at e14.5
E14.5 embryos, were generated from heterozygous intercrosses from DK16, DK73, and
DK13 lines When performing detailed phenotypic analysis of the embryogenesis of mutant
animals it is typical to obtain the wet and dry weights of entire embryos and the placentae,
the latter to account for any oedema related phenotype.
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Fig. 6.5 Postnatal weights of offspring of N1 heterozygote X C57Bl/6J wild type crosses
for all Dlk2 mutant lines
Sample sizes for each time point per line in table A.1.
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Fig. 6.6 Postnatal weights of offspring from N2 heterozygous intercrosses of DK1G,
DK73, and DK13, and DK1C N1 heterozygous intercrosses
Sample sizes for each time point per line in table A.2.
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Fig. 6.7 Postnatal weights of offspring from N2 heterozygous intercrosses of DK1G,
DK73, and DK13, and DK1C N1 heterozygous intercrosses
Sample sizes for each time point per line in table A.3.
The low sample sizes and high variability make interpreting the embryonic wet weight
and length data challenging. DK16 heterozygotes and homozygotes embryos may be lighter
than littermate wild type controls (figure 6.8). However, DK73 embryos show the opposite
trend with heavier homozygote and heterozygote animals, whereas there is no clear relation-
ship between genotype and embryonic weight for the DK13 line. It is unlikely that each line
possesses unique embryonic weight phenotypes. It is much more likely that these trends are
simply artefacts of sample size. Increasing the number of dissected litters will be necessary
to ascertain whether any of the trends hold true.
Similar limitations plague the wet placental weights (figure 6.9). Reassuringly the same
trends are maintained for the DK16 and DK73 placentae weights. This could be reflective
of genuine population wide phenotypes or may simply be due to uniquely heavy or light
homozygotes. Interestingly, the DK13 homozygote placenta is strikingly lighter than the
wild-type littermate control. However, no conclusions can be drawn and the sample size must
be increased.
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Fig. 6.8 Wet weights of heterozygous intercross N2 offspring 14.5 embryos for DK16,
DK73, and DK13 lines
Dlk2-/-, Dlk12+/- or Dlk2-/+, and wild type embryos were weighed at e14.5 for DK16,
DK73, and DK13 lines. Samples sizes for DK16: N (Dlk2-/-) = 1, N (Dlk2+/- or Dlk2-/+) =
10, N (wild type) = 3. Unpaired non-parametic Mann-Whitney tests were performed using
GraphPad Prism V7 between wild type and heterozygous (p=0.2128) mutants. Samples
sizes for DK73: N (Dlk2-/-) = 1, N (Dlk2+/- or Dlk2-/+) = 5, N (wild type) = 6. Unpaired
non-parametic Mann-Whitney tests were performed using GraphPad Prism V7 between wild
type and heterozygous (p=0.4286) mutants. Samples sizes for DK13: N (Dlk2-/-) = 1, N
(Dlk2+/- or Dlk2-/+) = 5, N (wild type) = 1. Statistical analysis was not performed between
groups where one had a sample size less than 3.
Crown-rump lengths of the same embryos (figure 6.8) show the same general trends as
the embryonic wet weights (figure 6.10). Homozygotes may be smaller for the DK16 line,
but larger in the DK73 line, and there is no real difference between the DK13 homozygote
and the wild type littermate control. It is not unexpected that the trend is maintained be-
tween embryonic wet weight (figure 6.8) and crown rump length (figure 6.10); it is likely
that heavier animals are also longer. Without larger sample sizes no conclusions can be drawn
Nevertheless, the trends observed are interesting. The postnatal weights, which also have
sample sizes insufficient for strong conclusions, suggest that the homozygotes, especially of
the DK73 line, may be lighter postnatally. That a similar trend may be seen in DK16 embryos
and placentae, and DK13 placentae is thus reassuring. However, the DK73 homozygotes
may be larger embryonically — a trend maintained at the e16.5 stage (figure 6.11). It is
unexpected for larger embryos to show postnatal growth restriction. However, mice with
restricted embryonic growth often catch up and then overtake their wild type littermates
postnatally. Indeed maternal undernutrition, forcing embryonic growth restriction, is often
used as an experimental model of this process [107].
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Fig. 6.9Wet weights of heterozygous intercross N2 offspring 14.5 placentae for DK16,
DK73, and DK13 lines
Dlk2-/-, Dlk12+/- or Dlk2-/+, and wild type placentae were weighed at e14.5 for DK16,
DK73, and DK13 lines. Samples sizes for DK16: N (Dlk2-/-) = 1, N (Dlk2+/- or Dlk2-/+) =
10, N (wild type) = 3. Unpaired non-parametic Mann-Whitney tests were performed using
GraphPad Prism V7 between wild type and heterozygous (p=0.2168) mutants. Samples
sizes for DK73: N (Dlk2-/-) = 1, N (Dlk2+/- or Dlk2-/+) = 5, N (wild type) = 6.Unpaired
non-parametic Mann-Whitney tests were performed using GraphPad Prism V7 between wild
type and heterozygous (p=0.0519) mutants. Samples sizes for DK13: N (Dlk2-/-) = 1, N
(Dlk2+/- or Dlk2-/+) = 5, N (wild type) = 1. Statistical analysis was not performed between
groups where one had a sample size less than 3.
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Fig. 6.10 Crown-rump lengths of heterozygous intercross N2 offspring 14.5 embryos
for DK16, DK73, and DK13 lines
Dlk2-/-, Dlk12+/- or Dlk2-/+, and wild type crown-rump lengths were measured at e14.5 for
DK16, DK73, and DK13 lines. Samples sizes for DK16: N (Dlk2-/-) = 1, N (Dlk2+/- or Dlk2-
/+) = 10, N (wild type) = 3. Unpaired non-parametic Mann-Whitney tests were performed
using GraphPad Prism V7 between wild type and heterozygous (p=0.3741) mutants. Samples
sizes for DK73: N (Dlk2-/-) = 1, N (Dlk2+/- or Dlk2-/+) = 5, N (wild type) = 6. Unpaired
non-parametic Mann-Whitney tests were performed using GraphPad Prism V7 between wild
type and heterozygous (p=0.2251) mutants. Samples sizes for DK13: N (Dlk2-/-) = 1, N
(Dlk2+/- or Dlk2-/+) = 5, N (wild type) = 1. Statistical analysis was not performed between
groups where one had a sample size less than 3.
Dlk1-/- mice are thought to display embryonic growth restriction and postnatal growth
expansion [158]. Wet embryonic (figure 6.12) and placental (figure 6.13) weights were
collected for offspring of Dlk1 heterozygous intercrosses High variability and low sample
size also limit the Dlk1 embryonic and placental weight data. Dlk1-/- embryos tend have
reduced mass compared to their wild type littermates at e12.5, e14.5, e16.5, and e18.5 (PhD
Thesis Isabel Gutteridge, University of Cambridge (2010)) (figure 6.12), with the weight
deficit increasing with developmental age. No such trend is seen in the placental weights
(figure
The similar relationship between genotype and embryonic wet weights at e14.5 in the
offspring of DK16 (figure 6.8) and Dlk1 (figure 6.12) heterozygous intercrosses is exciting.
Homozygotes tend to be lighter. Should the trends validate after increasing the sample sizes,
it would be interesting to speculate on the phenotypic similarities. Would this mean that
the embryonic growth retardation is related to the function of Dlk1 and, putatively, Dlk2 as
stem cell regulators? Which tissues would show growth restrictions, and would this help
determine where Dlk2 plays a dominant role, and vice versa. Comparisons to Dlk2-/-; Dlk1-/-
double mutants would also be beneficial. Increasing the quality of the postnatal weight data
for the Dlk2 mutants is also imperative. If both Dlk2-/- and Dlk1-/- embryos are lighter than
wild type littermates, but only Dlk2-/- animals maintain the trend postnatally and Dlk1-/-
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Fig. 6.11Crown-rump lengths and embryonic and placental weights of DK73 heterozy-
gous intercross N2 offspring at 14.5, and e16.5
Dlk2-/-, Dlk12+/- or Dlk2-/+, and wild type embryos and placentae were weighed, and their
crown-rump lengths measured, at e14.5 and e16.5 for the DK73 line. Samples sizes for e16.5
animals: N (Dlk2-/-) = 2, N (Dlk2+/- or Dlk2-/+) = 5, N (wild type) = 2. Samples sizes for
e14.5 animals: N (Dlk2-/-) = 1, N (Dlk2+/- or Dlk2-/+) = 5, N (wild type) = 6. Unpaired
non-parametic Mann-Whitney tests were performed using GraphPad Prism V7 between wild
type and heterozygous mutants for e14.5 embryos (p=0.4286), placentae (p=0.0519), and
crown rump lengths (p=0.2251). Statistical analysis was not performed between groups
where one had a sample size less than 3.
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Fig. 6.12 Wet weights of Dlk1 mutant heterozygous intercross offspring embryos at
e12.5, e14.5, e16.5, and e18.5
Dlk1-/-, Dlk1+/- or Dlk1-/+, and wild type embryos were weighed at e12.5: N (Dlk1-/-) = 3,
N (Dlk1+/- or Dlk1-/+) = 6, N (wild type)=3. Unpaired non-parametic Mann-Whitney tests
were performed using GraphPad Prism V7 between wild type and homozygous (p=0.7000)
and heterozygous (p=0.9048) mutants. Sample sizes of embryos weighed at e14.5 were
4, 8, and 9 for Dlk1-/-, Dlk1+/- or Dlk1-/+, and wild type, respectively. Unpaired non-
parametic Mann-Whitney tests were performed using GraphPad Prism V7 between wild
type and homozygous (p=0.2601) and heterozygous (p=0.0274) mutants. Sample sizes of
embryos weighed at e16.5 were 9, 8, and 9 for Dlk1-/-, Dlk1+/- or Dlk1-/+, and wild type,
respectively. Unpaired non-parametic Mann-Whitney tests were performed using GraphPad
Prism V7 between wild type and homozygous (p=0.0745) and heterozygous (p=0.7021)
mutants. Sample sizes of embryos weighed at e18.5 were 1, 2, and 2 for Dlk1-/-, Dlk1+/- or
Dlk1-/+, and wild type, respectively. Statistical analysis was not performed on e18.5 weights
due to insufficient sample sizes.
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animals show postnatal growth expansion, the then genes may be playing opposing roles.
Furthermore, homozygous placentae may only be lighter for Dlk2-/- mice (DK16 and DK13
lines) compared to wild type littermates (figure 6.9), whereas Dlk1-/- placentae are generally
comparable (figure 6.13).
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Fig. 6.13 Wet weights of Dlk1 mutant heterozygous intercross offspring placentae at
e12.5, e14.5, e16.5, and e18.5
Dlk1-/-, Dlk1+/- or Dlk1-/+, and wild type placentae were weighed at e12.5: N (Dlk1-/-) = 3,
N (Dlk1+/- or Dlk1-/+) = 6, N (wild type)=3. Unpaired non-parametic Mann-Whitney tests
were performed using GraphPad Prism V7 between wild type and homozygous (p=0.9999)
and heterozygous (p=0.3810) mutants. Sample sizes of placentae weighed at e14.5 were
4, 8, and 9 for Dlk1-/-, Dlk1+/- or Dlk1-/+, and wild type, respectively. Unpaired non-
parametic Mann-Whitney tests were performed using GraphPad Prism V7 between wild
type and homozygous (p=0.5287) and heterozygous (p=0.2359) mutants. Sample sizes of
placentae weighed at e16.5 were 9, 8, and 9 for Dlk1-/-, Dlk1+/- or Dlk1-/+, and wild type,
respectively. Unpaired non-parametic Mann-Whitney tests were performed using GraphPad
Prism V7 between wild type and homozygous (p=0.1139) and heterozygous (p=0.0830)
mutants. Sample sizes of placentae weighed at e18.5 were 1, 2, and 2 for Dlk1-/-, Dlk1+/- or
Dlk1-/+, and wild type, respectively. Statistical analysis was not performed on e18.5 weights
due to insufficient sample sizes.

7 General discussion
The purpose of this project was to contribute to our understanding of the role of Dlk2 in
mammalian development using classical expression studies and by generating a Dlk2-/-
mouse line. This work could then be compared to established knowledge regarding Dlk1 in
mice (section 1.4.3), and unpublished data concerning both genes in zebrafish (PhD thesis, Dr.
Ben Shaw). The multi-gene and multi-species analysis, combined with in silico evolutionary
analysis (section 2), will generate insights into the relationship between both genes and
ultimately address questions such as:
1. What role does Dlk2 play in mammalian development, and how well is it evolutionarily
conserved?
(a) Do more ancient and conserved gene functions rely more on NOTCH signalling
than more recently evolved functions?
2. What is the (functional) relationship between Dlk1 and Dlk2?
(a) Does Dlk2 share regions of expression overlap with Dlk1?
(b) Do Dlk1 and Dlk2 interact with each other in a similar manner to S- and M-DLK1
in the postnatal neurogenic niche [78]?
(c) If Dlk1 and Dlk2 interact with each other or share functional redundancy, does
this overlap imprinting related functions?
3. What is the evolutionary relationship between Dlk1 and Dlk2?
(a) Are the expression and functions of Dlk2 better conserved than Dlk1 across
vertebrates?
(b) Why did Dlk1 but not Dlk2 evolve to imprint?
(c) Are recently evolved imprinting related functions NOTCH independent?
This project was not completed due to time constraints, but will be continued by other
group members. Nevertheless despite the limited phenotypic analysis of the Dlk2 mutant
mice, preliminary insights can be drawn that address some of proposed questions.
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In summary, the results presented in this thesis demonstrate that although both Dlk2 and
Dlk1 are highly conserved across vertebrates, Dlk2 is the ancestral version of the gene. Dlk1
is much more evolutionarily dynamic than Dlk2, which may reflect the putative vertebrate
clade specific functions identified in section 1.4, especially those related to the emergence
of genomic imprinting (section 1.2.1). Dlk1 and Dlk2 show unique expression patterns,
with some overlap, throughout mouse development. Dlk2, in particular, is expressed widely
throughout the murine embryonic brain. Postnatally, both Dlk1 and Dlk2 are expressed in
various brain regions, with Dlk2 generally displaying predominant expression. Preliminary
analysis of the Dlk2-/- mice suggest that they do not display any significant gross phenotypic
abnormalities. Additional breeding is required to determine whether normal Mendelian ratios
are evident in offspring.
7.1 Dlk2 expression patterns are better conserved between
mice and zebrafish compared to those of Dlk1
A key conclusion from this project is that Dlk2 is most likely the ancestral of the two DLK
genes. Only DLK2 is found in three earliest vertebrate clades: hyperoartia, leptocardii, and
ascideiacea (section 2.1) and is better conserved across vertebrates than DLK1 (sections 2.2
and 2.3). The expression patterns of Dlk2 are more broadly conserved than those of Dlk1
between mice and zebrafish (data from Dr. Ben Shaw). It would be incorrect to assume that
the conservation of Dlk2 expression patterns relative to Dlk1 further suggests that Dlk2 is the
ancestral gene. After gene duplication, the parent gene is equally likely to show neofunction-
alisation and unique expression patterns as the child gene [20]. Overall then, the conserved
expression patterns (section 7.1) and evolutionary analysis (section 2.1) suggest that not only
is Dlk2 ancestral to Dlk1 but also its function has been retained across vertebrates.
It is challenging to compare heterologous systems, such as mice and zebrafish, especially
as they have such different life histories. For example, zebrafish possess a larval stage not
seen in mice. Nevertheless, comparisons of the overall expression patterns can be made. In
general, both Dlk1 and Dlk2 are broadly expressed early in murine development with Dlk2
expression becoming increasingly restricted to the mouse brain, and subsequently cortex,
until expression is lost at the end of development (section 3.2). Whereas Dlk1 remains more
widely expressed for longer in mouse development, although again expression is ultimately
lost. In zebrafish, Dlk1 is ubiquitously expressed during segmentation but is then constrained
to neuronal regions after hatching (48-72 h.p.f); and Dlk2 expression is restricted to the
anterior portion during segmentation and is also only expressed in neuronal lineages after
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(a) Mouse
(b) Zebrafish
Fig. 7.1 ISHs of Dlk2 on e14.5 wild-type mouse embryos and 5dpf zebrafish larvae
The ISHs on zebrafish were performed by Dr. Ben Shaw during his PhD. Sense controls not
shown.
hatching (PhD Thesis Dr. Ben Shaw, University of Cambridge (2017)). To the author’s
knowledge, Dlk1 and Dlk2 expression have never been examined during the segmentation
phase in mice making comparisons between this developmental stage challenging. Investi-
gating this in mice might be useful to fully interpret the evolutionary relationship of both
genes. Nevertheless, overall it seems that the overarching expression patterns of Dlk2 (figure
7.1) are better conserved than those of Dlk1 (figure 7.2) between zebrafish and mice.
Both Dlk1 and Dlk2 are more broadly expressed in the brain in zebrafish compared to
mice. The reduction in Dlk1 expression in murine brains, coupled with expanded expres-
sion throughout the body, may reflect that as Dlk1 gained additional mammalian specific
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(a) Mouse (b) Zebrafish
Fig. 7.2 ISHs of Dlk1 on e14.5 wild-type mouse embryos and 5dpf zebrafish larvae
The ISHs on zebrafish were performed by Dr. Ben Shaw during his PhD. Sense controls not
shown.
functions (section 1.4.3), it lost a more ancient brain specific function. This could be related
to the emergence of imprinting since many of the tissues with murine specific expression
are associated with putative mammalian neofunctionalism (section 1.4.3). Dlk1 is expressed
in lineages associated with multiple different parts of whole body metabolism including
the adrenal glands, placenta, pancreas, and stomach (section 3.2). Endocrine signalling by
S-DLK1 may be vital for the gene’s roles in metabolism (section 1.7.5), which are pos-
tulated to be mammalian specific and to have co-evolved with imprinting (section 1.7.5).
Biallelic Dlk1 expression, outside the postnatal neurogenic niche, results in gross phenotypes
[52] (discussed further in section 1.4.3), highlighting the evolutionary pressures of its dosage.
7.2 Dlk2 as a stem cell regulator 105
If the neuronal function of Dlk1 and Dlk2 is ancestral, conserved, and redundant, it is
not unexpected that Dlk1 expression is substantially reduced in embryonic murine brains
compared to Dlk2. As mammalian imprinting related neofunctionalism evolved, dlk2 may
have been evolutionarily selected to retain the ancient neuronal function in the developing
mammalian brain. The evidence of more stringent purifying evolutionary selection on Dlk2
(section 2.5) and reduced evolutionary dynamism (section 2.4) supports this hypothesis.
Furthermore, Dlk1 expression is biallelic in sites of postnatal neurogenesis in mice [78]. The
broader expression of Dlk2 expression in zebrafish compared to mice (figure 7.1) does not
compromise this hypothesis. Embryonic neurogenesis is not identical between both species.
There are far more sites of neurogenesis in the developing zebrafish (reviewed in [196])
compared to the developing mouse (reviewed in [261]).
There are some limitations with the proposed hypothesis to explain the expression patterns
of Dlk1 and Dlk2 in mice and zebrafish. Some murine ISHs were conducted on insufficient
numbers of biological replicates at certain developmental time points, in particular e16.5,
to be certain of their accuracy. However, the consistency of the Dlk1 ISHs to published
datasets (section 1.3) enables confidence in the Dlk1 data, at least. Furthermore, extensive
validation of the ISHs by qPCR or rtPCR was not performed. Brain, liver, heart, lung, tongue,
kidney, and placenta were harvested from litter mates of the dissected wild type embryos
at all developmental time points. However, attempts at qPCR and rtPCR, conducted over a
9 month period, on these tissues were extremely unsuccessful. In addition, the differences
in Dlk1 expression patterns between zebrafish and mice may be due to the absence of an
S-DLK1 isoform in zebrafish. Zebrafish Dlk1 lacks the juxtamembrane cleavage domain
(figure 2.3) and has evolved the most of any of the DLK1 genes (section 2.4). Until Dlk1
expression is assessed in another vertebrate species, ideally of the actinopterygii clade, it is
difficult to be sure that the absence of widespread Dlk1 in the zebrafish body at later stages
of development is not due to the absence of S-DLK1.
7.2 Dlk2 as a stem cell regulator
Given that Dlk2 is the ancestral paralogue and that the ancient function of Dlk1 is stem cell
regulation (section 1.4.1), it is a reasonable hypothesis that Dlk2 is a stem cell regulator as
well. Detailed phenotypic analysis of Dlk2-/- zebrafish suggest that Dlk2 is s regulator of
neurogenesis. There is an expansion in the number of neurons born early in neurogenesis
and a reduction in later stage neuron number (PhD thesis, Dr. Ben Shaw). This suggests
that there is a depletion of the progenitor pool and that Dlk2 might be behaving in a similar
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manner to Dlk1 in the postnatal murine neurogenic niche [78]: Dlk2 may limit differentiation
and promote the self-renewal of progenitor cells.
Although the evidence of Dlk2 mediated stem cell regulation is robust in zebrafish
(pers. comm. Dr. Ben Shaw), it is only circumstantial in mice. Dlk2 is expressed in
intramembranous and endochondral cartiladge at e12.5 (section 3.3) and work in cell lines
suggests that Dlk2 negatively regulates chondrogenesis [254]. Dlk2 is expressed in the same
lineages embryonically (section 3.2) and postnatally (sections 4.2, 4.3, and 4.4) in mice as it
is in zebrafish (pers. comm. Dr. Ben Shaw). However, the consequences of removing Dlk2
in murine neurogenesis has not been investigated making it challenging to ascertain whether
the role Dlk2 plays in murine neurogenesis is the same as in zebrafish. The preliminary
analyses of the gross phenotypic consequences of removing Dlk2 in mice (section 6) suggest
that there are none. However, there were also no gross phenotypic abnormalities in Dlk2-/-
zebrafish (pers. comm. Dr. Ben Shaw). The absence of a clear preliminary phenotype in the
Dlk2-/- mice is thus not discouraging.
7.3 The Dlk genes and NOTCH signalling
After resolving whether Dlk2 is indeed a stem cell regulator, a natural follow-up project
is to investigate the mechanisms underlying its function (section 7.4). Determining if the
mechanisms are shared with Dlk1 is imperative to working out the evolutionary relationship
between the genes. Did Dlk2 regulate stem cells across multiple tissues but then specialised
in brain specific regulation as Dlk1 took over stem cell regulation in non-brain lineages, and
was co-opted for additional clade specific functions (section 1.4.2 and 1.4.3)? If stem cell
regulation is the more ancient shared role between both genes, it is likely that Dlk2 and Dlk1
utilise the same signalling methods to carry out this function. Furthermore, it is also likely to
be related to NOTCH signalling since the DLK gene family evolved from duplication events
from the canonical NOTCH ligands: the DLL genes (section 1.2).
The Taylor group recently demonstrated that Notch2 is necessary for maintenance of
neural stem cell quiescence in the postnatal neurogenic niche in mice [71]. Knocking out
Notch2 leads to aberrant differentiation of neural stem cells and ultimately exhaustion of the
neurogenic niche [71], similar to the phenotypes seen in Dlk1-/- mice [78]. Although the
common phenotypes suggest that Dlk1 and Notch2 might regulate postnatal neurogenesis in
mice, Ferron and colleges were unable to detect any alterations of NOTCH activity via the
secreted isoform, measured as Hes5 expression, in the neurospheres derived from Dlk1-/-
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mice [78]. The study did not rule out the possibility that membrane-bound Dlk1 in neural
stem cells interact with NOTCH. Nevertheless, this characterisation of Notch signalling was
performed in ex vivo neurospheres [78] and the absence of Notch activity may not reflect
in vivo functions. Furthermore, in vivo reduction of Hes5 expression was used to validate
the Notch2 mutant [71]. The plethora of other signalling pathways implicated in Dlk1 stem
cell regulation (section 1.6.2) may reflect in vitro work; such studies were conducted almost
exhaustively on immortalised cell lines (section 1.6.2).
The phenotypes of Dlk2-/- zebrafish (unpublished characterisation by Dr. Ben Shaw) and
various Notch mutant zebrafish (table 7.1) are broadly consistent. However, the Dlk2-/- fish
show an increase in GFAP positive cells at 48hpf when the other mutants show a reduction,
however, by 72hpf the reduced/absence of radial glial are found in all phenotypes of all
members of the pathway, including Dlk2.
The subtle differences between the phenotypes of Dlk2-/- zebrafish and the other Notch
mutants is likely due to Dlk2 and Delta regulating NOTCH signalling in temporally specific
manners. Delta likely regulates neurogenesis in the earlier stages of zebrafish development
and is responsible for stem cell formation and/or early stem cell proliferation. This is why
knocking out various Delta ligands results in an expansion of the earliest neurons, a sub-
sequent depletion of the neurogenic cells and a reduction in later neural cell types. Dlk2,
however, probably regulates Notch signalling later in development. It is likely responsible
for maintaining cells in the neurogenic niche in a quiescent state, preventing premature
differentiation into neural cell types, in a manner similar to the role Dlk1 plays in the murine
postnatal neurogenic niche [78]. Knocking out Dlk2 has no affect on the earlier neural
populations. However, the absence of Dlk2 results in a premature expansion of a transient
amplifying cell population midway during neurogenesis. This expansion in turn depletes the
neurogenic stem cell pool within the niche and reduces the number of later born neurons.
Since there are no abnormalities in the earlier neurons, the overall neurogenesis defect is
less severe in Dlk2 mutants compared to Notch mutants; this is why the Dlk2 mutants are
homozygous viable.
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Despite the discussed caveats, these data collectively suggest that Dlk2 and Dlk1 both
behave as NOTCH agonists, at least with regards to functioning as stem cell regulators.
This is very interesting given the data suggesting that Dlk1 might function as a NOTCH
antagonist (section 1.6.1). Most of the evidence for DLK1 mediated NOTCH inhibition
comes from work in cell lines [232] or heterologous systems [29]. It is therefore unsurprising
that the most ancient gene functions likely arise through NOTCH agonism. The proposed
NOTCH interacting sites on DLK1 (EGFs 5 and 6) [232] are not fully conserved across the
18 vertebrate species in which the protein sequence was studied (section 2.3). On the other
hand, the DLK genes retain the OSM-11 motif, which has been shown to activate NOTCH
in C. elegans [123, 120], which is not a vertebrate. It might make sense for a likely ancient
and conserved gene function to have utilised a vestigial signalling method after its genome
duplication and early evolution.
7.4 Further experiments
Although the preliminary data is presented in this thesis is informative, a substantial body
of further work is needed to truly characterise the role of Dlk2 in mice and address its
(evolutionary) relationship with Dlk1.
7.4.1 Completion of our understanding of Dlk2 expression in wild type
mice
In order to fully interpret future experiments characterising Dlk2 function in mice (section
7.4.2), it is necessary to generate a robust understanding of the Dlk2 expression in wild-type
animals. The ISHs performed on wild type embryos (section 3.2) should be repeated such
that Dlk2 expression is investigated on a minimum of 3 biological replicates per time point.
These results should also be validated using an independent experimental method, such as
rtPCR or qPCR. Brain, liver, heart, lung, tongue, kidney, and placenta were harvested from
wild-type embryos from the same developmental stages investigated by ISH (section 3.2).
However, repeated attempts at qPCR and rtPCR were unsuccessful. With a Dlk2 qPCR
protocol now established (section 4.2), it might be appropriate to revisit validating the ISH
data using the collected samples.
It will also be necessary to characterise postnatal expression ofDlk2. The semi-quantitative
assessment of Dlk2 expression, relative to Dlk1, in postnatal wild-type brains does not yield
cellular resolution. Performing ISHs on coronal, saggital, and transverse postnatal brain
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sections would thus be useful. The sections have already been generated for brains harvested
from p7 C57BL/6J wild-type animals but similar sections from p60 mice will need to be
created. However, Dlk2 may also be expressed in non-neuronal tissues in the adult mouse.
It might be better to identify such tissues using methods with a higher throughput, such as
rtPCR or qPCR, before assessing the cellular resolution of the expression with ISH.
mRNA and protein expressions do not always correlate. Therefore, immunohistochem-
istry of DLK2 should be repeated on embryonic and postnatal wild-type sections Dlk2 ISH
was performed on. The retention or exclusion of the juxtamembrane domain has yet to be
experimentally observed for Dlk2 in any species. Experiments to resolve this are probably
essential for interpreting the relationship between Dlk1 and Dlk2. cDNA derived from RNA
extracted from a variety of murine tissues at a number of different time points could be used
to clone various Dlk2 variants in Escherichia coli. Gel electrophoresis of the mixture of
cloned proteins could determine if there are any size variants, which would likely represent
distinct DLK2 isoforms. These could then be sequenced.
7.4.2 Characterisation of Dlk2-/- mice
The generation of a Dlk2-/- mouse is perhaps the biggest contribution of this project to the
study of DLK gene function. Before the Dlk2 mutants can be used for characterisation of
Dlk2 gene function, validation is required. Western Blotting, using custom DLK2 antibodies
developed by Abcam, on homozygous animals at developmental time points, such as e12.5
or e14.5, with known high Dlk2 expression will be necessary to validate that DLK2 protein
expression is ablated. qPCR of Dlk2 on similar tissues and time points from wild-type
and mutant could also determine whether non-sense mediated decay occurs [94, 114, 146].
In addition, assessment of off-target effects will also be necessary before any phenotypic
conclusions can be drawn. Sequencing the exonic predicted off-target sites (described in
tables 5.6 and 5.7) from the founder animals would be useful. However, since off-target mu-
tagenesis can occur at non-computationally predicted sites [128]; it may be worth performing
systematic genome wide off-target analysis, perhaps using the recently described VIVO
system [11]. It is probably best that such a approach is used on the animals backcrossed to
generation 9 will have segregated out all but closely linked off-target effects and none are
predicted (section 5.3).
After validating the mutant and selecting 2 of the five Dlk2 mutant lines to characterise,
detailed phenotypic analysis can begin. As discussed in section 5.3, it is ideal to generate
heterozygous intercross colonies from mice backcrossed to an early (N=2), an intermediate
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(N=5), and a late (N=9) generation to look for phenotypic stabilisation. Some, but not
all, proposed experiments should be performed on all the colonies. Indeed, only the most
comprehensive analysis should be performed on the final generation to limit costs.
Initial phenotypic characterisation of the Dlk2 mutants should be very similar to the
approach used in section 6, but with significantly larger sample sizes. The sex and genotype
ratios of offspring born to heterozygous intercrosses should be assessed. These animals
should also be weighed postnatally. Should any gross weight phenotype arise, DEXA as-
sessments could be performed on a subset of the heterozygous intercrosses offspring at an
appropriate time point. DEXA assessments would identify an bone density and lean:fat
mass and so could identify the underlying cause of a weight phenotype. In addition, the wet
and dry embryo and placental weights should be assessed for the offspring of heterozygous
intercrosses throughout various stages of development. Furthermore, the sex and genotype
ratios of such offspring should also determine to ascertain when homozygous loss occurs, if
relevant.
It is challenging to predict what further phenotypic analyses would be useful to perform
on the Dlk2 mutant lines as the preliminary phenotypic data is so inconclusive (section 6).
As the mutations are moved onto pure C57BL/6J backgrounds gross phenotypes may emerge
that might inform the experimental design. However, given the widespread expression of
Dlk2 in the embryonic (sections 3.2 and 4.2) and postnatal (sections 4.3 and 4.4) wild-
type mouse brains, investigating the behaviour, though classic experiments such as the
Morris Water Maze, of Dlk2-/- mice versus wild-type litter-mate controls would probably
be informative. Given the hypothesis that Dlk2 is a stem cell regulator, it would be useful
to derive neurospheres from Dlk2-/- mice and perform similar experiments to those used to
characterise the role of Dlk1 in postnatal neurogenesis [78]. This experiment is on-going in
the Ferguson-Smith laboratory.
7.4.3 Investigating the relationship between Dlk1 and Dlk2
In order to understand the evolutionary relationship of Dlk1 and Dlk2 across various verte-
brates, it may be worth studying them in additional model organisms. In addition, it will be
essential to investigate the expression of both genes during segmentation in mice. Dlk1 and
Dlk2 have distinctive expression patterns during segmentation in zebrafish (PhD Thesis Ben
Shaw, University of Cambridge (2017)) but the expression patterns, during segmentation,
not been reported in mice. This makes it challenging to compare the overall expression
dynamics between the two species and limits the potential interpretation of Dlk1 function
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and expression relative to the evolution of imprinting (section 7.1). ISH of both genes should
thus be conducted during the segmentation period in mice.
Experiments investigating the expression of Dlk2, mRNA and protein, at various embry-
onic and postnatal stages in Dlk1-/- mice will help elucidate the relationship between Dlk1
and Dlk2. Dlk1-/- murine wax sections were harvested at the standard developmental time
points used in this study for Dlk2 ISHs that were not completed. Similarly brain, liver, heart,
lung, tongue, kidney, and placenta were extracted from Dlk1-/- mouse embryos but qPCR
was attempted, due to the lack of success of Dlk2 qPCR on wild-type tissues. A reciprocal
set of experiments for Dlk1 expression should be performed on the Dlk2-/- mice, after the
appropriate backcross generation has been reached.
Evaluating the functional relationship between DLK1 and DLK2 will be more challeng-
ing, as they likely share some functional redundancy. After the appropriate backcross has
been reached, the Dlk2-/- mice can be crossed with Dlk1-/- mutants. Offspring of these
crosses (Dlk1+/-; Dlk2+/-, Dlk1+/-; Dlk2-/+, Dlk1-/+; Dlk2+/-, and Dlk1-/+; Dlk2-/+) can
be crossed together to generate litters potentially including double knockouts which could
be compared to wild-type litter-mate controls. If the double mutant is viable then the com-
prehensive phenotypic analysis, including neurosphere assessment, described in section
7.4.2 should be repeated. If the double knockout mice display more severe phenotypes than
the individual knockout mice then there is likely some functional redundancy. The double
knockout could prove to be lethal. In such a scenario, it might be worth crossing the Dlk2-/-
mice with conditional Dlk1 mutants [18].
Although a zebrafish Dlk2 mutant has been generated, attempts to edit Dlk1 in zebrafish
to create mutations have been unsuccessful to date, however these experiments remain in
progress. Generating Dlk1-/- zebrafish and performing a similar suite of phenotypic experi-
ments would help inform the evolutionary relationship between Dlk1 and Dlk2. Generating
and phenotyping Dlk1-/-; Dlk2-/- zebrafish, if viable, would be ideal for this purpose.

8 Materials and methods
All procedures were performed in accordance with the Home Office Guidance on the Opera-
tion of the Animals (Scientific Procedures) Act 1986, published by Her Majesty’s Stationery
Office.
8.1 Mice
Mouse lines were maintained in the Combined Animal Facility, University of Cambridge.
Routine maintenance was performed by animal technicians, in particular Wendy Cassidy.
All mouse work was carried out in accordance with UK Government Home Office licensing
regulations under project licence PC9886123.
8.1.1 Routine mouse maintenance
All mice were housed in a temperature- and humidity-controlled room (21oC, 55% humidity)
with 15-20 air changes per hour and a 12 hour/12 hour light-darkness cycle (light 07:00-19:00,
dark 19:00-07:00). All mice were fed standard RM3 (E) diet (Special Diets Services) ad
libitum. They were given fresh tap water daily and re-housed in clean cages weekly. Mice
were weaned at 21 days postnatally, or a few days later if particularly small. Thereafter,
except when breeding, they were housed in single-sex groups (5 per cage maximum). If the
litter was small, mice would be single-sex housed in a maximum of 6 individuals for no more
than a week to enable genotyping. Mice were also occasionally singly housed.
The presence of pathogens was monitored using sentinel animals. Routine monitoring
detected the presence of murine norovirus, murine hepatitis virus, pinworm and Helicobacter
species. Early in 2017 the unit discovered a widespread mite infestation in the facility. This
was treated with 6 treatments of selamectin followed by 5 weeks of invermectin treated diet.
8.1.2 Timed matings
Timed matings were used to harvest embryonic materials at the correct developmental stage.
Matings between receptive females and relevant males were set up towards the end of the
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working day. The following morning, staff at the Combined Animal Facility checked if the
female had a waxy vaginal plug — indicating a successful mating. If there was no visible
plug the process was repeated the following morning. When a female had an observable
plug, she was removed to a new cage and the ’plug’ date recorded. From around e10.5,
the pregnant female was weighed daily to ensure that her weight increased as expected
during pregnancy. Pregnant females were sacrificed by a schedule 1 method at the correct
developmental time point and the embryos harvested. Non-pregnant females were returned
to the male to repeat the timed mating process.
8.1.3 Mouse lines used and their routine breeding
The Dlk1-/- mice were maintained on a C57BL/6J background, having previously been
backcrossed into this background for 10 generations. The various Dlk2 mutant lines were
generated using CRISPR/Cas9 in CBA x C57BL/6J hybrids. Backcrossing these mutants
onto a pure C57BL/6J background is on-going.
C57BL/6J
C57BL/6J mice were initially purchased from Harlan Laboratories, Charles River Laborato-
ries, or the Jackson Laboratories and thereafter maintained in-house by mating C57BL/6J
females with C57BL/6J males.
CAST/EiJ
CAST/EiJ mice were initially purchased from the Jackson Laboratories and thereafter main-
tained in-house by mating CAST/EiJ females with CAST/EiJ males.
C57BL/6J X CAST/EiJ hybrids
C57BL/6J X CAST/EiJ hybrids were generated by crossing C57BL/6J females (section 8.1.3)
with CAST/EiJ males (section 8.1.3). CAST/EiJ X C57BL/6J hybrids were generated by
crossing CAST/EiJ females (section 8.1.3) with C57BL/6J males (section 8.1.3).
The Dlk1 knockout line
The Dlk1 knock-out line was created by homologous recombination in SvJ129 embryonic
stem cells that resulted in the replacement of 3.8 kb of the endogenous Dlk1 allele with a
neomycin resistance cassette in the opposite orientation to the gene [181]. This recombi-
nation removed the Dlk1 promoter and its first three exons [181]. The Dlk1 knock-out line
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was routinely maintained by homozygous crosses (Dlk1-/- x Dlk1-/-) by Jennifer Cornish or
myself.
To compare embryonic weights of Dlk1-/- mice and wild type mice (section 6.5), internal
wild type littermate controls were needed. To achieve this C57BL/6J wild type animals were
crossed with Dlk1-/- mice to generate heterozygous offspring. These offspring were then
mated together in a timed mating (section 8.1.2) and the females sacrificed by a schedule 1
method at the relevant embryonic stage.
The Dlk2 mutant lines
The DK1C, DK1G, DK16, DK73, and DK13 lines were generated using CRISPR (section
8.7). Founder animals were initially housed in the MRC Cambridge Stem Cell Institute,
University of Cambridge, Animal Facility where routine mouse maintenance (section 8.1.1)
was performed by Clare Cunstance. She also collected ear biopsies (section 8.1.4) for the
founder mice. When the founder animals reached breeding age they were transferred to
the Combined Animal Facility, at the University of Cambridge, where they were mated to
C57BL/6J and their offspring genotyped.
The described lines were characterised and selected at the F1 stage. F1 mice of each
kept Dlk2 mutant line were then crossed again with C57BL/6J mice. This backcrossing
process was continued: F2 heterozygous offspring were crossed with C57BL/6J mice, then
F3 heterozygous offspring were crossed with C57BL/6J, and so on.
Heterozygous intercrosses of each line were achieved by crossing heterozygous F1 or
F2 mutants with each other. These colonies were then maintained by mating heterozygous
offspring of each cross together.
8.1.4 Collection of tissues for genotyping
All mouse lines were routinely genotyped from an ear biopsy taken, from p6 onwards, using
’The Punch’ (National Band). Ear biopsies were also taken between p3 and p6 for Dlk2
mutant lines using scissors by William Watkinson. Ear biopsies were stored at -20oC prior to
use.
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8.1.5 Genotyping
Dlk1 knock-out mice
Mice from theDlk1 knock-out line were genotyped by PCR (section 8.3.10) using low-quality
DNA extracted (section 8.3.2) from ear biopsies (section 8.1.4). This identified the presence
or absence of the neomycin resistance cassette or the BAC.
Dlk2 mutant lines
All Dlk2 mutant mice were genotyped by PCR (section 8.3.10) targeting exon 2, 3, or 5, as
required, using low-quality DNA extracted (section 8.3.2) from ear biopsies (section 8.1.4).
The PCR results were visualized using gel electrophoresis (section 8.3.4). With the exception
of the DK73 line, the DNA producted was extracted from the agarose gel (section 8.3.5).
Sanger sequencing by Genewiz or Source BioScience was performed on the extracted DNA.
The sequence traces were analysed by manual annotation to determine the genotype of each
animal.
8.1.6 Dissection of mice
Dissections of embryos and placentae were performed on pregnant females sacrificed by a
schedule 1 method, often with technical assistance of Jennifer Corish, Billy Watkinson, and
Frances Dearden. Embryos, contained inside their yolk sac, were removed from perinatal
cavity and placed into 1XPBS on ice until needed. During dissection of the embryos and
placentae, they were carefully removed from the yolk sac and amnion. After allowing as
much amniotic fluid to be removed as possible, the embryos and placentae were separately
weighed, and the embryo measured using a transparent ruler. From e16,5 onwards, embryos
were then decapitated. Tails were taken for genotyping (section 8.3.10). Afterwards the
embryos and placentae were then added to 4% PFA for histology (section 8.3.6) or further
tissues, such as brain and liver, were then dissected and snap frozen using liquid nitrogen
(section 8.3.14).
C57BL/6J X CAST/EiJ hybrids, and their reciprocal hybrids, were sacrificed using a
schedule 1 method by Dr. Lisa Hulsmann, and then dissected. She performed such dissections
on hybrids at p7 and p60 and isolated the brainstem, cerrebellum, cortex, hippocampus,
hypothalamus, liver (p7 only), and muscle (p7 only). She also dissected 16.5 hybrid embryos
as described above, isolating brain, liver and placenta. All tissues were snap frozen using
liquid nitrogen for RNA extraction (section 8.3.14).
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8.1.7 Weighing postnatal mice
Ear biopsies, taken as early as p3 (section 8.1.4), also functioned as IDs for individual mice.
From the biopsy onwards relevant litters were weighed postnatally, at regular intervals, in the
Combined Animal Facility, occasionally by William Watkinson or Frances Dearden. The
animals were placed into a large transparent container and weighed using the same scales.
8.2 General materials and equipment used
8.2.1 Common materials used
Where relevant the kits used will be described in the method text, however common materials
used are outlined below:
1. 0.2ml 8-Strip Non-Flex PCR Tubes: STARLAB I1402-3700-C
2. 10µl, 20µl, 300µl, and 1000µl filter sterile pipette tips: STARLAB S1120-3710-C,
S1123-1710-C, S1120-9710, and S1122-1800-C, respectively
3. 10µl, 200µl, 1000µl pipette tips: STARLAB, S1111-3700-C, S1113-1700-C, and
S1112-1720, respectively
4. 15ml centrifuge tube: Corning 430791 or ThermoFischer Scientific 11849650
5. 50ml centrifuge tube: Greiner Bio-One 227261 or ThermoFischer Scientific 430046
6. 96 well PCR plate: Axygen AXP401
7. 384 transparent qPCR plate: Roche 5102430001
8. 1kb ladder: Newmarket Scientific DM010X5
9. 100bp ladder: Newmarket Scientific DM001X5
10. Absolute ethanol: Sigma-Aldrich 32221
11. Ethylenediaminetetraacetic acid (EDTA): Sigma E5134
12. Formamide: Sigma-Aldrich 613339
13. Microcentrifuge tube; 1.5ml and 2ml: STARLAB e1415-1500 and LabCon 211-0034,
respetively
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14. Nuclease free water: Roche R0581, Sigma W4502, or DEPC treated water (section
8.2.2)
15. Plate sealers (PCR): STARLAB E2796-0793
16. Plate sealers (qPCR): Roche 4729757001
17. Protinase K: ThermoFischer Scientific 10103533
18. RNase A: Sigma-Aldrich A2760
19. Sodium Citrate: ThermoFischer Scientific S3320
20. Sodium Hydroxide (NaOH): ThermoFischer Scientific S4880
21. Sodium Chloride (NaCl): Honeywell Fluka 31343 or ThermoFischer Scientific S3120/60
8.2.2 Solutions generated
1X Maleic Acid Buffer
0.58g Maleic acid (ThermoFischer Scientific 63186), 0.44g NaCl, and 0.36g NaOH were
dissolved in a total of 50mL distilled water, which was subsequently filter sterilised.
1X Phosphate Buffered Saline (PBS)
Phosphate Buffered Saline (Dulbecco A) tablets (Oxoid) in nuclease free or distilled water,
as per the manufacturer’s instructions.
4% Paraformaldehyde (PFA)
5 PFA tablets (Oxoid BR0014G) were dissolved into 500ml distilled water on ice. 50ml
aliquots of the solution were stored at -20oC until use. The frozen PFA was used exclusively
for ISHs (section 8.5.2). All other PFA was generated by dilution of 40% PFA solution
(Sigma-Aldrich 441244).
20X SSC
175.3g NaCl and 88.2g sodium citrate were dissolved in 1L distilled water and the pH
adjusted to 7.0 using 10M NaOH.
8.2 General materials and equipment used 121
100X Denharts
20g ficoll (Sigma-Aldrich F5415), 20g polyvinylpyrrolidone (Bio Basic Canada 9003-39),
and 20g BSA (Fraction V, Sigma) were dissolved in 1L of distilled water and then filter
sterilised.
Blocking solution
1% blocking reagent (Roche 11096176001) was dissolved at 37oC in maleic acid buffer.
Chamber buffer
50ml chamber buffer was created with 20ml formamide, 12.5ml 20x SSC, and 17.5ml
nuclease free water.
Cresol-Red loading buffer
28% w/v Sucrose (ThermoFischer Scientific S-9378) and 0.008% w/v Cresol-red were added
to 50mL of distilled water. Communal lab stock originally generated by Frances Dearden.
DEPC treated water
0.1% DEPC (Sigma D5758) was added to distilled water and left over night. The mixture
was autoclaved the following morning to degrade the DEPC.
LB agar
10g tryptone, 5g yeast extract, and 10g NaCl were added to 1L distilled water before the pH
was adjust to 7.0 using 5M NaOH. The mixture was then autoclaved.
LB agar plates
10g tryptone, 5g NaCl, 5g yeast extract, and 15g agar were added to 1L distilled water. The
mixture was autoclaved. Before pouring the plates the autoclaved solution was melted in the
microwave and 0.5mL ampicillin (100ng/ml) was added.
NTMT solution
20ml 5M NaCl, 50ml 1M MgCl2, 100ml 1M TrisHCL pH9.5, and 5ml 20% Triton (Sigma-
Aldrich X100) were added to sufficient distilled water to create a solution with a total volume
of 1L.
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RNase free 0.5M sodium hydroxide
20g of NaOH was dissolved in RNase free water (section 8.2.1).
SOC media
20 mg/ml Tryptone, 5 mg/ml Yeast Extract, 85.6 mM NaCl, 2.5 mM KCl , 0.01 mM MgCl2,
0.02 mM Glucose were dissolved in distilled water. The pH was adjusted to 7.0, and the
solution was sterilised by autoclaving.
Tris-Glycine buffer
18.77g Tris-Base (Sigma-Aldrich T1503) and 30.29g glycine (Sigma-Aldrich G8898) were
dissolved in 500mL of distilled water.
8.2.3 Primers used
Name Use Forward Reverse
18s rRNA qPCR CGGCTACCACATCCAAG-
GAA
GCTGGAATTACCGCG-
GCT
Actin qPCR CCGGGACCTGACAGAC-
TACCT
GCCATCTCCTGCTC-
GAAGTCTA
DLK1 qPCR GCTTCGCAAGAAGAA-
GAACC
CTCATCACCAGCCTC-
CTTGT
DLK1
(WT)
GT Dlk1 line CCAAATTGTC-
TATAGTCTCCC
CTGTATGAAGAGGAC-
CAAGG
DLK1
(KO)
GT Dlk1 line CATCTGCACGAGAC-
TAGTG
CTGTATGAAGAGGAC-
CAAGG
DLK2 qPCR CCACTGGACCCTGCTGC-
TAC
TGCTAACCTGGCACTC-
CTGATC
DLK2 ex.
2
GT CRISPR
mut.
CAGACCTGGC-
TAGTGGGTTC
GTTGGCGAGGCAAG-
GTATC
DLK2 ex.
3
GT CRISPR
mut.
TGACCTCTGCTGGCTA-
GAGA
GAGAGTTCCCGAA-
GACAGGG
DLK2 ex.
5
GT CRISPR
mut.
ACTACCAGAGCTGAGAC-
CGG
AGAAAAGGGCGTTTAC-
CACA
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Table 8.1 (continued)
Name Use Forward Reverse
DLK2
ex2.
gRNA-1
CRISPR
gRNA— 1st
apt.
TAATACGACTCAC-
TATAGCCAGACGTGTAGA-
CACCTGT
TTCTAGCTCTAAAACCC-
CACAGGTGTCTA-
CACGTC
DLK2
ex2.
gRNA-2
CRISPR
gRNA— 1st
apt.
TAATACGACTCAC-
TATAGCCCACAGGTGTC-
TACACGTC
TTCTAGCTCTAAAACCC-
CACAGGTGTCTA-
CACGTC
DLK2
ex2.
gRNA
CRISPR
gRNA—
2nd apt.
TAATACGACTCACTATAG-
GCACACGAGATTTAGGCA
TTCTAGCTCTAAAACCT-
GCCTAAATCTCGTGTGC
DLK2
ex3.
gRNA
CRISPR
gRNA—
2nd apt.
TAATACGACTCACTATAG-
GTCAGGAGCGCAGCAG
TTCTAGCTCTAAAA-
CACGGCTGCTGCGCTC-
CTGA
DLK2
ex5.
gRNA
CRISPR
gRNA— 1st
apt.
TAATACGACTCACTATAGT-
GCAACCGCTCCGTTC-
CATA
TTCTAGCTCTAAAA-
CACGGCTGCTGCGCTC-
CTGA
DLK2
ex5.
gRNA
CRISPR
gRNA— 1st
apt.
TAATACGACTCACTATAGT-
GCAACCGCTCCGTTC-
CATA
TTCTAGCTCTAAAA-
CACGGCTGCTGCGCTC-
CTGA
DLK2
ex5.
gRNA
CRISPR
gRNA—
2nd apt.
TAATACGACTCACTATA-
GATTCTGGCAGGGT-
GATTGTG
TTCTAGCTCTAAAACC-
CGTCATACACA-
CACTGGC
TBP qPCR AGAGCAACAAA-
GACAGCAGC
CTGTGTGGGTTGCTGA-
GATG
Table 8.1 Primer pairs used throughout the project
Acronyms used: apt. — attempt, ex. — exon, GT — genotyping, KO — knockout allele, mut.
— mutants, WT — wild type allele.
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8.3 Common techniques used
8.3.1 Cloning
Prior to cloning, the plasmid was dephosphorylated to prevent self-ligation of and promote
plasmid phosphorylated insert ligation. Approximately 4mg of pBluescript II (gift from
Dr. Mitsu Ito) was added to 40µl NEBuffer 3 (New England Biolabs B7003S), 4µl 100X
fortified BSA (New England Biolabs B9000S), 4µl of EcoRV (Roche 000000011040197001)
and sufficient distilled water to make a total reaction volume of 400µl. After vortexing and
brief centrifugation, the reaction was incubated overnight at 37oC. 4µl of the reaction was
added to 4µl of Cresol Red (section 8.2.2) and run on a 1% agarose gel (section 8.3.4) to
check that the digestion was successful.
Following successful digestion, 4µl of Calf Intestinal Alkaline Phosphatase (New Eng-
land Biolabs M0290S) was added to the reaction and incubated at 37oC for 1 hour. Phenol
Chloroform extraction (section 8.3.7) was then performed followed by ethanol precipitation
(section 8.3.3) where the final product was resuspended in 20µl of nuclease free water. The
concentration was then assessed using the BioDrop uLite.
4µl of the ethanol precipitated linearised plasmid was added to a sufficient volume of
the phosphorylated (section 8.3.8) target insert for a vector:insert ratio of 1:3. This mixture
was added to 1µl of T4 DNA ligase (New England Biolabs (M0202S) and incubated at 16oC
for 30 minutes and then 65oC for 10 minutes. 1µl EcoRV (Roche 000000011040197001)
was then added to the reaction, which was the incubated at 37oC for another 30 minutes, to
break down any vector that self ligated. Finally, ethanol precipitation (section 8.3.3) was
performed and the product was resuspended into a final volume of 5µl of distilled water.
8.3.2 DNA extraction
DNA extraction of mouse ear clips was performed using the Rapid Extract PCR Kit (PCR-
BIO PB10.24-08), according to manufacturer instructions, or using the Extract-N-Amp kit
(Sigma-Aldrich XNAT2-1KT). Extractions using the sigma kit were prepared on ice: 20µl
lysis solution and 2L protienase K (10ng/µl) were added to cover each ear-notch. The
samples were then briefly centrifuged before being incubated at 55oC for 10 – 15 minutes
and subsequently 94oC for no more than 5 minutes. 20µl of neutralising solution was then
immediately added to each sample. Extracted DNA from both kits was stored at -20oC until
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used.
The DNA of transformed cells was extracted differently. After a colony of a desired
target (plasmid) had been expanded (section 8.4.1), the cells were centrifuged at 4oC for 10
minutes at 3000rpm. The broth and tooth pick were then removed and discarded appropriately
(addition of 2% Virkon (Appleton Woods 330013) for over an hour before disposal), before
the DNA of the pellet was extracted using the GenElute Plasmid Miniprep kit (Sigma PLN10).
DNA concentration was obtained using the BioDrop uLite.
8.3.3 Ethanol precipitation
Ethanol precipitation was performed using 20µl of the required RNA or DNA product. This
was added to 80µl of nuclease free water, 1µl of glycogen(ThermoFischer Scientific R0561),
35µl of 10M ammonium acetate and 250µl of 100% ethanol (at a temperature of -20oC).
Ethanol precipitation was performed at -20oC for at least 2 hours or overnight. The reaction
was then centrifuged for 20 minutes at 13,500rpm, and the supernatant removed. 500l of
70% ethanol (made with nuclease free water) was added to the pellet. The mixture was then
vortexed and subsequently centrifuged at 13,500rpm for 20 minutes. The supernatant was
again removed and the pellet was resuspended in the appropriate volume of nuclease free
water.
8.3.4 Gel electrophoresis
Ordinary agarose gels were generated by dissolving agarose (Melford Laboratories A20090-
500) into 0.5X TBE (Invitrogen 15581044) buffer using a microwave in a glass bottle.
Typical gel percentages were 1%, 1.5%, and 2%. After melting the agarose, the gel was
gently cooled by holding the bottle under a cold tap and shaking, carefully ensuring that no
water entered the gel. This step was taken as excessively hot gels can denature the SafeView
(NBS Biologicals NBS-SV1) used to visualise the DNA (pers. comm. Dionne Gray) and
damage the mould/cassette (pers. comm. Jennifer Cornish). After the cooling step, SafeView
was added to the gel at 5µl per 100ml gel. The SafeView was then dissolved in by gently
shaking the bottle and the gel poured into the prepared cassette, containing appropriately
sized combs. The gel was allowed to solidify for at least 20 minutes before being placed into
the tank.
If necessary 0.5X TBE buffer was added to the tank until the gel was completely covered.
The combs were removed and the samples, and appropriate ladders (section 8.2.1), were
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loaded into the wells. Unless stated all gels were then run at 120mV for 40-50 minutes
using voltmeter (Elektrophorese PP389). Gels were then visualised using a transilluminator
(Sygene Ugenius 3).
RNase free gels were also generated. Agarose gels were generated as described above
using 0.5X TBE buffer (diluted in nuclease free water). The bottle used to melt the agarose
was also autoclaved and soaked in 0.5M RNase free NaOH (section 8.2.2) for at least 15
minutes prior to use. The tank, combs and mould were also soaked in 0.5M RNase free
NaOH for at least 15 minutes before use.
8.3.5 Gel extraction
Gel extraction was performed using the MinElute Gel Extraction Kit (Qiagen 28604). The
manufacturer recommended protocol was modified for reagent conservation. The gels were
melted in buffer QG at 30oC using a heat block and were continuously shaken. Jennifer
Cornish had observed that the columns could only contain 650µl of solution and so this was
the maximum volume loaded at a given step. Furthermore, only 650µl of buffer PE and
300µl of the second use of buffer QG were used. Finally the distilled water, in which the
DNA was finally dissolved, was pre-warmed to 55oC.
8.3.6 Histology
Samples, dissected as described in section dissections, were fixed in 4% (w/v) paraformalde-
hyde pH 7.4 (Sigma-Aldrich 441244) in 1X PBS at room temperature or at 4oC for an
appropriate time period. Samples greater than 1cm wide or long were fixed for at least
overnight. Samples greater than 2cm wide or long were fixed for 48 hours. E16.5 and e18.5
embryos were decapitated to aid the fixation process.
Fixed samples were transferred to 70% ethanol for short-term storage. Samples with
bone were transferred to PBS as ethanol reacts with EDTA used in the decalcification process.
Samples were stored in PBS for no more than a week before transfer to the Helen Skelton in
the Histology Unit at the Pathology Department, University of Cambridge. Samples stored
in 70% ethanol, and some still undergoing the fixation process, were also delivered to her.
She performed all subsequent steps, including decalcification of bone, necessary for
embedding the samples in paraffin wax. She also sectioned the samples using a microtome to
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produce 10µm thick sections – this was the same thickness Dr. Mary Cleaton found optimal
for histological analysis during her PhD.
8.3.7 Phenol Chloroform extraction
An equal volume of phenol-chloroform was added to the target DNA and vortexed. The
mixture was then centrifuged at maximum speed for 15 minutes. The upper aqueous phase
was transferred to a new tube where an equal volume of phenol-chloroform was again added.
The mixture was again vortxed and centrifuged at maximum speed for 15 minutes and the
upper aqueous phase transferred to a new tube.
8.3.8 Phosphorylation of PCR products
1.5µl NEBuffer 3 (New England Biolabs B7003S), 1µl T4 Polynucleotide Kinase (New
England Biolabs M0201S), 2µl 10M ATP, and 0.5µl distilled water were added to 10ul of
ethanol precipitated (section 8.3.3) poly A tailed (section 8.3.9) PCR product (section 8.3.10).
This reaction was incubated at 37oC for 30 minutes followed by a 20 minute incubation at
60oC.
8.3.9 Poly A tailing
3µl of substrate DNA was added to 1µl dATP, 1µl Taq polymerase (Bioline BIO-21040), 1µl
Taq polymerase buffer (Bioline BIO-21040), and 3µl of distilled water. The reaction was
incubated for 15 minutes at 70oC before being stored on ice until use.
8.3.10 Polymerase chain reaction (PCR)
All PCRs were performed in 8 piece strips or plates (section 8.2.1) and contained negative
water controls, using the primers outlined in section 8.2.3.
Genotyping of Dlk1 mutant mice
7.5µl of Red Taq (Sigma-Aldrich R2523), 0.5µl 10mM forward primer (table 8.1), 0.5µl
10mM reverse primer (table 8.1), and 5.5µl of distilled water were added to 1µof DNA
of sample (extracted as in section 8.3.2). Presence of the WT and KO allelles were tested
separately. PCR conditions testing for the WT allele: 95oC for 5 minutes; 40 cycles of
95oC for 30s, 50oC for 30s, and 72oC for 30s; 72oC for 5 minutes; 10oC until needed. PCR
conditions testing for the KI allele: 95oC for 5 minutes; 35 cycles of 95oC for 30s, 60oC for
30s, and 72oC for 30s; 72oC for 5 minutes; 10oC until needed.
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Genotyping of Dlk2 mutant mice
This PCR was performed on 1:10 dilutions of extracted DNA (section 8.3.2) of samples.
Although different primers were used (table 8.1), the following protocol was the same for
genotyping alterations in all three targeted exons. 10µl Red Taq (Sigma-Aldrich R2523),
1µl 10mM forward primer (table 8.1), 1µl 10mM reverse primer (table 8.1), and 7µdistilled
water were added to 1µl of the sample DNA. PCR conditions: 95oC for 30s; 40 cycles of
95oC for 30s, 60oC for 30s, and 72oC for 1 minute; 72oC for 5 minutes; 10oC until needed.
ISH probe generation
This reaction was performed on C57BL/6J postnatal brain cDNA (section 8.3.11), using
high-fidelity DNA polymerase kit (Phusion M0530), to generate the substrate from which a
Dlk2 riboprobe could be generated (section 8.5.1). For 1 20µl reaction: 4µl 5X GC buffer,
0.4µl 10mM dNTPs, 1µl 10mM forward primer (table 8.1), 1µl 10mM reverse primer (table
8.1), 0.2µl DNA polymerase, 20-75ng of template cDNA (variable volume), and sufficient
nuclease free water to create a total reaction volume of 20µl. PCR conditions: 98oC for 30s;
35 cycles of 98oC for 30s, 67oC for 15s, and 72oC for 30s; 72oC for 10 minutes; 10oC until
needed.
8.3.11 Production of cDNA
cDNA synthesis was conducted in a RNase and DNase free area and RNase free filter tips.
The area, pipettes and pipette boxes were cleaned using the antibacterial spray followed
by 70% ethanol. cDNA was synthesised using the RevertAid H minus first strand cDNA
synthesis kit (ThermoFischer Scientific K1631) and, unless stated, took place on ice. 1µg
of template RNA, extracted as described in section 8.3.14, per sample was added to sterile,
nuclease free PCR tubes labelled as the rt (reverse transcriptase negative) controls. 1µl of
the kits random hexamers were then added to the same tubes. Nuclease free water was added
to create a total volume of 12µl in each rt tube. The overall reaction mastermix was then
assembled: a total volume of 7µl per sample included 4µl of 5X reaction buffer, 1L RiboLock
RNase inhibitor (20U/µl) and 2µl 10mM mixed dNTP (Qiagen 201913). All reagents were
vortexed and briefly centrifuged before assembly. The mastermix was then briefly centrifuged
before 7µl was added to each of the rt tubes. 1µl of RevertAid H minus M-MuLV Reverse
transcriptase (200U/µl) was then added to a fresh set of PCR tubes labelled at the +rt (reverse
transcriptase positive) samples. 16µl of the vortexed and briefly centrifuged samples from
each the rt controls was then added to the corresponding +rt tubes. rt and +rt reactions
were then incubated at 25oC for 5 minutes and then 45oC for 60 minutes. Samples were
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then immediately stored on ice to aliquot and, if appropriate, dilute. All cDNA was stored at
-80oC.
8.3.12 qPCR
qPCR was performed, with technical assistance from Billy Watkinson, on extracted RNA
(section 8.3.14) that had been converted to cDNA (section 8.3.11). A single reaction consisted
of 0.5µl of the 10mM forward primer (section 8.2.3), 0.5µl of the 10mM reverse primer
(section 8.2.3), 5µl of Sybr II Brilliant master mix (Aligent 600828), 3µl of nuclease free
water, and 1µl of cDNA samples. The primers used are available in section 8.2.3. The
reaction mixture (total volume 9µl) without the cDNA sample was generated and then added
to the 384 qPCR plates, before 1µl of cDNA (diluted 1/20 from the cDNA synthesis product,
generated as described in section 8.3.11) was added to the relevant well as quickly as possible
to limit cDNA degradation. The negative control of every sample was included in every
qPCR experiment. Negative controls were the result of a portion of the same RNA sample
that underwent the same cDNA synthesis reaction without the reverse transcriptase enzyme.
Theoretically these samples should have no cDNA present and thus they test for contamina-
tion. After successfully loading the plate, it was sealed with a Thermo Scientific AB-0580
Thermal adhesive seal. The qPCR was centrifuged for 10-20 seconds prior to qPCR.
The qPCR was run on a LightCycler 480 (Roche) machine using LightCycler 480 SW1.5
software. Reaction conditions were 95oC for 10 minutes, followed by 45 cycles of 95oC for
15 seconds and 60oC for 15 seconds. The reaction ended with a melt curve assessment step.
Several quality control measures were taken. Technical duplicates or triplicates of the
same sample were loaded on every qPCR plate. The duplicates with the closest absolute ct
values were used in the analysis. Samples, with technical duplicates with differences greater
than 0.4 between ct values, were excluded from the analysis. In addition, samples with single
in the negative control reactions were also discarded. The melt curve of every sample was
also assessed to ensure that there was only one correctly sized peak (representing a pure
cDNA product). Samples with poor melt curves were also excluded.
8.3.13 qPCR data processing
Since the entirety of the cDNA samples used for qPCR had been diluted 1/20 before being
gifted to me, it was not possible to create standard curves of pooled samples. Standard curves
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are essential for the Delta-Delta CT method of analysing qPCR data. Consequentially an
alternative approach was used.
After the initial quality control steps described in section 8.3.12 to control for technical
variability, the raw ct values were added the value of 40 (arbitrarily chosen). This was because
the raw ct values are negative and adding them to a positive number made all the ct values
positive. In other words, the negative ct value was made positive and then subtracted from the
value of 40. This step insured that graphically all the data was positive, which puts the expres-
sion data on the conventional axis, and the relationships between each sample are maintained.
After this cosmetic processing, normal data analysis steps were performed. The technical
replicates of a given sample were averaged. The Dlk1 and Dlk2 expression averages of each
sample were then normalised against the corresponding average expression of Tbp in the
sample sample.
8.3.14 RNA extraction
All RNA was extracted from tissues. Prior to dissection, 0.2-0.3mL of lysing matrix P bulk
beads (MP Biomedicals 116540434) were added to labelled 2ml graduated skirted tubes
(STARLAB e1420-2340), ensuring that the beads never touched anything but the inside of
the sterile RNase and DNase free tubes. During the dissection, the tissues were added to
the relevant prepared tube and snap frozen in liquid nitrogen. The snap frozen tissues were
stored at -80oC before RNA extraction.
Sterile, RNase free, and DNase free filter pipette tips were used during all stages of RNA
extraction. TRI reagent (Sigma-Aldrich T9424) was first added to the samples (1 ml per
50100 mg of tissue), which were then homogenised for 40 seconds with a MagNA Lyser
(Roche). The homogenate was then centrifuged at 12,000g for 10 minutes at 4oC. The clear
supernatant was subsequently carefully transferred to freshly labelled tubes. With samples
possessing high fat contents, there was a layer of fatty material on the surface of the aqueous
phase that was removed.
The transferred samples were then allowed to stand at room temperature for 5 minutes
to allow dissociation of the nucleoprotein complexes. 0.1mL of 1-bromo-3-chloropropane
(Sigma-Aldrich B9673) per 1ml of TRI reagent used was the added to the samples. Sam-
ples were vortexed for 15 seconds before standing at room temperature for 2-15 minutes.
Centrifugation followed at 10,000g for 10 minutes at 4oC. The upper aqueous phase was
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then transferred to fresh tubes. 0.5ml of 2-propanol (Sigma-Aldrich 278475) per 1ml of TRI
reagent used were added to the samples. The samples were again allowed to stand at room
temperature, for 5-10 minutes, and were again centrifuged: 12,000g for 10 minutes at 4oC.
All subsequent steps of RNA extraction took place in an RNase free environment: the entire
workstation, pipettes, and pipette boxes were cleaned with the antibacterial spray and 70%
ethanol.
In the RNase free environment, the supernatant was carefully removed and 1mL of 70%
ethanol (diluted in nuclease free water) was added per 1ml of TRI reagent used. The samples
were then vortexed and centrifuged at 7,500g for 5 minutes at 4oC; if the pellets floated upon
addition of ethanol they were centrifuged at 12,000g. The supernatant was removed and the
pellet air-dried for 5-10 minutes at room temperature. An experimentally relevant volume
of nuclease free water was then added before the samples. The sample concentration and
quality were ascertained using the BioDrop. Samples with A260/A280 ratios less than 1.7
were not used.
8.3.15 Sequencing
Sanger sequencing was performed by Genewiz and Source Bioscience. Samples and, where
relevant, corresponding primers were prepared according to company instructions. Sequenc-
ing was performed on samples directly after gel extraction (section 8.3.5) or on an undigested
plasmid. Results were analysed using SnapGene Viewer (V4.2.1).
8.4 Microbiology
8.4.1 Colony expansion
Colonies to expand were taken from glycerol stocks (stored at -80oC) or from LB/Amp
plates (stored at 4oC). Sterile toothpicks were used to obtain cells from the glycerol stocks,
by scraping off a tiny piece of frozen cells, or from a single colony on an LB/Amp plate. The
toothpicks were added to 5mL LB/Amp media (1µl Ampicillin per 1 mL LB) and incubated
overnight at 37oC in a shaking incubator. The expanded colonies were then used immediately
or stored at 4oC.
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8.4.2 Glycerol stock generation
Sterile 100% glycerol (sigma G551G) was microwaved for 20 seconds before 500µl was
added to a cryovial (STARLAB E1420-2340). 500µl of an expanded colony (section 8.4.1)
was subsequently added. The glycerol stocks were then stored at -80oC.
8.4.3 Transformation
2µl of target plasmid was added to 1.5ml tubes on ice, where competent cells were being
defrosted. After the competent cells had thawed, 30µl were added to the plasmid and mixed
gently by flicking the tube. The cell-plasmid mix was left on ice for 30 minutes before
being heat shocked at 42oC for 42 seconds. The cells were returned to the ice for 2 minutes.
Afterwards, 100µl room temperature SOC media was added. The cells were the incubated,
shaking, at 37oC for 1 hour. 10-100µl of transformed cells was spread onto LB/Amp plates
(pre-warmed to 37oC). The plates were then wrapped in Clingfilm and incubated overnight at
37oC. The following morning, the plates were removed from the incubator and stored at 4oC.
8.4.4 Testing transformation success of a given colony
Successful transformation was tested using restriction digestion or by PCR. To test via
restriction digestion, restriction endonucleases were chosen that would confirm the presence
of the plasmid (and its insert). For each digestion, 10µl of colony DNA (previously extracted
as described in section 8.3.2) was added to 15µl of distilled water, 3µl of the appropriate
buffer, 1µl of restriction endonuclease 1 and 1µl of restriction endonuclease 2. The reaction
was incubated at 37oC for 2 hours or overnight. Transformation of the Dlk1 riboprobe was
confirmed using restriction enzymes BamHI (NEB R0136L) and EcoRI (NEB R0101S) with
a NEB 2.1 buffer (NEB B7202S).
15µl of Cresol red (section 8.2.1) was added to the each reaction before all 15µl of
the dyed reaction was run on a 1% agarose gel section 8.3.4 against a 1kb ladder. The
results were then visualised using the transilluminator to check the band size and assess
whether successful transformation occurred. Sequencing was used to validate colonies with
transformations confirmed by restriction digest. Undigested DNA (extracted as described
in section 8.3.2) was Sanger sequenced (section 8.3.15). The resulting sequence was then
analysed to ensure correct transformation occurred.
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8.5 In situ hybridisation
8.5.1 Generating in situ hybridisation probes
The ISH probe for Dlk2 was designed to span the final exon of Dlk2. Primer3 [124] was used
to find good quality primers (section 8.1) within exon six. BLAT [112] then confirmed that
the in silico PCR product was specific to the targeted region. The target region was amplified
from C57BL/6J genomic DNA by PCR (section 8.3.10). The product was run on a 1-2%
agarose gel (section 8.3.4) and then purified (section 8.3.5). This product was then phospho-
rylated (section 8.3.8) before being cloned into the pBlueScriptII vector (section 8.3.1). The
Dlk1 riboprobe described by Da Rocha et. al [51] was originally cloned into pBlueScript and
was provided as a gift by Dr. Marika Charalambous. The plasmids containing Dlk1 and Dlk2
riboprobes were then transformed into competent cells (section 8.4.3), whose colonies were
then expanded (section 8.4.1) before glycerol stocks were generated (section 8.4.2). After
the transformation of the colonies was tested (section 8.4.4), and colonies with the optimal
clone were chosen to generate riboprobes from.
DNA previously extracted (section 8.3.2) from the chosen colonies was used for riboprobe
generation. The circular DNA was linearized using an appropriate endonuclease: antisense
Dlk1 probes were linearized with EcoRI (NEB R0101S) and Dlk1 sense probes with BamHI
(NEB R0136L). 10µl DNA was added to 16µl distilled water, 3µl of an appropriate buffer
and 1µl of an appropriate endonuclease per reaction. The reaction was incubated at 37oC for
2 hours. The success of the digestion was confirmed by running 5µl of the reaction (added to
5µl of Cresol red loading buffer) on a 1% agarose gel (section 8.3.4). The concentration of
DNA was ascertained using the BioDrop. The MinElute PCR Purification kit (Qiagen 28004)
was used to purify the DNA according to manufacturer instructions.
In vitro transcription produced sense and antisense RNA probes from the forward and
reverse linearized plasmids. A single reaction was generated by adding 2µl of DTT (Strata-
gene 600098-S3)to 0.5µl RNase inhibitor, 2µl of a mix of DIG-labelled nucleotides (Roche
11277065910), 2µl RNA polymerase (MEGAscript T7 and MEGAscript T3 enzymes for
antisense and sense probes, respectively (ThermoFischer Scientific AM1334 and AM1338,
respetively)), and 1µg of the linearized DNA. Sufficient volume of nuclease free water was
added to create a total reaction volume of 20µl. The reaction was incubated overnight at
37oC.
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Prior to continuing the protocol the following day, the workstation was prepared so that it
was RNase free. The area, pipettes and pipette boxes were cleaned using the antibacterial
spray followed by 70% ethanol. 100% ethanol was also placed in the -20oC freezer. 2µl
of DNase I (ThermoFischer Scientific EN0521) was added to each sample and incubated
for 1 hour at 37oC before 2µl of DNase I stop solution was added followed by a 10-minute
incubation at 65oC.
Ethanol precipitation (section 8.3.3) was then performed using 20µl of the existing
reaction. The product was ultimately resuspended in 100µl of nuclease free water. The
transcribed RNA was stored at -80oC until needed.
The quality of the transcribed RNA was tested in two ways. The concentration of the
transcribed RNA was tested using the BioDrop. In addition, 1l of the transcribed RNA was
added to 9µl of an RNase free loading buffer (gift from Dione Gray) and run on a 1% RNase
free agarose gel (section 8.3.4) against a 100bp RNA ladder.
8.5.2 In situ hybridisation
ISH initially took place in an RNase free environment. The area, pipettes and pipette boxes
were cleaned using the antibacterial spray followed by 70% ethanol. In addition, all solutions
were generated with nuclease free water. 50mL copffin jars, their lids, and tweezers were
sterilised by heating them at 65oC for 40 minutes.
ISH was performed on paraffin wax sections of whole embryos and placentae prepared
as described in section 8.3.6. Prior to ISH the selected sections would be labelled, using
pencil, for the probe being used. Sense and antisense probes were used for each gene in every
experiment.
The slides were placed into the sterilised and cooled copffin jars using the tweezers. The
relevant solution would be poured into the jar and the lid added for each was. Changing
solutions was achieved by pouring away the previous solution (either saving for reuse or
for disposal), and immediately pouring in the next solution. This step was performed as
quickly as possible to minimise dehydration of the wax samples. Certain washes had to be
performed in the fume hood; during these steps slides were transferred between copffin jars
using tweezers. This ensured that one sterile copffin jar (and lid) was suitable work outside
the fume hood as it wouldnt have been exposed to the chemicals requiring the same degree
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of projection.
ISH was initiated by rehydrating the sections. Slides were washed in histoclear (National
Diagnostics HS202) for 10 minutes. This step was then repeated. The histoclear washes were
followed by 2 5-minute washes in 100% ethanol. This was followed by a rehydration series
consisting of 1-minute washes of 95% ethanol, 90% ethanol, 80% ethanol, 70% ethanol, 50%
ethanol, and ending with 30% ethanol. A 5-minute wash in PBS then followed. The slides
were then refixed in 4% PFA in PBS for 30 minutes. This step was followed by 2 5-minute
PBS washes.
Proteolysis achieved antigen retrieval. The slides were incubated in proteinase K solution
(0.025mg/mL proteinase K in PBS) for up to 2 minutes before 2 5-minute PBS washes, and a
15 minute refixation step in 4% PFA in PBS. 2 5-minute washes in PBS then followed. This
was succeeded by 2 5-minute washes in 2X SSC and incubation in tris-glycine buffer for at
least 30 minutes.
Hybridisation then followed. The hybridisation buffer was generated by adding 400l of
40% formamide to 10µl of 100x denharts, 250µl of 20x SSC, 9.2µl of 10g/l tRNA (Sigma
R5636), and 8.8µl of 100g/l herring sperm (Sigma D7290). 25ng/µl of sense or antisense
Dlk1 probe was added to the total whereas 15ng/µl were added for the Dlk2 probes. After
the probes were added to the hybridisation buffers, they were heated at 95oC for 5 minutes
and immediately removed to ice.
60µl of the hybridisation buffer was added per slide, which was then covered using a
custom generated parafilm coverslip (paraffin cut to just cover the sample). The prepared
slides were then placed on the exposed pipettes in a damp chamber; two 20ml pipettes per
slide kept the slides flat. The damp chamber consisted of a plastic box that had pipettes
cut to exactly fill it lying above tissues soaked in chamber buffer. The chamber was sealed
to prevent evaporation by several rounds of wrapping with parafilm. The chamber was
incubated at 65oC in a hybridisation oven over the weekend.
All solutions used in steps after hybridisation were made with distilled, but not nuclease
free, water. After hybridisation, the damp chamber was opened and the parafilm coverslips
were carefully removed from the slides submerged under pre-warmed 5xSSC. After the
coverslips were removed the slides were placed in another copffin jar for the subsequent
steps. Unless stated, all steps were performed with rocking. The first washes were 3 15-
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minute washes in 5xSSC at room temperature. Slides were then incubated for 40 minutes at
60oC in Posthyb buffer (20% formamide/0.5xSSC). This was followed by a 15-minute room
temperature wash in 2xSSC. The slides were then incubated in RNase A solution (1.25mg
RNase A/100ml 2xSSC) at 37oC for 15 minutes, and was followed by another 15-minute
wash in 2xSSC at room temperature. A 20-minute wash in Posthyb buffer at 60oC followed.
This process was ended by 2 25-minute room temperature washes in 2xSSC.
During the final washing steps, the antibody was prepared. Anti-DIG AP fab fragments
(Roche 11093274910) were diluted 1:1000 in blocking solution. After the final washing
steps, 200µl of the diluted antibody solution was added per slide and covered with parafilm
coverslips as described above. The prepared slides were again added to a damp chamber,
filled with 2xSSC, and incubated at 4oC overnight.
The following day the slides were submerged in PBS to remove the coverslips. After-
wards, they were washed, with rocking, in PBS for at least 4 hours. Typical timings of the
washes were 3 10-minute washes, 3 30-minute washes, and then 2 1-hour washes. After
the PBS washes, the slides were washed 3 further times in NTMT solution with each wash
lasting 10 minutes. During the final wash the staining solution was generated: 1 NBT/BCIP
tablet (Roche 11697471001) was added to 10ml distilled water and kept in the dark.
0.5ml of staining solution was added per slide and covered with a parafilm coverslip
as described above. The staining reaction was incubated in the dark until a signal was
visible, typically overnight. Incubating the slides in 1mM EDTA/PBS in copffin jars stopped
the staining reaction. The slides were then counterstained with Fast Red (G-Biosciences
786-1053).
After counterstaining, the slides were washed several times in PBS until no red colour
was visible in the liquid and glass of the copffin jar. Afterwards, the sections were dehydrated
via an ascending ethanol series. This consisted of 1 minute washes of 30% ethanol, 50%
ethanol, 70% ethanol, 80% ethanol, 90% ethanol, and 95% ethanol. This was followed by 2
5-minute washes in 100% ethanol, and 2 10-minute washes in Histoclear. The slides were
then mounted.
Prior to mounting the slides were removed from the copffin jar and the excess liquid
surrounding the section was carefully removed using tissue paper. Afterwards, DPX (Sigma-
Aldrich 44581) was dropped onto the slide above the sections and the coverslips were then
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placed on top of the slides. Coverslip placement was done extremely carefully to avoid the
introduction of bubbles. After the DPX dried the slides could be studied and imaged.
8.6 Evolutionary analysis
8.6.1 Alignments
DNA and protein sequences were aligned using ClustalO (V1.2.4) [132] with default settings
aligned against the input order. The protein domains were identified for each species using
InterPro (V29.0) or through comparison the the amino acid sequence for the juxtamembrane
domain previously characterised in the lab by Dr. Carol. Edwards for a variety of species
(unpublished data). Identified regions were then manually highlighted in the alignment at
correct coordinates.
8.6.2 Calculation of Ka/Ks values
Ka/Ks values were calculated for DLK1 and DLK2 with Dr. Carol Edwards. Coding
sequences (appendix A.1) for each orthologue of each gene were in silico translated and
aligned with ClustalW using TranslatorX [1], under default conditions. The Ka/Ks values
were then calculated using SeqinR (V1.0) [39].
8.6.3 Calculation of percentage identity and percentage similarity
Protein sequences, obtained as described in section 8.6.5, were aligned using ClustalO
(V1.2.4) [132] (section 8.6.1). Percentage similarity of the sequences between species were
obtained using ’Ident & Sim’ tool in the sequence manipulation suite [218] using default
settings.
8.6.4 Evolutionary distances analysis
Dr. Carol Edwards generated a maximum likelihood tree for DLK1 and DLK2 from se-
quences, aligned by ClustalO (V1.2.4) [132], using PhyML [90]. Unless stated default
settings were used. The akaike information criterion was used in the default model selection
setting. No starting tree was used and the algorithm was bootstrapped 500 times.
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8.6.5 Sequences used
Protein sequences for DLK1 and DLK2 were obtained by Dr. Carol Edwards or myself
from Ensembl, UCSC [113] and NCBI. The sequences were assessed for their quality; poor
sequences were discarded. For instance a significantly truncated DLK2 protein sequence
was observed in the Sep2010 WUGSC 7.0/petMar2 Lamprey genome on the UCSC browser.
This sequence was not used in the analysis. Additional quality control measures included
removing additional start sequences. The relevant cDNA sequences were then obtained from
the same source. A list of the cDNA and protein sequences used in this analysis in located
within Appendix A.1.
8.7 CRISPR/Cas9 mediated genome editing
Genetically altering Dlk2 with CRISPR/Cas9 was attempted twice (tables 5.1 and 5.2).
8.7.1 gRNA design and synthesis
gRNAs for the first CRISPR/Cas9 genome editing attempt were designed using the Well-
come Trust Sanger Institute Genome Editing database [97]. 2 gRNAs targeted exon 2 and 2
gRNAs targeted exon 5 (table 8.2). Dr. Celia Delahaye designed the gRNAs for the second
CRISPR/Cas9 genome editing attempt targeting exons 2, 3, and 5 (table 8.2). All gRNAs
were selected so that there would be a guanine adjacent to the PAM domain, as it has been
demonstrated that this strongly promotes cleavage SpCas9 in cell lines [38, 62] and zebrafish
embryos [161].
CRISPR attempt Exon targeted gRNA
1 2 CCAGACGTGTAGACACCTGTGGG
1 2 CCCACAGGTGTCTACACGTCTGG
1 5 TGCAACCGCTCCGTTCCATAGGG
1 5 ATTCTGGCAGGGTGATTGTGAGG
2 2 GGCACACGAGATTTAGGCAG
2 3 GTCAGGAGCGCAGCAGCCGT
2 5 GGCCAGTGTGTGTATGACGG
Table 8.2 gRNAs used in CRISPR/Cas9 mediated genome editing
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The gRNAs were synthesised using the GeneArt Precision gRNA Synthesis Kit (Ther-
moFischer A29377) according to manufacturer instructions using the primers described in
section 8.2.3. The concentration of the gRNAs was ascertained using a Qubit 3.0 according
to manufacturer instructions.
8.7.2 Pronuclear microinjections
gRNAs (section 8.2) and Cas9 mRNA (ThermoFischer A29378) or protein (ThermoFischer
B25640) were injected into F1 x F1 (CBA x C57BL6/J) hybrid zygotes by William Mansfield
at the MRC Cambridge Stem Cell Institute, University of Cambridge.
During the CRISPR mediated genome editing attempt 1, 74 zygotes were injected with
Cas9 protein (42ng/µl) and gRNAs targeting exon 2 (table 8.2) at 50ng/µl (25ng/µl of each
gRNA) and transferred into psuedopregnant females. 28 zygotes were also injected with
Cas9 mRNA (100ng/µl) and gRNAs targeting exon 5 (table 8.2) at 50ng/µl (25ng/µl of each
gRNA) and transferred into psuedopregnant females.
During CRISPR mediated genome editing attempt 2, only Cas9 protein (42ng/µl) was
injected into the hybrid zygotes, along with a single gRNA (50ng/µl) targeting exons 2, 3, or
5 (table 8.2). 66 injected zygotes were transferred into pseudopregnant females for exon 2,
42 for exon 3, and 54 for exon 5.
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A.1 Sequences used in evolutionary analysis
A.1.1 Protein sequences used for DLK1
Human DLK1
MTATEALLRVLLLLLAFGHSTYGAECFPACNPQNGFCEDDNVCRCQPGWQGPLCDQCVT-
SPGCLHGLCGEPGQCICTDGWDGELCDRDVRACSSAPCANNGTCVSLDDGLYECSCAP-
GYSGKDCQKKDGPCVINGSPCQHGGTCVDDEGRASHASCLCPPGFSGNFCEIVANSCTP-
NPCENDGVCTDIGGDFRCRCPAGFIDKTCSRPVTNCASSPCQNGGTCLQHTQVSYECLCK-
PEFTGLTCVKKRALSPQQVTRLPSGYGLAYRLTPGVHELPVQQPEHRILKVSMKELNKK-
TPLLTEGQAICFTILGVLTSLVVLGTVGIVFLNKCETWVSNLRYNHMLRKKKNLLLQYNS-
GEDLAVNIIFPEKIDMTTFSKEAGDEEI
Mouse DLK1
MIATGALLRVLLLLLAFGHSTYGAECDPPCDPQYGFCEADNVCRCHVGWEGPLCDKCV-
TAPGCVNGVCKEPWQCICKDGWDGKFCEIDVRACTSTPCANNGTCVDLEKGQYECSCTPGF-
SGKDCQHKAGPCVINGSPCQHGGACVDDEGQASHASCLCPPGFSGNFCEIVAATNSCTP-
NPCENDGVCTDIGGDFRCRCPAGFVDKTCSRPVSNCASGPCQNGGTCLQHTQVSFECLCKPPFMG-
PTCAKKRGASPVQVTHLPSGYGLTYRLTPGVHELPVQQPEQHILKVSMKELNKSTPLL-
TEGQAICFTILGVLTSLVVLGTVAIVFLNKCETWVSNLRYNHMLRKKKNLLLQYNSGEELAVNI-
IFPEKIDMTTFNKEAGDEEI
Cow DLK1
MAATAALLPALLLLLAFGRSAHGAECFPACHPENGFCDDDSVCRCQPGWQGPLCDQCVTF-
PGCVNGLCVEPWQCICKDGWDGHLCDLDIRACTSTPCANNGTCLNLDDGQYECSCAPGF-
SGKDCQEMDGPCVVNGSPCQHGGSCVDDEGRAPHAVCLCPPGFSGNFCEIVTNSCIP-
NPCENQGICTDIGGDFRCRCPAGFMDKTCSRPVNTCTSEPCLNGGTCLQHSQVSFECLCK-
PAFTGPRCGRKRAAGPQQVTRLPSGYGLTYRLTPGVHELPVPQPEHRVLKVSMKELNKST-
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PLLSEGQAICFTILGVLTSLVVLGTMGIVFLNKCEAWVSNLRYNHMLRKKKNLLLHYNS-
GEELAVNIVFPEKIDMTTFTKEAGEEEI
Dog DLK1
MTATAALLPVLLLLLAFGHSVHGAECFPACHPQNGFCEDDNVCRCQPGWQGPLCDQCVTF-
PGCVNGLCVEPWQCICDDGWDGNLCDIDIRACASAPCANNGTCVNLDASHYECSCAPGF-
SGKDCQKKDGPCVINGSPCQHGGSCVDDEGRASHASCLCPPGFSGNFCEIVANSCTPN-
PCENQGICTDIGGDFRCRCPAGFVDKTCSRPVSNCASDPCLNGGTCLQHTQVRYECLCK-
PEFTGPICGRKRAPSPQQVTRLPSGYGLTYRLTPGVHELPVPQPEHRILKVSMKELHKNT-
PLLSEGQAICFTILGVLTSLVVLGTMGIVFLNKCEAWLSNLRYNRMLRQKKNLLLHYNS-
GEDLA VNIIFPEKIDMTTFSKEAGEDDI
Elephant shrew DLK1
MIVTAVLPRVLLLLLAFGHSTHGDDTNCSPACHPVHGSCEDDNVCRCQPGWQGPLCD-
HCVPFPGCVNGICFEPWQCVCNQGWEGHLCDIDARPCSSNPCANNATCENLEVGGYK-
CACVPGFQGDRCEEKRPGPCVINGSPCQHGGTCVDDEGRASHASCLCPPGFSGIFCEIVAN-
SCTPNPCENDGVCTDIGGDFRCRCPPGFIDKTCSRQVTSCASSPCLNGATCLQHGQVSYE-
CLCKPDFTGPTCAKRRAAGPPQSSLPSSYGLTYRLTPGVPQPEHRILKVSMKEFNKSSPIFTEGQAVCFTIL-
GVLTGLVVLATVGIIFINKCEAWVSSLRYSHMLRKKKSLLLQASSGEDLAVNIIFPEKIHMT-
TFNKEAGEEEI
Nine banded armadillo DLK1
MTATGALLPVLWLLLAFGPRAHGADCYPPCHPLNGFCDDDDVCRCHPGWDGPQCND-
CLPDPECVNGICYDEPGQCVCDDGWDGKFCDIDTRACISGPCANNGTCVNIEKGHYTC-
SCPPGYSGRVCEKKIGPCVVNGSPCQHGGTCVDDEGRASHASCLCPPGYSGNFCEILAASCVP-
NPCENNGVCTDIGGDFRCRCPPGFVDKTCSRPVTLCSSSPCQNGGTCLPHSQVSYECLCKPGFT-
GLTCAKKRPSGAQQVTRVPSGYGLTYRLTPGVHELPVPQPEHRILKVSMKELNRSEPLLSEGQAICFTVL-
GVLTGLVVLGTVGIVFLNKCEAWVSNLRYGHLLRKKKNLLLHYNSGEDLAVNIIFPEKID-
MATFSREAGEDDV
Opossum DLK1
MFALGSFLLLCLLGPPFGFFSALGLECEVDCHRDRGICEKDLCRCRPGWQGPLCNECVTF-
PGCLHGSCSLPWQCICEDGWIGSLCDIDLQLCAAKPCPKNGTCTASEEGGSSCSCAPSSS-
GRNCHFKEGPCVINGSPCQNGGACIDDNGLASYTSCLCPDGFSGNFCELNMNSCDPN-
PCENGGMCTDIGGDFHCRCPLGFMDKTCGRPVGDHCASGPCEHGGTCVPQARGGFE-
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CLCKPEFSGPTCNHGHPNHSHPGPKTKRGPGLSDQFVPETQGRIATHQPSHRMLKITM-
RELTKNSKPLLNESQAICFTILGVLTCLVVLGTISIVFFNKCEVWLSNAKYSRLLRKKKN-
LLLRYSNGDEHTINIILPEKMNLKSYSKCLNEI
Tammar wallaby DLK1
MFAPGSWLLLCVLGPPLCFFSALGLECEVDCHPDRGICDKDQCRCRPGWQGPLCNECVPF-
PGCLHGSCSLPWQCICEDGWIGSLCDIDLQLCAAKPCHKNGTCTGSEEGGSSCSCVPGSS-
GRNCHLKEGPCVINGSPCQNGGACIDDNGLASYTSCLCPEGFSGNFCELNMNSCVPN-
PCENGGVCTDIGGDFRCRCPLGFMDKTCSRRVGDHCASGPCEHGGTCVPHARGGFE-
CLCRPEFSGPTCNHGHPGTKTKRDPGLADQLPPETQGKIATHQPNHRMLKITMRELTKN-
SKPLLNESQAICFTILGVLTCLVVLGTVSIVFFNKCEVWLSNAKYSRLLRKKKNLLLRYS-
NGDEHTINIILPEKMNLKSYSKCLNEI
Tasmanian devil DLK1
MFAPESLLLLCVLGSPFCFFSALGLECEVSCHPDRGICDKDQCRCRPGWQGPLCNECVSF-
PGCLHGICSLPWQCICEDGWIGSLCDIDLQLCAAKSCHKNGTCTGSEESGSRCSCAPGSS-
GRNCRFKEGPCVINGSPCQNGGACIDENGLASYTSCLCPEGFSGNFCELDMNSCVPN-
PCENGGVCTDIGGDFRCRCPLGFMDKTCSQHVVDHCASGPCEHGGTCVPHARGGFE-
CLCRPEFSGPTCNHGHPNHSHPGTKTKRGPGLPDQFSPETQGRLAAHQPNHRMLKITM-
RELTKNSKPLLNESQAICFTILGVLTCLVVLGTISIVFFNKCEIWLSNAKYSRLLRKKKNSLL-
RYSNGDEHTINIILPEKMNLKSYSQCLNEI
Platypus DLK1
MEGSAEPRLLCAFLLPLALSAAAQGIACKPGCHPTNGFCANPNECRCQPGWRGPLCTE-
CIPFPGCLHGGCTLPWQCVCQEGWVGSLCDIDTHPCSATPCTNNSTCIETGDGGYVCLCGPGFT-
GKNCHLRKGPCIINGSPCQNGGACVDGDGSAPHASCLCPSGFTGHFCELDADDCHPN-
PCAHGGACTDIGRDFRCHCPTGFTGKSCGRRLPACLDSVGGPGLECVCPHGLSGPTC-
AHFGHNSTGPSRSPERGEGPGDPPAQEALRGASGHHQERRVLKISLKEVIRHADPWLSH-
SQVTCLIVLGLLTCLVVLGTTAIVFYSKCETWLANAKYSRLLRKKKRRLMTSNNGETLSVNI-
IFPEKVKLTSYSTCSAAM
Chicken DLK1
MRLRAAGLLGCCCCCCCLLPLVLPAAPGVSCKAGCHPVNGFCEFPSECRCLPGWQGAL-
CNQCVPFPGCLHGSCVKPWQCICEEGWVGSLCDIDIQPCSAKPCTNNSTCIETGDGGY-
ICLCAQGFTGKNCHLRKGPCIINGSPCQNGGTCIDDNGFAPHASCLCPSGFAGNFCEIDRD-
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DCESNPCENGGTCTDIGAGFSCLCPHGYTGKLCSSRVTFCASDPCENGGTCKEHPQG-
GFKCICKPEFVGATCKHASKNTSLSAVNIGTKNMQNYKIPPKAHHRSVHQEHEILKITMKE-
TIQNADLLLSKSQVICFVVLGLLTCLVVLGTTGIVFFSKCEMWLANAKYSHLLRKKKN-
FLLKSSNGENLSVNIIFPEKIKLTNYTKNYTAI
Anole lizard DLK1
MHLCLWRGLCALLLACLPLAQGTDCKPGCHPVNGFCEVSNECRCRSGWQGPLCDQCIPF-
PGCLHGTCVKAWQCMCEEGWIGSHCDTDVHPCASKPCTSNSSTCVETGNGGYICLCA-
EGYTGKSCHMKKGPCIVNGSPCQHGGTCVDDDGSAPHASCLCLPGFTGNFCEIDIDD-
CEPNPCENGGTCTDIGRGFHCHCPMGFSGALCSSHVSACTSNPCQNGGICRVHPSRGFE-
CRCKPHFVGVTCASADRNKSLNGEVKHRLNHHSHMRVHHKPVHAQEREVLTIKETIEN-
RQPFLNKNQMICFMVLGLLTCLVVLGTTGIIFFSKFERWLANAKYSQLVRKERDDFLKA-
NEGENLSVKIIFPDQTEE
Chinese soft shell turtle DLK1
MDFRAATLNCCCFALVLPVSQGVACKPGCHPVNGFCEVPSECRCQPGWQGALCNQCVPF-
PGCVHGSCAKPWQCVCEEGWVGSLCDIDIHPCSSKPCTNNATCIETGDGGYICLCAKGFT-
GKNCHLKKGPCIINGSPCQNGGTCVDDNGFSAHASCLCLPSFSGNFCEIDIDDCEPNPCD-
NGGTCTDIGRGFNCHCPIGYMGQSCNSHVLFCASSPCENGGTCHEHPGGRFECLCKPE-
FVGVTCTYPSRNTSLHGMNTEAKTGQRYNLPPNAHPKSAHHQEHKVLKITMKETIQN-
TEPLLNKSQLICFIVLGLLTCLVVLGTTAIVFFSKCEIWLANAKYSHLLRKKKNCFLQSNNGENLSVNI-
IFPEKIKLTNYTKNYTDI
Western clawed frog DLK1
MELTASCILCLFLSRFITTETKEIACMPGCHPVNGFCESQGECRCRTGWKGQFCDQCIPF-
PACMHGSCTKPWQCICEEGWVGSLCDIDVHPCAAKPCSSNSTCIETGDGGYICLCSLGYT-
GKNCLLKKGPCSTNGSPCQNGGKCTDNNGFASYASCQCPPGFIGNYCEIQIDIDDCNPN-
PCRNGGSCTDIGSGFHCHCPLGFSGQFCNDLTPLCSSNPCANGGTCYQIGEKFQCFCQP-
KYTGTTCSFPHRNMSLHLYERRNSLPSYHKSPQHEVLKITVKETIQNVDPLLNKSQVIC-
FIVLGLLTCLIVLITTGIVFFSKCETWFANAKYSRLLRKKKNIYMQRSRGEDRDVKIIFPEGVK-
FEDCCRDYAST
Ceolacanth DLK1
MEGTVIPLSCVAVVSESDLILYYRIDCKPGCHSVNGYCEKPGECRCNEGWRGALCNKCVRF-
PGCLHGSCNKPWQCVCEEGWVGSLCDIDIHPCAVRPCANNSTCIETRDGGYICVCAQ-
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GYTGKNCHQKKGPCYTSGSPCQNGGTCVDGNGFAHYTSCMCPPGFTGDFCEIRNND-
CNPSPCENGGVCTNIGSEISCLCPSGYIGPSCSTRVIACLSDPCENGGTCLEHPGGRFNCI-
CKPEFVGDICSHLKRNMSRFVMNTEVKHKQHHNLHPNVFHKSTHQQEHEVLKITLKETVQHS-
GILLNKSQVICFIVLGLLTCLVVLVTTGIVFFSKCEMWLANAKYSHLIRKQRNRFMKSNS-
GEELSVNIIFPEKIKLTNYSKSYTSI
Zebrafish DLK1
MSVLLRLGFCFLLLFCCAAAQGPDCGAGCHRHHGFCEQSGECRCKSGWRGAVCDQCVP-
SADCVHGWCESPGECICESGWSGARCDRDVRPCSSQPCSADSRCVDAAGGRGHVCI-
CTATHCRTEETHCTVNGSLCQNGGSCVSSSSSFNTSSSSSNTSSSPSSSSSSSCLCPAGFT-
GSLCELQSAVCKSSVCVNGGRCVRRGLSYRCVCARRFSGSSCERHRPRVKAPQQHHTALHK-
PLETPGALASRSQLICFSVLALLTVLVVLGSTAIVFFQRCEVWMANVRYRQLVAQQRELIQDQATVNI-
ILPEKIKLSSYSRHYTSI
Medaka DLK1
MMMHLIWVVFILSVAGMVKGWECSAGCSPENGFCERQGKCRCKPGWEGENCDRCIPF-
PGCLHGSCEKAWQCICKEGWVGSLCDQDTRLCSSRPCSSNATCVETGEGGYMCICPQGFAGKD-
CHLKKQLCLENGSPCQNGGTCVDASGSAASPFCSCPSGFSGDFCEIGVDSCQPNPCLNYGNCTNHGLTFTCVCPPGF-
SGFTCNDSTSSSSCAGRPCSNSGTCVRQLDGTFQCVCQKGFAGPTCSLRHRPKSRNKLL-
GARPVEHHMLALAPQHYSLPAHAFHKLLKPPDRDLLKITLKETVHSSGVLVTHGQLICFGM-
LALLTCLVILGTTGIVLFGRCETWLANAKYSQLVRQQREHLLREVGSPSQEEPEHSVNI-
ILPEKIRLSSFGRHYTSI
Australian ghost shark DLK1
MAHHSAASVLVVSLLLPLLTGTRTQGTECKPDCHPLHGFCQDTGECRCQSGWQGDL-
CDQCTPIPGCLHGSCTKPWQCCCEEGWSGILCDTAPHTCSSEHPCANNSTCIESEGGGYR-
CICGEEFTGNHCQLRKGNFCINGSLCQNGGSCIDGNGFGSQASCLCLKGFTGVLCETK-
ISDCDSNPCANNGTCTDLVSGYSCLCPLGFTGGSCDYLITSCLSHPCKNGGTCHDLPEG-
GFDCACLPGYEAETCHEHISSKHDTKQNISKHVRVSWVRHGKLFNPPLHAFHKPTHHQGNEM-
LKITVKETIHTSNSLLNRSQVICFVMLGLLTCLVILGTTLIIFFSKCKMWMANAKYRQYL-
RKQKNHFLNDEETSVKIIFPDMSKLTNYRKSYISM
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A.1.2 Protein sequences used for DLK2
Human DLK2
MPSGCRCLHLVCLLCILGAPGQPVRADDCSSHCDLAHGCCAPDGSCRCDPGWEGLHCER-
CVRMPGCQHGTCHQPWQCICHSGWAGKFCDKDEHICTTQSPCQNGGQCMYDGGGEY-
HCVCLPGFHGRDCERKAGPCEQAGSPCRNGGQCQDDQGFALNFTCRCLVGFVGARCEVN-
VDDCLMRPCANGATCLDGINRFSCLCPEGFAGRFCTINLDDCASRPCQRGARCRDRVHDFD-
CLCPSGYGGKTCELVLPVPDPPTTVDTPLGPTSAVVVPATGPAPHSAGAGLLRISVKEVVR-
RQEAGLGEPSLVALVVFGALTAALVLATVLLTLRAWRRGVCPPGPCCYPAPHYAPACQDQEC-
QVSMLPAGLPLPRDLPPEPGKTTAL
Mouse DLK2
MPSGCRCLNLVCLLCILGATSQPARADDCSSHCDLAHGCCAPDGSCRCDPGWEGLHCER-
CVRMPGCQHGTCHQPWQCICHSGWAGKFCDKDEHICTSQSPCQNGGQCVYDGGGEY-
HCVCLPGFHGRGCERKAGPCEQAGFPCRNGGQCQDNQGFALNFTCRCLAGFMGAHCEVN-
VDDCLMRPCANGATCIDGINRFSCLCPEGFAGRFCTINLDDCASRPCQRGARCRDRVHDFDYL-
CPSGYGGKTCELVLPAPEPASVGTPQMPTSAVVVPATGPAPHSAGAGLLRISVKEVVR-
RQESGLGESSLVALVVFGSLTAALVLATVLLTLRAWRRGICPTGPCCYPAPHYAPARQDQEC-
QVSMLPAGFPLSPDLPPEPGKTTAL
Cow DLK2
MPSGCRCLHLVCLLCILGAPVKPARGNDCSSLCDLAHGCCAPDGSCRCDPGWEGLHCER-
CVRMPGCQHGTCHQPWQCICHTGWAGKFCDKDEHICTTQSPCRNGGQCVYDGGGDY-
HCVCPPGFHGRDCERKAGPCEQAGSPCRNGGQCQDDQGFALNFTCRCLAGFMGARCEVN-
VDDCLMRPCANGATCLDGINRFSCLCPEGFTGRFCTINLDDCASRPCQRGARCRDRVHDFD-
CLCPSGYGGKTCELVLPVPGPAATADSPPGPTLAVLVPATGPIPHSAGAGLLRISVKEVVR-
RQEAGLGEPSLVAVVVFGAVTAALVLSTVLLTLRAWRRGFCPPGPCCYPAPHYAPARQDQEC-
QVSMLPTGLPLPPDLPPEPGKTTAL
Dog DLK2
MPSGCRCLHLVCLLCILGAPVQPAGADDCSSHCDLAHGCCAPDGSCRCDPGWEGLHCER-
CVRMPGCQHGTCHQPWQCICHSGWAGKFCDKDEHICTTQNPCRNGGQCVYDGGGEY-
HCVCPPSFHGHDCERKSGPCEQAGSPCRNGGQCQDDQGFALNFTCRCLVGFVGSRCEVN-
VDDCLMRPCANGATCLDGINRFSCLCPEGFAGRFCTVNLDDCASRPCQRGARCRDRVHDFD-
CLCPSGYGGKTCELILPVSEPATIVDIPLGTTSALAVPATGPVPHSVGAGLLRISVKEVVR-
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RQEAGLGVSSLVAVVVFGALTTALVLSTMLLTLRAWRRGVCPPGPCCYPAPHYAPACQDQEC-
QVSMLPAGLPLSPDLPPEPGKTTAL
Elephant DLK2
MPSGCRCLHLVCLLCILGPPGQPARADDCSSHCDLAHGCCAPDGSCRCDPGWEGLHCER-
CVRMPGCQHGTCHQPWQCICHSGWAGKFCDKDEHICTTQSPCQNGGQCMYDGGGEY-
HCVCPPGFHGHDCERKAGPCEQAGSPCQNGGQCQDNQGFALNFTCRCLAGFVGARCEVN-
VDDCLMRPCANGATCLDGINRFSCLCPEGFAGRFCTINLDDCASHPCQRGARCRDRVHDFD-
CLCPSGYGGKTCELVLPVPDPFTTADLPLGPTSAVVVPTTGPVPHSAGAGLLRISVKEVVR-
RQEAALAESSLVAVVVFGALTAALVLATGLLTLRAWRRGVRPPGPCCYPIPHYAPARQDQEC-
QVSMLPAGLPLPPDLPGEPGKTTAL
Opossum DLK2
MPSGCRCLQLVSLLWILGASGQPTHADDCSSHCDLAHGCCEPDGTCRCDPGWEGLHCE-
QCVRMPGCQHGTCHQPWQCICSNGWAGKFCDKDEHICTKQPPCQNGGKCVYEGDGEY-
HCVCPPGFHGHNCERKTGPCEHAGSPCRNGGQCQDDQGFAENFTCRCLAGFVGPRCEVN-
VDDCLMRPCANGATCHDGINRFSCHCPKGFAGRFCTVNLDDCASRPCQHGARCRDRVHDFD-
CLCPDGFGGKTCEIVLPALDLPTEPDSAPGPTPAAVVPFTVPAPFSVGAGLLRISVKEVVR-
RQEAGIGDSSLIVLFIFGAITITGVFGTGLVIFWVRRHGHCPTGPCCCPYHQYAPPPERHDQEC-
QVSMLPAGISPPPDFPSELGKTTAL
Tasmanian devil DLK2
MPHGCRCLQLVSLLWILGASGQPTPANDCSSHCDLAHGCCEPDGTCRCDPGWEGLHCER-
CVRMPGCQHGTCHQPWQCICHNGWAGKFCDKDEHICTKQPPCQNGGKCVYEGDGEY-
HCVCPPGFHGHNCERKTGPCEHAGSPCRNGGQCQDDQGFAKNFTCRCLAGFVGPRCEVN-
VDDCLMRPCANGATCHDGINRFSCHCPEGFAGRFCTINLDDCASRPCQHGARCRDRVHDFD-
CLCPDGYGGKTCEIALPALDLPTEPESAAGSTPAAVVPFTVPAPFSVGAGLLRISVKEVVR-
RQEAGLGESSLLVLVIFGVLTATLVLTTGLLIFWAWCHGHCPAGLCCYPFRQYAIPPEQHDQEC-
QVSMLPAGISPPPGSPPEPGKTTAL
Chicken DLK2
MLRSFCLQLMSLLWILLAHHQLAQGDDCSEHCNLAHGSCDQDGKCRCDPGWEGDYCEECVRMPG-
CLHGTCHQPWQCICHSGWAGKFCDKDVHICEHQSPCQNGAQCIYDRDGDYSCLCPEGFHGKD-
CEMKAGPCEKAGSPCKNGGQCQDENGFATNFTCRCLAGFVGALCEHDVDDCLMRPCAN-
GATCHDGINRFSCQCQVGFEGRFCTININDCASQPCKNGAKCYDRINDYDCLCSDRFT-
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GKTCEISIPEPTWAPPYHPANHESSWAMRSTTSEMPEVTQPEPVRTAVTGRRVANHSEKVPGGGLLK-
ISVKEVVTQRDSGLSEAQLVTVLVFGVLTAVLVLITVLLILRNWQRGRQRSNWCQSPSQAARK-
LQDQECQVGMLNTVLIEPRKTTEL
Anole lizard DLK2
MLRSFYLQLMSLLWILVAHHHFTQGDDCSDHCNLAHGSCEDGKCRCDPGWDGASCE-
QCVRMLGCIHGTCHQPWQCICQSGWAGKFCDKDVHICEHQPPCQNGAECIYDRDGEYSCLCLEEFHGKD-
CELKTGPCEKSGFPCKNGGLCQDKNGFASNYTCKCLAGFTGAHCEIDVDDCLMQPCAN-
GATCLDGMNRFSCQCQAGFEGRFCTINIDDCANQPCRNGAKCYDRINDFDCLCPEGFVGK-
TCELPAPEPTWVTAFEPGHKDNDNAVTSIDPWTAQSDPARTAVTGKRITNYSEKSNGGGLLISVKEVVTQQDS-
GLSQSQLILLLVFGLLTMLLVFVTVLMVLLKNWQRGNQRCQSPSQSARKLQDQECQVGML-
STVLIEPRKTTEL
Chinese soft shell turtle DLK2
MLRSFCLQLMSLVWILLAHHHLAQGDDCSEHCNLAHGSCDQDGKCRCDPGWEGEYCE-
QCVRMPSCLHGTCHQPWQCICHNGWAGKFCDKDVHICEHNPPCQNGAGCVYDGDGEYSCLC-
SEGFHGKDCERKTGPCEKAGFPCRNGGQCQDENGFAKNFTCRCLAGFVGALCEEDVD-
DCLMRPCANGAICQDGINRFSCQCQVGFEGRFCTININDCASHPCKNGAKCYDRINDFD-
CVCPEGFTGKTCEASAPEPTWVPFYLSANKENNDALKSTTSEYLWVTQPEPVRTVVT-
GKRVANHSEKASGGGLLKISVKEVVTQRDTGLSESQLVTVLVFGTLTAALVLVTILLML-
RNWQRGRRRSNWCQSPSQAARKLQEQECQMGMLNTVMVEPRKTTEL
Zebrafish DLK2
MKLAVVLLLCGCCVLFKHNCEAQVLFSSEETSPTPSASNCTCEIGHGKCAENGDCRCDPG-
WGGPMCDDCVRMPGCVHGTCHQPWQCSCMDGWAGRFCDKDVYVCSRQQPCHNGATCELS-
DSGDYSCLCPEGFHGRDCELKAGPCQKTKSPCKNGGLCEDLGGYAPELSCRCLAGFT-
GARCETNMDDCLMRPCANGATCLDGVNRFSCLCPAGFTGRFCTINLDDCASQPCLNG-
GRCIDRVSNFQCVCPLGFTGRTCELVSPTKSPLKAEHNPNMTLKPSHWTTPSGGEERL-
LKITFRTPAGGEGLSEFQLIVLLVLGGMTLAVVGLTAALVLRGYFQDRSASCQCRPAHRTQRKHSQQECK-
ISFLQSPEKKRLNTDVI
Medaka DLK2
MAPVRAEGVLLLLSCWFVLHIQSSAGQGSDCSCNMTNSRCDESGICRCDPGWEGEHC-
DRCVLMPGCVHGSCQQPWQCTCEPGWGGRFCDKDLSVCSNQQPCRNGATCAMKDS-
GDFTCLCPQGYHGHLCQRKSGPCHQIRSPCKNGGLCEDADGFAADLTCRCLAGFTGS-
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FCETDIDDCLLKPCANDAICLDGINRFSCICPSGFTGRFCTVNLDDCASQPCLNGGRCLD-
LAGGFRCICQLGYMGNTCEMSLSSPNWTTKGEKGKGKRSSNITQHGNRLMKVTVSDR-
GIASLSDIQLIVVVVLGGVTLVAVALTSGLVLWGRCQNCSYTAGWSPPCSQGAERSRRRGQSETQQC-
QISFLNSVEPQKKLNLEAV
Coelacanth DLK2
MRPSGRPALQLLHFVWMLLLQRPVRGADCKSSCNLAHGRCDVNGDCRCDPGWEGDSCER-
CVRMPGCLHGTCHQPWQCICLSGWAGRFCDKDVHICEHQRPCQNSARCINDREGDYSCVCPDGFHGKNCEVKRG-
PCELAGSPCQNGGTCLDNNGYADAFACRCLAGFVGDLCELDVDDCLMRPCANGATCHDG-
INRFSCKCPAGFEGRFCTSNLDDCASQPCRNGGKCYDRVNDFDCVCPEGYAGKSCATVLEPQREE-
QVQTAPRNAQRVNYFTPESATQVPPQGTRPQPIGKPDAARRKGNQSEALSGERRAGGLLK-
ISVKEVVAQEESGLAETRFVILAVFGACTLLLALVTATLVLWSHWQGRPSSEAQRPDSAS-
RPEKKQLNAEEYESHLPLRHNQLTQKLNSFDVL
Australian ghost shark DLK2
MRGIRDWGLPLWGLACFLCSPSMAAGAEDVQCNPGCNLLHGRCESSECRCDPGWEGEL-
CERCVRSPGCVHGTCHQPWQCICQTDWAGRFCDKDIHACTHQQPCQNGGSCFDTGEGE-
HWCSCPDGFYGKNCELRAGPCTKSRSPCKNGGTCLDRDGFADTLTCRCLAGFVGPRCEED-
VDDCLMRPCANGATCRDGVNRFSCICPQGFEGRFCTVNWDDCTSGPCQNGGRCYDR-
VADFDCVCLKGYSGKTCSLPVPQWRKERPALSRRDPGITIPQPDHATRQGLAALPAASP-
TQPVREQERLLKVEVKELLSEPSSALAHSQIVGLSVFGALTALLVSVTVVVMLLCRRQEEP-
SRKPPRSGERGQAEGAISFLQPPAPESRKELYLDLM
Ciona DLK2
MSIKLILLLCSVAIGLAVGKPTDTTTCPSRCNLSHGFCNPRQQCTCFPGWEGPECNQCSTLIG-
CLHGSCDRPGQCNCDVGWGGRKCDRDLQYCERHRPCRNGATCINNLLGGFKCICPT-
GLTGTTCQETATTTPPITPRSGGKPRCSNGGTCIRGNAELGCESCRCPTGFTGQLCEQIVRM-
CVMRPCANGGKCQDVIGNFRCDCAHGYRGRYCTEDINECTVLGRHACENGGTCVN-
RFGGYTCACSDGYYGSRCQSKIIQIQARVTTTVKPTTTTTTTTTTEATTTKSTTETLKEIVVVPN-
LKKPFRKNIKVTHIVRQVEVETSNGDMTFIRDVVDHQGPNSAENEAQSSVTTVQALT-
FAFLGVAIALFIGIVIFMWIHCSKKGRNLRQRCTGESPTEETPMNENSREPSIVKTRHASYSP-
PQYVLEECQPKPGYPMRSVALPSDDREPIDCLYVALPNNSTPDVASMANRVLNSPSLPAY
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A.1.3 Coding sequences used for Dlk1
Human Dlk1
ATGACCGCGACCGAAGCCCTCCTGCGCGTCCTCTTGCTCCTGCTGGCTTTCGGCCACAGCAC-
CTATGGGGCTGAATGCTTCCCGGCCTGCAACCCCCAAAATGGATTCTGCGAGGATGA-
CAATGTTTGCAGGTGCCAGCCTGGCTGGCAGGGTCCCCTTTGTGACCAGTGCGTGAC-
CTCTCCCGGCTGCCTTCACGGACTCTGTGGAGAACCCGGGCAGTGCATTTGCACCGACG-
GCTGGGACGGGGAGCTCTGTGATAGAGATGTTCGGGCCTGCTCCTCGGCCCCCTGT-
GCCAACAACGGGACCTGCGTGAGCCTGGACGATGGCCTCTATGAATGCTCCTGTGC-
CCCCGGGTACTCGGGAAAGGACTGCCAGAAAAAGGACGGGCCCTGTGTGATCAACG-
GCTCCCCCTGCCAGCACGGAGGCACCTGCGTGGATGATGAGGGCCGGGCCTCCCAT-
GCCTCCTGCCTGTGCCCCCCTGGCTTCTCAGGCAATTTCTGCGAGATCGTGGCCAACAGCT-
GCACCCCCAACCCATGCGAGAACGACGGCGTCTGCACTGACATTGGGGGCGACTTC-
CGCTGCCGGTGCCCAGCCGGCTTCATCGACAAGACCTGCAGCCGCCCGGTGACCAACT-
GCGCCAGCAGCCCGTGCCAGAACGGGGGCACCTGCCTGCAGCACACCCAGGTGAGC-
TACGAGTGTCTGTGCAAGCCCGAGTTCACAGGTCTCACCTGTGTCAAGAAGCGCGCGCT-
GAGCCCCCAGCAGGTCACCCGTCTGCCCAGCGGCTATGGGCTGGCCTACCGCCTGAC-
CCCTGGGGTGCACGAGCTGCCGGTGCAGCAGCCGGAGCACCGCATCCTGAAGGTGTC-
CATGAAAGAGCTCAACAAGAAAACCCCTCTCCTCACCGAGGGCCAGGCCATCTGCTTCAC-
CATCCTGGGCGTGCTCACCAGCCTGGTGGTGCTGGGCACTGTGGGTATCGTCTTCCT-
CAACAAGTGCGAGACCTGGGTGTCCAACCTGCGCTACAACCACATGCTGCGGAAGAA-
GAAGAACCTGCTGCTTCAGTACAACAGCGGGGAGGACCTGGCCGTCAACATCATCTTC-
CCCGAGAAGATCGACATGACCACCTTCAGCAAGGAGGCCGGCGACGAGGAGATCTAA
Mouse Dlk1
ATGATCGCGACCGGAGCCCTCCTGCGCGTCCTCTTGCTCCTGCTGGCTTTCGGCCACAGCAC-
CTATGGGGCTGAATGCGACCCACCCTGTGACCCCCAGTATGGATTCTGCGAGGCTGA-
CAATGTCTGCAGGTGCCATGTTGGCTGGGAGGGTCCCCTCTGTGACAAGTGTGTAACT-
GCCCCTGGCTGTGTCAATGGAGTCTGCAAGGAACCATGGCAGTGCATCTGCAAGGATG-
GCTGGGACGGGAAATTCTGCGAAATAGACGTTCGGGCTTGCACCTCAACCCCCTGCGC-
CAACAATGGAACTTGCGTGGACCTGGAGAAAGGCCAGTACGAATGCTCCTGCACAC-
CTGGGTTCTCTGGAAAGGACTGCCAGCACAAGGCTGGGCCCTGCGTGATCAATGGTTCTC-
CCTGCCAGCACGGAGGCGCCTGCGTGGATGATGAGGGCCAGGCCTCGCATGCTTC-
CTGCCTGTGCCCCCCTGGCTTCTCAGGCAACTTCTGTGAGATCGTAGCCGCAACCAACAGCT-
GTACCCCTAACCCATGCGAGAACGATGGCGTCTGCACCGACATCGGGGGTGACTTC-
CGTTGCCGCTGCCCAGCTGGATTCGTCGACAAGACCTGCAGCCGCCCGGTGAGCAACT-
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GCGCCAGTGGCCCGTGCCAGAACGGGGGCACCTGCCTCCAGCACACCCAGGTGAGCTTC-
GAGTGTCTGTGCAAGCCCCCGTTCATGGGTCCCACGTGCGCGAAGAAGCGCGGGGC-
TAGCCCCGTGCAGGTCACCCACCTGCCCAGCGGCTATGGGCTCACCTACCGCCTGAC-
CCCCGGGGTGCACGAGCTGCCTGTTCAGCAGCCCGAGCAACACATCCTGAAGGTGTC-
CATGAAAGAGCTCAACAAGAGTACCCCTCTCCTCACCGAGGGACAGGCCATCTGCTTCAC-
CATCCTGGGCGTGCTCACCAGCCTGGTGGTGCTGGGCACCGTGGCCATCGTCTTTCT-
CAACAAGTGCGAAACCTGGGTGTCCAACCTGCGCTACAACCACATGCTTCGCAAGAA-
GAAGAACCTCCTGTTGCAGTATAACAGCGGCGAGGAGCTGGCGGTCAATATCATCTTC-
CCCGAGAAGATTGACATGACCACTTTCAACAAGGAGGCTGGTGATGAGGAGATCTAA
Cow Dlk1
ATGGCCGCGACCGCAGCCCTCCTGCCCGCCCTCTTGCTCCTGCTGGCTTTCGGCCGCAGT-
GCCCATGGAGCTGAATGCTTCCCGGCCTGCCACCCTGAAAATGGATTCTGCGACGAT-
GACAGTGTGTGCAGGTGCCAGCCTGGCTGGCAGGGTCCCCTGTGTGACCAGTGCGT-
GACCTTTCCCGGCTGTGTGAACGGCCTCTGCGTGGAGCCATGGCAGTGCATCTGCAAG-
GACGGCTGGGACGGACACCTCTGTGACCTAGACATCCGGGCTTGCACCTCGACCC-
CCTGCGCCAACAACGGCACCTGCCTGAACCTCGATGACGGCCAGTACGAGTGCTC-
CTGCGCCCCCGGGTTCTCAGGAAAGGATTGTCAGGAAATGGATGGGCCCTGCGTG-
GTGAATGGCTCGCCCTGCCAGCACGGAGGCAGCTGCGTGGACGATGAGGGCCGGGC-
CCCCCACGCTGTCTGCCTGTGCCCCCCTGGCTTCTCGGGCAACTTCTGCGAGATCGT-
GACCAACAGCTGCATCCCCAACCCGTGCGAGAACCAGGGCATCTGCACCGACATCGGGGGT-
GACTTCCGCTGCCGTTGCCCCGCCGGCTTCATGGACAAGACCTGCAGCCGCCCGGT-
GAACACCTGCACCAGCGAGCCGTGCCTCAACGGCGGCACCTGCCTGCAGCACTCCCAGGT-
GAGCTTCGAGTGTCTGTGCAAGCCCGCGTTCACCGGCCCCCGGTGTGGCCGGAAGCGCGCG-
GCGGGCCCCCAGCAGGTCACCCGTCTGCCCAGCGGTTACGGGCTGACCTACCGCCT-
GACCCCCGGGGTGCACGAGCTGCCGGTGCCGCAGCCCGAGCACCGCGTCCTGAAG-
GTGTCCATGAAGGAGCTCAACAAGAGCACTCCGCTCCTCTCCGAGGGACAGGCCATCT-
GCTTCACCATCCTGGGCGTGCTCACCAGCCTGGTGGTCCTGGGCACCATGGGCATCGTCTTC-
CTCAACAAGTGCGAGGCCTGGGTGTCCAATCTGCGCTACAACCACATGTTGCGCAA-
GAAGAAGAACCTGCTGCTGCACTACAACAGCGGGGAGGAGCTGGCCGTCAACATCGTCTTC-
CCGGAGAAGATCGACATGACCACCTTCACCAAGGAGGCCGGCGAGGAGGAGATCTGA
Dog Dlk1
ATGACCGCGACCGCAGCCCTCCTGCCCGTCCTCTTGCTCCTGCTGGCCTTCGGCCACAGT-
GTCCATGGAGCTGAATGCTTCCCGGCCTGCCACCCCCAAAATGGATTCTGCGAGGAT-
GACAATGTTTGCAGGTGCCAGCCTGGCTGGCAGGGTCCCCTGTGTGACCAGTGCGT-
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GACCTTTCCCGGCTGTGTTAACGGACTCTGCGTGGAACCCTGGCAGTGCATTTGTGAC-
GACGGCTGGGACGGCAACCTGTGCGACATAGACATCCGGGCCTGTGCCTCGGCCC-
CCTGCGCCAACAATGGCACCTGCGTGAACCTCGATGCCAGCCACTACGAGTGCTCCT-
GCGCCCCTGGGTTCTCGGGCAAGGACTGTCAGAAGAAGGACGGGCCCTGCGTGAT-
CAATGGTTCCCCCTGCCAGCACGGAGGCAGCTGCGTGGATGATGAGGGCCGGGCCTC-
CCATGCCTCCTGCCTGTGCCCCCCTGGCTTCTCAGGCAATTTCTGCGAGATCGTGGC-
CAACAGCTGCACCCCCAACCCGTGCGAGAACCAGGGCATCTGTACGGACATCGGGGGC-
GACTTCCGCTGCCGATGCCCCGCCGGCTTCGTGGACAAGACCTGCAGCCGCCCCGT-
GAGCAACTGCGCCAGCGACCCGTGCCTCAACGGGGGCACCTGCCTGCAGCACACCCAGGT-
GAGGTACGAGTGTCTGTGCAAGCCCGAGTTCACAGGCCCCATCTGTGGCCGGAAGCGT-
GCCCCGAGCCCCCAGCAGGTCACCCGTCTGCCCAGCGGGTACGGGCTGACCTACCGC-
CTGACCCCCGGGGTGCACGAGCTGCCGGTGCCCCAGCCCGAGCACCGCATCCTCAAG-
GTGTCCATGAAGGAGCTCCACAAGAACACCCCCCTCCTCTCCGAGGGCCAGGCCATCT-
GCTTCACCATCCTGGGCGTGCTGACCAGTCTGGTGGTGCTGGGCACCATGGGCATCGTCTTC-
CTCAACAAGTGCGAGGCCTGGCTGTCCAACCTGCGCTACAACCGCATGCTGCGCCA-
GAAGAAGAACCTCCTGCTGCACTACAACAGCGGGGAGGACCTGGCCGTCAACATCATCTTC-
CCCGAGAAGATCGACATGACCACCTTCAGCAAGGAGGCTGGCGAGGACGACATCTAA
Elephant shrew Dlk1
ATGATCGTGACCGCAGTCCTCCCGCGCGTCCTCCTGCTCCTGCTGGCCTTCGGCCACAGCAC-
CCATGGTGATGATACTAACTGCTCCCCGGCCTGTCACCCGGTCCACGGGTCCTGCGAG-
GATGACAACGTTTGCAGATGTCAGCCCGGCTGGCAGGGCCCCCTGTGTGACCACTGCG-
TACCATTTCCTGGCTGTGTCAATGGGATTTGCTTCGAGCCCTGGCAGTGTGTTTGCAAC-
CAAGGCTGGGAGGGACACCTTTGTGACATAGATGCGCGCCCTTGCAGCTCCAACCC-
CTGTGCCAACAACGCCACCTGCGAGAACCTGGAGGTCGGAGGCTACAAGTGCGCCT-
GCGTCCCTGGCTTCCAAGGGGACCGCTGTGAGGAGAAGCGCCCCGGGCCCTGCGT-
CATCAATGGCTCCCCGTGCCAGCACGGAGGCACGTGCGTGGACGATGAGGGCCGGGC-
CTCCCACGCCTCCTGCCTGTGCCCCCCTGGCTTCTCAGGCATCTTCTGCGAGATTGTG-
GCCAACAGCTGCACCCCCAATCCGTGCGAGAATGATGGTGTCTGCACCGACATTGGGGGC-
GACTTCCGCTGCCGCTGCCCACCCGGCTTCATCGACAAGACTTGCAGCCGCCAGGT-
GACCAGCTGCGCCAGCAGCCCCTGCCTGAACGGGGCCACCTGCCTGCAGCACGGCCAGGT-
GAGCTACGAGTGTCTGTGCAAGCCCGACTTCACAGGGCCCACTTGTGCCAAGAGGCGGGCG-
GCGGGGCCCCCGCAGAGCAGCCTGCCCAGCAGCTACGGGCTCACCTACCGCCTGAC-
CCCCGGGGTGCCACAGCCCGAGCACCGCATCCTCAAGGTGTCCATGAAGGAGTTCAA-
CAAGAGCTCCCCCATTTTCACCGAGGGGCAGGCCGTCTGCTTCACCATCCTGGGCGT-
GCTCACCGGCCTGGTGGTGCTGGCCACCGTGGGCATCATCTTCATCAACAAGTGCGAG-
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GCCTGGGTGTCCAGTCTACGCTACAGCCACATGCTCCGGAAGAAGAAGAGCCTTCT-
GCTGCAGGCCAGCAGCGGCGAGGACCTGGCGGTCAACATCATCTTCCCGGAGAAAATC-
CACATGACCACCTTCAACAAGGAGGCGGGCGAGGAGGAGATCTGA
Nine banded armadillo Dlk1
ATGACCGCGACCGGAGCCCTCCTGCCCGTCCTCTGGCTCCTGCTGGCCTTCGGCCCCAGGGC-
CCATGGAGCTGATTGCTACCCGCCTTGCCACCCCTTAAACGGATTCTGCGACGATGAC-
GACGTTTGCAGGTGCCATCCTGGCTGGGATGGCCCCCAGTGCAACGACTGCCTGC-
CCGATCCCGAATGTGTCAATGGAATCTGCTACGACGAGCCTGGGCAGTGCGTGTGC-
GATGATGGCTGGGACGGAAAGTTCTGCGACATAGACACCCGGGCTTGCATCTCCGGC-
CCCTGCGCCAACAACGGGACCTGCGTCAACATCGAGAAAGGCCACTACACGTGCTC-
CTGTCCCCCTGGCTACTCGGGGCGGGTCTGCGAGAAGAAGATCGGCCCCTGCGTG-
GTCAACGGCTCCCCTTGCCAGCACGGAGGCACCTGCGTGGACGACGAGGGCCGGGC-
CTCCCACGCCTCCTGCCTGTGCCCCCCGGGCTACTCGGGCAATTTCTGCGAGATCCTG-
GCCGCCAGCTGCGTGCCCAACCCCTGCGAGAACAACGGCGTCTGCACCGACATCG-
GCGGCGACTTCCGCTGCCGCTGCCCGCCCGGCTTCGTCGACAAGACCTGCAGCCGC-
CCGGTGACCCTGTGCTCCAGCAGCCCCTGCCAGAACGGGGGCACCTGCCTGCCGCACTC-
CCAGGTGAGCTACGAGTGTCTGTGCAAGCCCGGGTTCACGGGCCTCACCTGCGCCAA-
GAAGCGGCCGTCCGGCGCCCAGCAGGTCACCCGCGTGCCCAGCGGCTACGGGCTGAC-
CTACCGCCTGACGCCGGGGGTGCACGAGCTGCCCGTGCCGCAGCCCGAGCACCGCATC-
CTCAAGGTGTCCATGAAGGAGCTCAACCGCAGCGAGCCGCTGCTCAGCGAGGGCCAGGC-
CATCTGCTTCACCGTCCTCGGCGTGCTCACCGGCCTCGTGGTGCTGGGCACGGTGGGCATCGTCTTC-
CTCAACAAGTGCGAGGCCTGGGTGTCCAACCTGCGCTACGGCCACCTGCTGCGCAA-
GAAGAAGAACCTGCTGCTGCACTACAACAGCGGCGAGGACCTCGCGGTCAACATCATCTTC-
CCCGAGAAGATCGACATGGCCACCTTCAGCAGGGAGGCCGGCGAGGACGACGTCTGA
Opossum Dlk1
ATGTTCGCCTTGGGATCCTTTCTGCTGTTGTGCCTTCTTGGGCCACCTTTTGGCTTCTTCTCT-
GCGCTAGGCCTTGAATGTGAGGTGGACTGTCACCGGGATAGAGGAATCTGTGAAAAG-
GACCTGTGTAGGTGTCGACCTGGTTGGCAGGGACCCCTGTGCAATGAGTGTGTTAC-
CTTTCCTGGTTGCCTACATGGAAGTTGTTCTCTTCCCTGGCAATGTATCTGTGAGGATG-
GCTGGATTGGGAGCCTCTGTGATATAGATCTCCAGCTGTGTGCTGCCAAGCCCTGC-
CCCAAGAATGGGACATGCACTGCTTCTGAAGAAGGTGGTTCCAGCTGCTCTTGTGC-
CCCAAGCTCTTCAGGAAGAAACTGTCATTTTAAGGAAGGACCTTGTGTTATTAATG-
GTTCTCCCTGCCAGAATGGAGGCGCTTGCATTGATGACAATGGCCTTGCTTCTTACAC-
CTCCTGCTTATGCCCAGATGGCTTCTCTGGCAACTTCTGTGAGCTGAACATGAACAGCT-
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GTGACCCGAATCCATGTGAGAATGGAGGTATGTGCACTGACATTGGTGGGGACTTTCATTGTCGCT-
GTCCACTGGGGTTCATGGACAAGACTTGTGGTCGACCTGTGGGGGACCATTGTGCCAGTG-
GCCCCTGTGAGCATGGGGGTACTTGTGTGCCTCAAGCCAGAGGAGGCTTTGAATGC-
CTCTGCAAACCAGAATTCTCTGGACCCACTTGTAACCATGGCCACCCAAACCATAGC-
CACCCAGGACCCAAGACCAAGAGGGGTCCTGGGCTGTCTGACCAATTTGTCCCTGA-
GACTCAGGGCAGGATTGCCACCCATCAGCCCAGTCACAGAATGCTAAAGATCACCAT-
GAGGGAACTGACCAAGAATAGCAAACCTCTACTTAATGAAAGCCAGGCCATCTGCTTCAC-
CATCCTGGGGGTTCTGACATGCCTGGTTGTGCTGGGCACCATCAGCATTGTTTTCTTCAA-
CAAGTGTGAGGTGTGGCTCTCCAATGCCAAGTACAGTCGTCTCCTCCGTAAAAAAAA-
GAATTTGCTCCTCAGGTACAGCAATGGGGATGAGCATACCATTAACATCATCTTACCT-
GAGAAGATGAATCTGAAATCCTACAGTAAGTGCTTGAATGAGATATGA
Tammar wallaby Dlk1
ATGTTCGCCCCGGGATCCTGGTTGCTGTTGTGCGTTCTTGGGCCACCTCTTTGCTTCTTCTCT-
GCTCTAGGCCTGGAATGTGAGGTGGACTGTCACCCAGACAGAGGAATCTGTGACAAG-
GACCAGTGTAGATGTCGACCTGGTTGGCAGGGACCCTTGTGCAATGAGTGTGTGCC-
CTTTCCTGGCTGTCTACATGGAAGTTGTTCCCTGCCCTGGCAATGTATCTGTGAGGATG-
GCTGGATCGGAAGTCTCTGTGACATAGATCTCCAGTTGTGTGCTGCCAAACCCTGT-
CACAAGAATGGGACATGCACTGGTTCTGAAGAAGGTGGCTCCAGCTGTTCTTGTGTTC-
CTGGCTCTTCAGGAAGAAACTGTCATTTGAAGGAAGGACCTTGTGTTATTAATGGTTCTC-
CCTGTCAAAATGGAGGAGCTTGCATTGATGACAATGGTCTTGCCTCCTATACCTCCT-
GCTTGTGCCCAGAAGGCTTTTCTGGCAACTTCTGCGAACTGAACATGAACAGCTGT-
GTCCCAAATCCATGTGAGAATGGAGGTGTGTGCACTGACATTGGTGGGGACTTCCGTTGTCGCT-
GTCCGCTGGGGTTCATGGATAAGACTTGCAGCCGACGTGTGGGGGACCATTGTGCCAGTG-
GTCCCTGTGAGCATGGGGGTACCTGTGTGCCTCATGCCAGAGGAGGCTTTGAATGC-
CTCTGTCGACCAGAATTCTCTGGGCCCACTTGTAACCATGGCCACCCAGGAACCAA-
GACCAAGAGAGATCCTGGGCTAGCTGACCAACTTCCCCCTGAGACTCAGGGTAAGATTGC-
TACCCATCAACCCAACCACAGAATGCTGAAGATCACCATGAGGGAGTTGACCAAGAACAGTAAAC-
CTCTGCTTAATGAAAGCCAGGCCATCTGCTTCACCATCCTTGGGGTTCTGACGTGC-
CTAGTTGTCCTGGGCACTGTTAGCATTGTGTTCTTCAACAAGTGTGAGGTGTGGCTCTC-
CAATGCCAAGTACAGCCGTCTCCTTCGTAAAAAAAAGAACTTGCTTCTCAGATACAGCAATG-
GTGATGAGCACACCATTAACATCATCTTACCTGAGAAGATGAATCTGAAATCCTACAGTAAGT-
GCCTGAATGAGATATGA
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Tasmanian devil Dlk1
ATGTTCGCCCCGGaATCCTtGcTGCTaTTGTGCGTTCTTGGGtCACCTtTTTGCTTCTTCTCT-
GCTCTAGGCCTGGAATGTGAGGTcagCTGTCACCCgGACAGAGGAATCTGTGACAAG-
GACCAGTGTAGgTGTCGACCTGGTTGGCAGGGACCCcTGTGCAATGAGTGTGTttCCTTTC-
CTGGCTGTCTACATGGAAtcTGTTCCCTGCCaTGGCAATGTATCTGTGAGGATGGCTG-
GATCGGAAGTCTCTGTGAtatagATCTCCAaTTGTGTGCTGCCAAAtCCTGcCACAAGAATGGGA-
CATGCACTGGcTCTGAgGAAaGTGGCTCCAGaTGTTCTTGTGccCCaGGCTCTTCAGGAA-
GAAACTGTCGTTTtAAGGAAGGACCTTGTGTaATTAATGGTTCTCCCTGcCAgAATGGAG-
GAGCTTGCATTGATGAaAATGGcCTTGCCTCCTATACCTCCTGCTTGTGtCCgGAgGGCTTCTCTG-
GCAACTTtTGtGAAtTGGACATGAAtAGCTGTGTCCCtAATCCATGTGAGAATGGAGGT-
GTGTGCACaGACATCGGTGGGGACTTtCGcTGTCGCTGcCCGCTGGGGTTCATGGACAA-
GACcTGCAGCCaACaTGTGGtGGACCAcTGTGCCAGTGGcCCCTGTGAGCATGGGGGTAC-
CTGTGTcCCTCATGCCAGAGGAGGtTTTGAATGCCTCTGTaGACCAGAATTCTCTGGc-
CCtACTTGTAACCATGGCCACccgaaccatagccacCCAGGAACCAAGACCAAGAGgGgTCCTGGGCTtc-
CTGACCAAtTTtCCCCTGAGACTCAGGGTAgGcTTGCcgCtCATCAgCCCAACCACAGAAT-
GCTGAAaATCACCATGAGGGAGTTGACtAAGAACAGTAAACCTCTGCTTAATGAAAGC-
CAaGCCATCTGCTTCACtattcTGGGtGTTCTGACaTGtCTgGTTGTCCTGGGCACcaTaAG-
CATcGTGTTCTTCAACAAGTGTGAGaTaTGGCTCTCCAATGCCAAGTACAGCCGTCTC-
CTTCGTAAAAAAAAGAACTcaCTTCTCAGgTACAGCAATGGTGATGAGCAtACCATTAA-
CATCATCTTACCTGAGAAaATGAATCTGAAATCCTACAGTcAGTGCCTGAATGAGATATGA
Platypus Dlk1
ATGGAGGGGTCGGCGGAGCCTCGACTGCTCTGCGCCTTCCTCCTGCCCCTCGCCCTCTC-
CGCCGCTGCCCAAGGAATTGCTTGTAAGCCAGGATGTCACCCTACAAATGGATTCT-
GTGCCAACCCCAATGAGTGCAGATGTCAACCAGGATGGAGGGGCCCTCTCTGCACT-
GAATGCATTCCCTTTCCAGGGTGCCTGCACGGCGGATGTACCCTCCCCTGGCAGTGT-
GTCTGTCAAGAAGGCTGGGTTGGAAGTCTGTGTGACATAGATACTCACCCTTGCTCT-
GCAACGCCCTGCACCAACAACTCCACCTGCATCGAGACAGGAGATGGTGGCTATGTCT-
GCTTGTGTGGCCCAGGGTTTACAGGGAAAAACTGCCATCTTAGGAAAGGGCCCTG-
TATTATTAATGGCTCTCCCTGCCAGAACGGCGGTGCCTGCGTGGACGGCGACGGCTCG-
GCCCCCCACGCCTCCTGCCTGTGCCCCAGTGGCTTCACCGGTCATTTCTGTGAGCTTGACGCT-
GATGACTGCCACCCCAACCCGTGCGCCCACGGCGGTGCCTGCACCGACATCGGCCGGGACTTC-
CGCTGCCATTGCCCCACCGGCTTCACGGGCAAGTCCTGTGGCCGCCGGCTCCCAGC-
CTGCCTGGACTCTGTGGGCGGGCCCGGACTCGAGTGTGTCTGCCCCCATGGCCTCTC-
CGGCCCGACGTGCGCCCACTTTGGCCACAACTCCACTGGGCCATCCAGGAGCCCG-
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GAACGTGGGGAAGGGCCCGGAGACCCTCCGGCCCAGGAGGCCCTCCGTGGGGCATCTG-
GCCATCACCAGGAGCGCCGCGTCCTGAAGATCTCCCTGAAGGAGGTGATTCGACACGCA-
GACCCGTGGCTCAGCCACAGCCAGGTGACCTGCCTCATCGTCCTCGGTTTACTGAC-
CTGCCTGGTGGTGCTGGGGACAACAGCTATCGTCTTTTACTCCAAGTGTGAGACGTG-
GCTCGCCAACGCCAAGTACAGCCGCCTCTTGCGCAAGAAGAAGCGCCGCCTAATGACTTC-
GAACAATGGCGAGACTCTCTCCGTCAACATCATATTCCCAGAAAAGGTCAAATTGAC-
TAGCTACAGCACGTGCTCCGCTGCCATGTAA
Chicken Dlk1
ATGAGGCTGCGCGCCGCCGGGCTCCTCGGCTGCTGCTGCTGCTGCTGCTGCCTTCT-
GCCCCTCGTCCTCCCCGCCGCCCCAGGTGTGAGCTGTAAAGCTGGCTGCCACCCAGT-
GAATGGATTTTGTGAATTTCCCAGTGAATGCAGGTGTCTGCCTGGTTGGCAGGGCGCTCTCT-
GCAATCAGTGTGTCCCTTTTCCTGGGTGCTTGCACGGCAGCTGTGTCAAACCCTGGCAGT-
GCATCTGTGAGGAGGGCTGGGTTGGCAGCCTCTGTGACATAGATATTCAGCCGTGCTCT-
GCAAAGCCCTGCACCAATAACTCAACATGCATAGAGACTGGTGATGGAGGATATATTTGTTTGT-
GTGCCCAGGGATTTACAGGAAAAAACTGCCATCTCAGGAAAGGACCATGTATTATTAATG-
GCTCTCCCTGCCAGAATGGAGGAACATGCATTGATGACAATGGTTTTGCACCCCAT-
GCTTCCTGTCTATGCCCTTCTGGTTTTGCTGGAAATTTCTGTGAAATAGATAGGGAT-
GACTGTGAATCCAACCCATGTGAAAATGGAGGAACGTGCACAGATATTGGTGCAGGTTTCAGCT-
GTTTATGTCCCCATGGCTATACAGGAAAGCTCTGCAGCAGCCGTGTCACATTCTGTG-
CAAGTGACCCATGTGAGAATGGAGGAACATGCAAAGAACATCCACAGGGAGGATTCAAAT-
GCATCTGTAAGCCAGAATTTGTTGGTGCCACCTGCAAACATGCCAGCAAAAACACAAGTCTTTCT-
GCTGTGAATATCGGCACAAAGAACATGCAGAATTACAAGATACCCCCAAAAGCTCAT-
CACAGATCAGTGCATCAAGAACATGAAATCCTGAAAATAACAATGAAAGAAACAATC-
CAAAATGCAGATCTCTTGCTCAGTAAAAGTCAAGTGATATGTTTTGTGGTACTGGGAT-
TACTTACTTGTCTTGTAGTTTTGGGTACAACTGGGATTGTATTTTTTTCAAAGTGTGAAAT-
GTGGTTGGCTAATGCCAAATATAGTCATCTCCTGCGCAAGAAAAAGAACTTTCTTCT-
GAAGTCTAGCAATGGGGAAAACCTTTCTGTTAATATTATCTTCCCAGAGAAAATCAAATTGAC-
GAATTACACCAAGAACTACACTGCCATCTAG
Anole lizard Dlk1
ATGCATCTCTGCCTCTGGCGCGGGCTCTGCGCCCTTCTCCTCGCTTGCCTCCCTCTCGC-
CCAAGGAACTGATTGCAAACCTGGTTGCCATCCAGTGAATGGGTTTTGTGAAGTTTCAAAT-
GAATGCAGATGTCGATCTGGTTGGCAAGGCCCTCTGTGTGATCAATGTATCCCATTC-
CCTGGTTGCTTGCATGGGACCTGTGTCAAAGCATGGCAGTGCATGTGTGAAGAAGGGTG-
GATTGGCAGCCACTGTGATACAGATGTTCATCCCTGTGCTTCAAAACCATGTACAAG-
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TAACTCAAGCACATGTGTAGAGACAGGCAATGGTGGCTACATTTGTTTGTGTGCTGAAG-
GATATACGGGAAAAAGCTGCCATATGAAAAAGGGACCCTGCATAGTTAATGGCTCAC-
CTTGTCAGCATGGAGGAACCTGTGTGGATGATGATGGATCTGCGCCTCATGCTTCCT-
GCCTGTGCCTTCCTGGGTTTACTGGAAATTTTTGTGAAATCGATATTGATGACTGTGAGC-
CAAACCCATGTGAAAATGGGGGCACATGCACAGATATCGGCAGAGGCTTCCACTGC-
CACTGCCCAATGGGGTTCAGCGGGGCTTTGTGCAGCAGCCATGTGTCAGCCTGTAC-
TAGCAACCCCTGTCAAAATGGTGGGATTTGTCGTGTGCACCCCAGCAGAGGTTTTGAGT-
GTCGCTGCAAACCCCATTTTGTTGGTGTTACCTGTGCTTCTGCTGACAGAAACAAGAGTCT-
GAATGGGGAGGTTAAACATAGGTTAAATCATCACTCCCATATGAGAGTTCACCACAAAC-
CTGTTCACGCCCAGGAACGGGAGGTCTTGACCATCAAAGAGACGATTGAAAACCGTCAGC-
CTTTTCTCAATAAGAACCAAATGATCTGCTTTATGGTTCTGGGCTTGCTGACATGCCTTGTTGTTC-
TAGGTACAACCGGGATTATCTTTTTTTCCAAATTTGAAAGGTGGCTGGCCAATGCCAAG-
TATAGCCAACTGGTCCGCAAGGAGAGAGATGATTTTCTGAAAGCAAATGAAGGTGA-
GAACCTCTCAGTGAAGATAATCTTTCCAGATCAAACTGAGGAATGA
Chinese soft shell turtle Dlk1
ATGGATTTCCGGGCTGCCACTTTAAACTGCTGCTGCTTTGCCCTCGTCCTCCCCGTTAGC-
CAAGGTGTTGCTTGTAAACCTGGCTGCCACCCAGTGAATGGATTTTGTGAAGTTCCCAGT-
GAATGCAGGTGTCAACCTGGGTGGCAAGGAGCTCTCTGTAATCAGTGTGTTCCTTTTC-
CTGGTTGTGTGCATGGCAGCTGTGCCAAACCATGGCAGTGTGTCTGTGAAGAAGGATGGGTTG-
GCAGCCTTTGTGATATAGATATTCATCCATGTTCTTCAAAACCCTGCACCAATAATGCAA-
CATGCATAGAGACTGGAGATGGTGGATATATTTGTTTGTGCGCCAAAGGATTTACAGGAAAAAACT-
GCCATCTGAAAAAAGGGCCCTGCATTATTAATGGCTCTCCCTGTCAGAATGGGGGAA-
CATGTGTTGATGATAATGGATTTTCAGCTCATGCCTCCTGTTTGTGCCTTCCAAGTTTTTCTG-
GCAATTTTTGTGAAATAGATATAGATGACTGTGAACCCAACCCATGTGACAATGGAG-
GAACATGCACGGATATTGGTAGAGGCTTCAACTGCCATTGCCCTATTGGCTATATGGGCCAGTC-
CTGCAACAGCCATGTCCTATTCTGTGCTAGCAGCCCATGTGAGAATGGAGGAACAT-
GTCATGAGCATCCTGGAGGAAGATTTGAATGTCTTTGTAAGCCAGAATTTGTTGGTGT-
GACCTGTACCTATCCCAGCAGAAACACAAGTCTCCATGGCATGAATACAGAGGCCAAAACTGGGCA-
GAGGTATAATCTACCCCCAAATGCTCATCCCAAGTCAGCTCATCACCAAGAACATAAAGTCTTGAAAATAA-
CAATGAAAGAAACAATCCAAAACACAGAGCCCTTGCTTAATAAAAGTCAATTGATAT-
GCTTCATTGTTCTGGGCTTGCTTACATGTCTTGTTGTGTTGGGTACAACTGCAATTG-
TATTTTTCTCCAAATGTGAAATATGGCTTGCTAATGCCAAATATAGCCATCTCCTACG-
CAAGAAGAAGAATTGTTTTCTTCAATCTAACAATGGGGAAAACCTTTCAGTTAACATAATTTTC-
CCAGAGAAGATCAAACTTACTAACTACACTAAGAACTATACTGACATTTAG
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Western clawed frog Dlk1
ATGGAGTTAACTGCCTCGTGCATTCTGTGCCTGTTTCTGTCTCGCTTCATAACCACA-
GAGACTAAAGAAATCGCCTGCATGCCTGGCTGCCATCCAGTAAATGGGTTTTGTGAAAGT-
CAAGGAGAATGCAGGTGTCGTACCGGCTGGAAAGGACAATTCTGTGATCAATGTATC-
CCATTTCCTGCTTGTATGCATGGGAGCTGTACAAAACCATGGCAGTGCATCTGTGAA-
GAAGGATGGGTTGGAAGCCTCTGTGATATAGATGTTCACCCGTGTGCAGCCAAGCC-
CTGCTCCAGCAACTCTACCTGCATCGAAACGGGGGATGGTGGATACATTTGCTTGT-
GCTCTCTGGGGTATACAGGAAAAAACTGTCTTCTTAAAAAGGGACCCTGCAGTACAAATG-
GATCTCCCTGTCAGAATGGAGGCAAATGCACAGACAACAATGGCTTTGCATCGTAT-
GCCTCTTGTCAGTGTCCCCCTGGTTTTATTGGTAATTATTGTGAAATACAAATAGATATTGAC-
GATTGCAACCCCAATCCTTGCAGAAATGGTGGAAGCTGCACAGACATTGGATCAGGATTTCACT-
GTCATTGCCCTTTGGGGTTTTCTGGGCAGTTCTGTAATGATCTCACCCCACTGTGCAGTAG-
CAATCCATGTGCAAACGGTGGGACGTGTTATCAGATAGGAGAGAAATTCCAGTGTTTTTGTCAGC-
CCAAATATACAGGAACTACTTGCTCTTTTCCCCATAGAAACATGAGCTTACACCTATAT-
GAGAGAAGAAATAGTCTGCCTTCATATCATAAATCTCCACAACATGAAGTACTTAAAAT-
TACAGTCAAAGAGACTATTCAAAATGTGGACCCACTCCTTAACAAAAGTCAGGTTATCT-
GTTTTATTGTGTTAGGGCTACTGACCTGTCTCATTGTCCTCATTACCACGGGGATTGT-
GTTCTTTTCTAAGTGCGAGACATGGTTTGCCAATGCCAAATATAGCCGTCTTTTAAGAAA-
GAAAAAGAACATTTACATGCAAAGAAGTCGAGGAGAGGACCGTGATGTCAAAATAATATTC-
CCAGAAGGAGTTAAGTTTGAAGACTGCTGCAGGGATTATGCTTCTACATAA
Coelacanth Dlk1
ATGGAAGGTACTGTAATCCCTTTATCTTGTGTTGCTGTGGTTTCTGAAAGTGATCTCATTCTC-
TATTACAGGATTGATTGTAAACCTGGCTGCCACTCAGTGAATGGATACTGTGAAAAAC-
CTGGAGAATGCAGATGCAACGAGGGTTGGCGGGGAGCACTCTGCAACAAATGTGTTCGTTTC-
CCTGGTTGCCTGCATGGTAGCTGCAACAAACCCTGGCAGTGTGTTTGTGAGGAAGGGTGGGTGGGCAGC-
CTCTGTGACATAGATATCCACCCTTGTGCTGTCAGACCCTGTGCCAACAACTCAACTTG-
TATAGAAACCAGAGATGGTGGATACATCTGTGTATGTGCACAGGGATATACAGGAAAAAACT-
GCCACCAGAAAAAAGGACCTTGTTACACCAGTGGCTCTCCTTGCCAAAATGGAGGAACTTGT-
GTTGATGGAAATGGATTTGCTCACTATACTTCATGTATGTGCCCTCCTGGGTTCACTG-
GTGATTTCTGTGAAATACGTAACAATGACTGTAACCCCAGTCCTTGTGAAAATGGTG-
GAGTTTGCACAAATATTGGCTCTGAAATCAGTTGCCTTTGTCCTAGTGGGTATATTG-
GCCCATCTTGCAGCACCCGTGTGATCGCGTGTCTCAGTGACCCCTGTGAAAATGGAG-
GAACATGTCTTGAGCATCCAGGAGGGAGGTTCAACTGTATCTGCAAACCAGAATTTGTTG-
GAGATATTTGCAGTCATTTGAAAAGAAACATGAGTAGATTTGTCATGAACACAGAAGT-
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GAAACACAAGCAGCATCACAATCTGCATCCTAATGTTTTTCATAAATCCACACACCAA-
CAAGAGCATGAAGTGTTGAAGATCACATTGAAAGAAACTGTACAGCACTCTGGTATTT-
TACTCAATAAGAGTCAAGTGATTTGCTTCATTGTACTGGGTTTACTTACGTGCCTTGTTGTCTTG-
GTCACAACCGGGATTGTGTTTTTCTCCAAGTGTGAGATGTGGCTTGCCAATGCCAAAT-
ACAGTCACCTTATACGCAAGCAGAGAAACCGTTTTATGAAGTCTAACAGTGGGGAA-
GAACTCTCTGTGAACATAATTTTCCCTGAAAAAATAAAACTGACCAACTACAGTAA-
GAGTTATACATCTATCTAA
Zebrafish Dlk1
ATGAGTGTGCTTCTCCGGCTCGGGTTTTGCTTTCTGCTGCTCTTCTGCTGCGCTGCT-
GCTCAAGGTCCAGACTGTGGAGCTGGATGTCACCGACACCACGGGTTCTGTGAGCAGTCTG-
GAGAATGCAGGTGCAAGTCTGGCTGGCGAGGCGCAGTGTGTGATCAGTGTGTTCC-
CTCAGCTGACTGTGTTCACGGCTGGTGTGAATCTCCCGGCGAGTGTATCTGTGAGTC-
CGGCTGGAGCGGCGCGCGCTGCGATCGAGATGTTCGTCCGTGTTCATCGCAGCCCT-
GCTCTGCAGACTCCAGATGTGTGGACGCTGCAGGAGGACGAGGACACGTCTGCATCT-
GCACTGCTACACACTGCCGCACGGAGGAGACACACTGCACAGTCAACGGATCTCTCT-
GCCAGAATGGAGGCTCCTGTGTGTCCAGTAGCTCCTCCTTCAACACATCTAGCTCCTC-
CTCCAACACTAGCTCCTCCCCCAGCTCCTCTAGCTCCTCCTCCTGCCTCTGTCCGGCTGGGTTCACTG-
GTTCTCTCTGTGAGCTCCAGTCTGCCGTGTGTAAGTCCAGTGTGTGTGTGAATGGCGGGC-
GATGCGTCCGGCGTGGTCTCTCCTACAGGTGTGTGTGCGCGCGCCGCTTCAGCGGGT-
CATCGTGCGAGCGACACAGGCCCAGAGTAAAAGCGCCACAGCAGCACCACACAGCACTC-
CACAAGCCGCTGGAGACCCCCGGCGCTCTGGCGTCCCGCAGTCAGCTCATCTGCTTCTC-
CGTCCTGGCTCTCCTCACGGTCCTCGTGGTCCTGGGCTCCACCGCTATCGTCTTCTTCCAGCGCT-
GCGAGGTCTGGATGGCCAACGTGAGGTACAGGCAGCTGGTGGCGCAGCAGAGGGAGCT-
GATCCAGGACCAGGCCACCGTGAACATCATCCTGCCTGAGAAGATCAAGCTGAGCAGC-
TACAGCAGACACTACACCTCCATCTGA
Medaka Dlk1
ATGATGATGCATCTGATCTGGGTGGTCTTCATTCTTAGTGTGGCAGGCATGGTAAAAG-
GCTGGGAATGCAGCGCAGGGTGCAGTCCAGAAAATGGGTTTTGTGAGAGGCAGGGGAAGT-
GCAGGTGCAAACCTGGGTGGGAAGGAGAGAACTGTGACCGGTGCATTCCCTTCCCTG-
GATGTCTGCACGGCTCATGTGAAAAGGCATGGCAGTGTATCTGCAAAGAGGGCTGGGTGGGCAGC-
CTGTGTGACCAAGATACCCGCCTGTGCTCATCCAGGCCGTGTTCCAGCAACGCCAC-
CTGCGTAGAGACGGGAGAGGGAGGATACATGTGTATCTGTCCTCAAGGCTTTGCTG-
GAAAAGACTGCCATTTGAAGAAGCAACTCTGCCTGGAGAATGGCTCCCCTTGTCA-
GAATGGAGGCACATGTGTGGACGCTAGTGGCTCAGCCGCATCCCCTTTCTGTTCCT-
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GTCCCTCTGGGTTTTCCGGAGACTTCTGTGAGATCGGTGTTGACAGCTGCCAGCCTAAC-
CCCTGCCTCAACTATGGCAATTGTACAAACCACGGCCTCACGTTCACGTGTGTCTGTC-
CACCGGGCTTCTCGGGTTTCACCTGCAACGACAGCACCAGCAGCTCCTCCTGTGCTG-
GCAGGCCCTGTTCCAACAGCGGGACATGTGTCCGTCAGCTTGATGGAACGTTCCAGT-
GTGTCTGCCAGAAAGGGTTTGCGGGTCCAACTTGTTCTCTGCGTCACAGACCAAA-
GAGCAGAAACAAACTGCTTGGTGCTAGACCGGTGGAGCACCACATGCTCGCCCTAGC-
CCCCCAACACTACTCTCTGCCCGCCCACGCCTTTCACAAGCTGCTTAAACCTCCCGATA-
GAGACCTGCTGAAGATCACCCTGAAGGAGACTGTCCACTCCTCTGGCGTTCTTGTCACT-
CACGGTCAGCTCATCTGCTTCGGCATGCTGGCCTTGCTCACCTGCCTGGTTATTCTAG-
GCACGACGGGAATAGTTTTATTTGGCCGCTGCGAGACGTGGCTGGCCAATGCCAAG-
TACAGCCAGCTTGTTCGACAGCAACGGGAACACCTGCTGAGAGAAGTCGGAAGCC-
CGAGCCAAGAAGAGCCGGAGCACTCGGTAAACATCATCCTGCCAGAGAAGATTAGACTCTCCAGCTTTGGGA-
GACACTACACCTCAATCTGA
Australian ghost shark Dlk1
ATGGCTCATCACTCCGCAGCCTCTGTGCTGGTGGTCAGTCTCCTGTTACCGCTGCTCACTG-
GTACCCGGACTCAGGGGACTGAATGCAAACCCGACTGTCACCCACTGCATGGATTCT-
GCCAGGATACTGGGGAATGCAGGTGTCAGTCTGGCTGGCAGGGAGACTTGTGTGATCAGT-
GCACTCCCATTCCTGGCTGTTTACATGGGAGTTGCACAAAACCTTGGCAGTGCTGTTGT-
GAAGAGGGTTGGTCAGGCATCCTCTGCGACACAGCTCCCCACACCTGTTCCTCAGAA-
CACCCATGCGCTAACAATTCAACGTGTATAGAGAGTGAAGGAGGTGGCTACAGATG-
TATCTGTGGAGAGGAGTTTACAGGGAACCATTGCCAGCTCAGGAAAGGAAATTTCT-
GCATAAATGGGTCACTGTGTCAGAATGGAGGAAGTTGCATAGATGGTAATGGATTTG-
GATCCCAGGCTTCCTGCCTGTGCTTGAAGGGTTTTACTGGGGTCTTGTGTGAGACCAAAATCAGT-
GACTGTGACTCTAATCCATGTGCAAACAATGGGACTTGCACAGACCTGGTTTCTGGC-
TACAGCTGCCTCTGTCCCCTTGGTTTTACTGGCGGATCTTGCGATTATCTAATCACATC-
CTGCCTTAGTCATCCATGCAAGAATGGAGGCACTTGCCATGATCTTCCTGAGGGGGGTTTTGATTGCG-
CATGCTTGCCTGGTTATGAAGCAGAAACCTGTCACGAGCATATCTCTTCTAAACATGAT-
ACAAAGCAAAACATATCCAAGCACGTGAGAGTAAGTTGGGTCAGACATGGCAAGCTTTTCAATC-
CACCGCTGCATGCCTTTCACAAGCCCACCCACCATCAAGGTAATGAGATGCTGAAGAT-
CACCGTCAAAGAAACCATCCACACATCGAATTCCCTGCTCAACAGAAGTCAAGTCATCT-
GCTTTGTCATGCTTGGATTGCTGACTTGTCTCGTGATCCTGGGAACGACACTGATCATCTTTTTCTC-
CAAGTGTAAAATGTGGATGGCAAATGCTAAATATCGTCAATACCTACGGAAACAAAAAAAT-
CACTTTCTCAACGACGAAGAGACTTCAGTCAAAATCATATTCCCGGACATGAGTAAATTGA-
CAAACTACAGGAAAAGTTACATCTCGATGTGA
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A.1.4 Coding sequences used for Dlk2
Human Dlk2
atgcccagcggctgccgctgcctgcatctcgtgtgcctgttgtgcattctgggggctcccggtcagcctgtccgagccgatgactgcagctc-
ccactgtgacctggcccacggctgctgtgcacctgacggctcctgcaggtgtgacccgggctgggaggggctgcactgtgagcgct-
gtgtgaggatgcctggctgccagcacggtacctgccaccagccatggcagtgcatctgccacagtggctgggcaggcaagttctgtga-
caaagatgaacatatctgtaccacgcagtccccctgccagaatggaggccagtgcatgtatgacgggggcggtgagtaccattgtgt-
gtgcttaccaggcttccatgggcgtgactgcgagcgcaaggctggaccctgtgaacaggcaggctccccatgccgcaatggcgggcagt-
gccaggacgaccagggctttgctctcaacttcacgtgccgctgcttggtgggctttgtgggtgcccgctgtgaggtaaatgtggatgact-
gcctgatgcggccttgtgctaacggtgccacctgccttgacggcataaaccgcttctcctgcctctgtcctgagggctttgctggacgcttct-
gcaccatcaacctggatgactgtgccagccgcccatgccagagaggggcccgctgtcgggaccgtgtccacgacttcgactgcctct-
gccccagtggctatggtggcaagacctgtgagcttgtcttacctgtcccagaccccccaaccacagtggacacccctctagggcccac-
ctcagctgtagtggtacctgccacggggccagccccccacagcgcaggggctggtctgctgcggatctcagtgaaggaggtggtgcg-
gaggcaagaggctgggctaggtgagcctagcttggtggccctggtggtgtttggggccctcactgctgccctggttctggctactgtgttgct-
gaccctgagggcctggcgccggggtgtctgcccccctggaccctgttgctaccctgccccacactatgctccagcgtgccaggaccaggagt-
gtcaggttagcatgctgccagcagggctccccctgccacgtgacttgccccctgagcctggaaagaccacagcactgtga
Mouse Dlk2
atgcccagcggctgccgctgcctaaatctcgtgtgcctgctgtgcatcctgggggcaaccagccagcctgccagagcggatgactgcagctc-
ccactgtgacctggcccacggctgctgcgctcctgacggctcctgcaggtgtgacccaggctgggaggggctgcactgtgagcgct-
gtgtgaggatgcctggctgccagcacggtacctgccaccagccctggcagtgcatctgccacagtggctgggcaggaaagttctgtga-
caaagatgagcacatctgtacctcacaatcaccctgccagaatggaggccagtgtgtgtatgacgggggtggtgagtaccactgtgtgt-
gcctgccaggcttccatggacgtggctgtgagcgcaaggctggaccttgtgagcaggcaggcttcccgtgccggaatggagggcagt-
gccaggacaaccagggttttgccctcaacttcacatgccgctgcttggcaggattcatgggtgcccactgtgaggtcaatgtggacgact-
gtctgatgcggccttgcgccaatggtgccacatgcattgatggcataaaccgcttttcctgcctctgtcctgagggcttcgctggacgcttct-
gcaccatcaacctggatgactgtgccagccgcccatgccagagaggggcccgctgcagggaccgtgtccatgactttgactacctgt-
gccccagtggctatggtggtaagacttgtgaacttgtcctacctgctccagagcctgcctcagtgggcaccccacaaatgcccacctcagct-
gtagttgtacctgccacggggccggcccctcacagtgcgggggcgggcctgctaaggatctcagtgaaggaggtggtacggaggcaa-
gagtctgggcttggtgaatctagcctggttgccctggtggtgtttgggtctctcactgctgcgctggtcctggccacggtgctgctgacc-
ctgagggcatggcgccgaggtatatgccccactggaccctgctgctacccagccccacactatgccccagctcggcaggatcaggagt-
gccaggttagcatgctgccagcggggttccctctgtccccagacctgccccctgagcctggtaagaccacagcgctgtga
Cow Dlk2
atgcccagcggctgccgctgcctacatctcgtttgcctgttgtgcatcctgggggcacccgtaaagcctgccagaggcaatgactgcagctc-
cctctgtgacctggctcacggctgctgcgcgcctgacggctcttgcaggtgtgacccaggctgggaggggctgcactgtgagcgctgt-
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gtgagaatgcctggctgccagcacggtacctgtcaccagccctggcagtgcatctgtcacactggctgggcaggcaagttctgtgacaaa-
gatgaacacatctgtaccacgcagtccccctgccggaacggaggccagtgcgtgtatgacgggggcggtgattaccattgtgtgtgc-
ccaccaggcttccacgggcgtgattgtgagcgcaaggccggaccctgtgagcaggcaggctccccgtgccggaacggtgggcagt-
gccaggacgaccagggctttgccctcaacttcacctgccgctgcctggcgggcttcatgggtgcccgctgcgaggtgaatgtggatgact-
gtctgatgcggccctgtgctaacggcgccacatgcctggacggcatcaaccgcttctcctgcctctgccccgagggcttcaccgggcgcttct-
gcaccatcaacctggatgactgtgccagccgcccctgccagagaggggcccgctgtcgggaccgggtccacgactttgactgtctct-
gccccagcggctatggtggcaagacttgtgagctagtcttaccggtcccgggtcctgccgccacagcggacagccccccagggcc-
caccttggctgtgcttgtacctgccacggggcccatccctcacagcgcgggcgccgggctgctgcgcatctccgtgaaggaagtggt-
gcggcgacaggaggccgggctgggcgagcccagcctggtggccgtggtggtgtttggggccgtcactgccgccctggtcctgtccacg-
gtgttgctgaccctgagggcctggcgccggggcttctgtccccctggaccctgctgctaccctgccccacactacgccccagcacgccaggaccaggagt-
gtcaggttagcatgctgcccacggggctccctctgccgcctgacctgccccccgagcctgggaagaccaccgctctgtga
Dog Dlk2
atgcccagcggctgccgctgtctacatctcgtgtgcctgttgtgcatcctgggggcgcccgttcagcctgcgggagccgatgactgcagctc-
ccactgtgacctggcccacggctgctgtgcgcctgacggctcctgcaggtgtgacccaggctgggaagggctgcactgtgagcgct-
gcgtgagaatgcctggctgccagcatgggacctgccaccagccctggcagtgcatctgtcatagtggctgggcaggcaagttctgtga-
caaagatgagcacatctgtaccacacagaacccctgtcggaatggtggccagtgtgtctatgacgggggtggtgagtaccactgtgtgt-
gtccaccaagtttccatggacatgactgcgagcgcaagtctggaccctgtgaacaggcaggctccccatgccggaatggtgggcaat-
gccaggatgaccagggctttgctctcaacttcacctgccgctgtctggtaggctttgtgggttctcgttgtgaggtcaatgtagacgactgtct-
gatgcgaccttgtgccaatggcgccacctgcctggatggcataaaccgcttctcctgcctctgccctgagggctttgctggtcgcttctg-
cacagtcaacctggatgactgtgccagccgtccgtgccagagaggggcccgctgtcgggaccgcgtccatgactttgactgtctctgc-
cccagcggctatggcggcaagacctgcgagctcatcttaccggtctcagaacccgccaccatagtggacatccccttggggaccac-
ctcggctctggcagtacctgccacagggcctgtcccccacagcgtgggggcgggtctgctgcgcatctcagtgaaagaggtggtgcg-
gaggcaagaggctgggctaggtgtatctagcctggtggctgtggtggtctttggggccctcaccaccgccctggtcctgtccacaatgttgct-
gaccctgagggcctggcgccggggtgtatgcccccctggaccctgttgctaccctgccccacactatgccccggcatgccaggaccaggagt-
gtcaggttagcatgctgccggcagggctccccctgtcacctgacctgccccctgagcctggaaagaccacagcactgtga
Elephant Dlk2
atgcccagcggctgccgctgcctacatctcgtgtgcctgttgtgcatcctggggccacccggtcagcctgcccgagcggatgactgcagctc-
ccactgtgatctggcccacggctgctgcgcgcctgacggctcctgcaggtgtgacccgggctgggaggggctgcactgcgagcgct-
gtgtgaggatgcctggctgccagcacggaacctgccaccagccctggcagtgcatctgccacagtggctgggcggggaagttctgt-
gacaaagatgagcacatctgtaccacacagtccccctgccagaacggaggccagtgcatgtatgacgggggcggtgagtaccactgt-
gtgtgcccaccaggtttccacgggcacgactgtgagcgcaaggctgggccctgtgagcaggcaggctccccatgccagaatggcgggcagt-
gccaggacaaccagggctttgccctgaacttcacatgccgctgcttggcaggatttgttggtgcccgctgtgaggtgaatgttgatgact-
gcctgatgaggccttgtgcaaacggcgccacctgccttgatggcataaaccgcttctcctgcctctgtcctgagggctttgctggacgcttct-
gcaccatcaacctggatgattgtgccagccacccatgccagagaggggcccgatgtcgggaccgcgtccatgactttgactgtctctgc-
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cccagtggctatggcggcaagacttgtgagcttgtcttaccagttccagaccctttcaccacggcggaccttcccctgggtcccacctcagct-
gtggtggtacccaccacggggccagttccccatagtgcaggggccggtttacttcggatctccgtgaaggaggtggtgcggagacaa-
gaggcggcgctggcggagtctagcctggtggccgtggtggtatttggggctctcactgctgccctggtcctggccactggattgctgac-
cctgagggcctggcgccggggtgtccgcccccctggaccctgttgctaccccattccacactatgccccagcacgccaggaccaggagt-
gtcaggttagcatgctgccagctgggcttcccctgccacctgacttgcccggtgagcccggaaagactacagcactgtga
Opossum Dlk2
atgcccagcggctgccgctgtctccagcttgtgtccctgctgtggatcctgggggcatccggacagcccacccatgctgatgactgtagttc-
ccactgtgatctggcccacggctgttgtgagcctgacggcacgtgcaggtgtgaccctggctgggagggattacactgtgagcaatgt-
gtcaggatgcctggctgccagcatgggacctgtcaccaaccctggcagtgtatctgcagtaatggctgggcaggcaaattctgtgacaaa-
gatgagcatatctgcaccaagcagccaccctgtcagaatggagggaagtgtgtctatgaaggggatggagaataccactgtgtgtgc-
ccaccaggcttccacgggcacaactgtgagcgcaagactgggccctgtgagcacgctggatctccttgccggaatggtgggcagtgc-
caagatgatcaaggcttcgcagagaactttacatgccgctgcttggcaggctttgtgggtccacgctgtgaggtcaatgtggatgactgc-
ctaatgaggccctgtgccaatggtgccacctgtcatgacggcatcaaccgcttctcctgccactgccccaaaggctttgctggccgattct-
gcactgtcaacctggatgactgtgccagccgaccgtgccagcatggtgcccgctgccgggaccgagtccatgactttgattgcctctgc-
cctgatggctttgggggcaagacatgtgagattgttctcccagccctggacctgcctacagagccagacagtgcccctggacccacc-
cctgcagccgtggttcctttcacagtaccagcccccttcagtgtgggcgcagggctactgaggatctcagtgaaggaggtagtacggc-
gacaagaggcagggataggggattcaagcctgattgttttgttcatatttggggccatcactattactggggtctttggcacagggctggt-
gattttttgggtacgacgccatggccactgccccactgggccttgctgctgcccttatcaccagtatgccccaccccctgagcgacatgaccaggagt-
gccaggtcagcatgctcccggctgggatctcccctccacctgacttcccatctgagcttggcaagaccacggcattgtga
Tasmanian devil Dlk2
atgccccacggttgccgctgcctccagctcgtgtctctactctggatcctgggggcatccggacagcccacccctgccaatgattgtagttc-
ccattgtgatctggcccacggctgctgtgagccagacggcacttgcagatgtgaccctggctgggagggactacactgtgagcgctgt-
gtcaggatgcctggttgccaacatggcacttgtcaccaaccctggcagtgtatctgccataatggctgggctggcaaattctgtgacaaa-
gatgagcacatctgcaccaagcagccgccctgccagaacggagggaagtgtgtgtatgagggggatggggagtaccactgcgtgt-
gcccaccaggttttcacgggcataactgtgagcgcaagactgggccctgtgagcatgctgggtccccttgccggaatggtgggcaat-
gccaagatgatcaaggctttgcgaagaacttcacatgccgctgcttggcaggctttgtggggccacgctgtgaagtcaacgtggatgact-
gcctaatgaggccgtgtgccaatggtgccacctgtcatgatggcatcaaccgcttctcctgccactgtcctgaaggctttgctggccgcttct-
gtactatcaacctggatgactgtgccagccgcccatgccagcatggtgcccgctgccgggaccgtgtccatgacttcgattgcctctgc-
cctgatggctatgggggcaagacatgtgagattgccctcccagccctggacctccctacggagccagagagtgctgctggatccactc-
ctgcagctgtggttcctttcacggtaccagcccccttcagcgtgggggcagggctgctgcggatctcagtgaaggaggtagtaaggc-
gacaggaggcaggcctaggggagtcaagcctgcttgtgttagtgatatttggggtcctcactgccaccctggtccttaccacagggct-
gctgatcttttgggcatggtgccatggccactgccctgctgggctctgctgctacccttttcgccaatatgccataccccccgagcagcat-
gaccaggagtgccaggtcagcatgctccctgccggaatctcccctccacctggctccccacctgagcctggcaagaccacagcact-
gtga
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Chicken Dlk2
atgctcaggagcttctgccttcagctcatgtccttgctttggatcctcttggcccatcaccagcttgcccaaggtgatgactgcagcgagcact-
gcaatctggcccacggcagctgcgaccaggatgggaagtgcaggtgtgacccaggctgggagggcgactactgtgaggagtgcg-
tacgcatgccgggctgcctccatgggacctgccaccagccctggcagtgcatctgtcacagcggctgggccggcaagttctgcgacaag-
gatgtccacatctgcgaacatcagtcaccatgccagaatggggctcagtgcatctacgaccgagatggggactactcctgcctgtgtcca-
gagggcttccatgggaaggactgtgagatgaaggcaggaccatgtgagaaggcagggtctccatgcaagaacgggggacagtgtcaa-
gatgaaaatggctttgccaccaacttcacctgccggtgccttgctggcttcgtgggggctctctgtgagcacgacgtggatgactgcct-
gatgcggccctgcgccaacggtgccacctgccatgatggcatcaaccgcttctcctgccagtgccaggtgggcttcgaggggcgtttct-
gcaccatcaacatcaacgactgcgccagccagccctgcaaaaacggggccaagtgctatgaccgcatcaatgactatgactgcttgt-
gttctgaccgtttcactggcaaaacctgtgagatctccatccctgaacccacctgggctcccccctaccaccctgcgaaccacgagagcagctgggc-
gatgaggagcaccaccagcgagatgcccgaggtgacacagccagagcccgtgaggactgcggttacggggcggcgcgtggccaac-
cacagtgagaaagtgccaggaggagggttgttaaaaatctctgtgaaggaggtggtgacccaaagggactcggggctgagcgaagc-
ccagctggtgacagtgctggtgttcggggtgctgacggcggtgctggtcctcatcaccgtcctgctcatcctgaggaactggcagaggggc-
cgacagcggtcgaactggtgccaaagcccttcgcaggctgccaggaagctccaagatcaggagtgccaggtgggcatgttaaacacg-
gtcctgatcgagcccaggaaaacaacagagctgtga
Anole lizard Dlk2
ATGCTCAGGAGCTTCTATCTTCAGCTCATGTCCTTGCTTTGGATCCTGGTGGCCCAT-
CACCATTTTACCCAAGGTGATGACTGTAGCGACCATTGTAATTTGGCTCACGGCAGCT-
GTGAAGATGGCAAATGCAGATGTGACCCAGGCTGGGATGGGGCATCTTGTGAGCAGT-
GTGTGAGGATGCTGGGCTGTATCCATGGAACATGCCACCAACCCTGGCAATGTATCT-
GTCAAAGTGGCTGGGCCGGCAAGTTCTGTGACAAAGATGTGCACATTTGTGAGCACCAGC-
CTCCATGTCAAAATGGAGCCGAGTGCATCTATGATCGTGATGGCGAATATTCATGCCT-
GTGCCTTGAAGAATTCCATGGGAAGGACTGCGAGCTGAAGACAGGGCCATGTGAGAAGTCAGGGTTTC-
CATGCAAGAATGGTGGGCTGTGCCAGGATAAGAATGGCTTTGCTAGCAACTACACCT-
GCAAGTGCCTTGCTGGCTTCACTGGTGCGCATTGCGAGATTGATGTAGATGACTGC-
CTGATGCAGCCCTGTGCCAATGGTGCCACCTGCCTCGATGGCATGAACCGTTTCTC-
CTGCCAATGCCAGGCTGGTTTTGAAGGCCGTTTCTGCACTATCAACATTGATGACTGT-
GCCAACCAGCCTTGCAGAAATGGGGCCAAGTGTTATGACCGCATCAATGATTTTGATTGCT-
TATGCCCTGAGGGCTTTGTTGGCAAGACCTGTGAGCTCCCTGCACCAGAACCAACATGGGT-
TACTGCATTTGAGCCTGGTCACAAGGACAATGATAATGCTGTGACCAGTATTGACCCTTG-
GACAGCCCAGTCTGATCCTGCAAGGACTGCAGTTACTGGGAAAAGAATCACTAACTACAGT-
GAGAAATCAAATGGGGGAGGGCTCCTCATCTCTGTGAAAGAGGTGGTGACCCAGCAGGACTCGGGGC-
TAAGCCAATCGCAGCTGATTTTACTGCTGGTGTTTGGCCTGCTCACTATGCTTTTGGTCTTTG-
TAACTGTCTTGATGGTGCTGCTCAAGAACTGGCAGAGAGGGAATCAGAGGTGCCA-
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GAGCCCATCCCAGTCTGCAAGGAAACTTCAGGACCAAGAGTGTCAAGTGGGAATGT-
TAAGTACAGTCTTGATAGAACCCAGGAAAACAACAGAGCTGTAA
Chinese soft shell turtle Dlk2
ATGCTCAGAAGTTTCTGTCTTCAGCTCATGTCCTTGGTTTGGATCCTCTTGGCCCAT-
CATCATCTTGCCCAAGGTGATGACTGCAGTGAGCACTGTAACCTGGCCCACGGCTC-
CTGTGACCAGGACGGCAAGTGCAGGTGTGACCCAGGCTGGGAAGGAGAATATTGC-
GAGCAGTGTGTGCGGATGCCGAGCTGTCTCCATGGTACATGCCATCAGCCGTGGCAAT-
GCATCTGTCACAATGGCTGGGCTGGCAAGTTCTGTGACAAAGATGTACACATTTGC-
GAACACAACCCCCCCTGCCAGAATGGGGCTGGATGCGTCTACGATGGGGACGGGGAG-
TATTCCTGCCTGTGTTCTGAGGGCTTTCATGGAAAGGACTGTGAGCGGAAGACAGGGC-
CATGTGAAAAGGCAGGGTTTCCGTGCAGGAATGGTGGGCAGTGCCAGGACGAGAACG-
GCTTTGCTAAGAACTTCACCTGCAGGTGCCTGGCTGGCTTTGTCGGTGCCCTCTGT-
GAGGAGGATGTAGATGATTGCCTGATGCGCCCCTGTGCCAATGGTGCCATCTGCCAGGACG-
GTATCAACCGCTTTTCCTGCCAGTGCCAGGTGGGCTTTGAGGGGCGTTTTTGCACCAT-
CAACATCAACGACTGTGCCAGCCACCCGTGCAAAAATGGGGCAAAGTGTTACGATCG-
CATCAATGATTTTGACTGCGTGTGTCCTGAGGGTTTTACTGGCAAAACGTGTGAGGC-
CTCTGCTCCGGAACCGACCTGGGTCCCCTTCTACCTTTCTGCTAACAAGGAGAACAAT-
GATGCTCTGAAAAGCACAACCAGCGAGTATCTCTGGGTTACGCAGCCCGAGCCAGTCAGGACT-
GTGGTTACTGGAAAGCGGGTTGCCAACCACAGTGAGAAAGCCAGTGGGGGAGGGCT-
GTTGAAAATTTCTGTGAAAGAGGTGGTGACCCAGCGGGACACAGGGTTGAGTGAGTC-
CCAGCTGGTGACCGTGCTGGTCTTTGGGACACTCACAGCCGCACTGGTCCTGGTGAC-
CATACTGTTAATGCTGCGGAACTGGCAGAGAGGGCGTCGGAGGTCAAACTGGTGC-
CAAAGCCCCTCACAGGCTGCAAGGAAGCTCCAGGAACAAGAATGTCAAATGGGCAT-
GTTAAATACAGTCATGGTAGAGCCCAGGAAGACAACAGAGCTGTGA
Coelacanth Dlk2
ATGAGACCCAGCGGACGGCCTGCTCTTCAGCTCCTGCATTTCGTCTGGATGCTGTTGCTCCAGCGC-
CCTGTCCGAGGTGCAGACTGCAAGTCTAGCTGTAACCTGGCCCACGGCCGCTGTGAT-
GTCAACGGAGATTGCAGGTGTGACCCCGGCTGGGAGGGAGACAGCTGTGAACGCT-
GTGTGCGGATGCCCGGCTGCCTTCATGGCACGTGCCACCAACCGTGGCAGTGTATTTGTTTGAGTG-
GATGGGCTGGCAGATTTTGTGATAAGGATGTGCACATCTGCGAGCACCAGCGTCCGT-
GTCAGAACAGCGCCCGCTGCATCAACGACCGGGAGGGCGATTACTCCTGCGTCTGC-
CCCGACGGCTTCCACGGCAAGAACTGCGAGGTGAAGAGGGGCCCGTGCGAACTCGCAGGATCTC-
CGTGTCAAAATGGCGGCACCTGCTTGGACAACAACGGCTACGCTGACGCTTTTGC-
CTGTCGCTGCCTGGCTGGCTTCGTTGGTGACCTCTGTGAGCTCGATGTGGATGACT-
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GCCTGATGCGCCCCTGCGCCAACGGTGCCACCTGCCATGACGGCATCAACCGCTTCTC-
CTGCAAGTGCCCGGCGGGCTTCGAGGGGCGCTTCTGCACCAGCAACTTGGACGACT-
GTGCCTCCCAGCCGTGCCGCAATGGCGGCAAATGCTACGACCGGGTGAACGACTTTGATTGCGTCT-
GCCCCGAAGGCTACGCGGGTAAATCCTGCGCCACGGTCTTGGAACCACAGCGGGAA-
GAGCAAGTGCAAACGGCCCCCAGGAATGCCCAGCGCGTCAACTATTTTACACCCGAAAGT-
GCCACCCAGGTCCCTCCGCAAGGAACTCGCCCTCAGCCCATCGGTAAGCCCGACGCT-
GCCAGGCGGAAGGGCAATCAGTCAGAGGCATTAAGCGGTGAGCGGCGAGCAGGAGGGCT-
GTTGAAAATCTCAGTGAAGGAGGTGGTGGCACAGGAGGAGTCGGGGCTGGCGGA-
GACCCGTTTCGTCATCCTGGCCGTCTTTGGCGCCTGCACGCTGCTCCTGGCCTTGGT-
GACGGCCACTCTGGTCCTGTGGAGCCACTGGCAGGGAAGGCCAAGCAGTGAGGCTCAGCGC-
CCGGACTCCGCCTCCAGACCAGAGAAGAAGCAGCTCAACGCGGAGGAATATGAGAGC-
CACCTCCCACTGAGACATAACCAGCTAACCCAAAAACTCAACAGCTTTGATGTCTTATAA
Zebrafish Dlk2
ATGAAACTCGCTGTCGTTCTGCTGCTCTGTGGCTGCTGTGTGCTGTTTAAACACAACT-
GTGAAGCTCAAGTTTTATTTTCCTCAGAAGAAACGTCTCCGACTCCATCAGCCAGTAACT-
GCACGTGTGAAATTGGCCACGGAAAATGTGCCGAAAATGGCGACTGCAGGTGTGATC-
CGGGATGGGGCGGGCCGATGTGTGACGACTGTGTTCGGATGCCCGGATGTGTCCACG-
GCACCTGTCATCAGCCCTGGCAGTGCTCCTGCATGGACGGGTGGGCAGGAAGATTCT-
GCGACAAAGATGTTTACGTGTGCTCCAGACAGCAGCCGTGTCATAACGGGGCCACTTGT-
GAACTGAGTGACTCTGGAGATTATAGCTGCTTGTGTCCTGAAGGCTTCCACGGCCGGGACT-
GTGAACTCAAAGCTGGGCCCTGCCAAAAGACCAAATCTCCCTGCAAGAACGGCGGTCT-
GTGTGAGGATCTGGGTGGTTACGCTCCAGAACTGTCCTGTCGATGCCTTGCAGGATTCAC-
CGGTGCCCGCTGCGAGACCAACATGGATGACTGCCTGATGCGCCCCTGTGCCAACG-
GTGCCACCTGTTTGGACGGCGTGAATCGTTTTTCCTGCCTGTGCCCTGCCGGATTCACAGGACGTTTCT-
GCACCATCAACCTGGACGACTGCGCCAGCCAACCCTGCCTAAACGGAGGACGCTG-
CATAGATCGAGTCTCCAACTTCCAGTGCGTCTGCCCTCTAGGATTCACCGGGAGAACTTGC-
GAGTTGGTATCTCCAACCAAATCTCCGCTTAAAGCTGAACACAACCCAAACATGACGCT-
GAAGCCCTCCCATTGGACGACTCCAAGCGGAGGCGAGGAACGCCTGCTTAAGATCACTTT-
TAGAACTCCAGCCGGTGGAGAAGGGCTGTCGGAGTTTCAGCTCATCGTTCTGCTGGTTT-
TAGGTGGGATGACGCTGGCTGTAGTGGGATTAACAGCTGCTCTGGTGCTTCGCGGGTATTTCCAGGAC-
CGATCGGCTAGCTGTCAGTGCAGACCGGCTCACCGGACGCAGAGGAAACATTCGCAACAGGAGT-
GCAAGATCAGTTTCCTCCAATCTCCGGAGAAGAAGAGGCTGAACACTGATGTTATT-
TAG
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Medaka Dlk2
ATGGCGCCGGTCCGAGCTGAAGGCGTCCTGTTGCTCCTGAGCTGCTGGTTTGTCCTC-
CACATCCAGTCATCAGCAGGTCAAGGAAGTGACTGCAGCTGCAACATGACCAACAGTCGCT-
GTGATGAGTCTGGAATATGCAGGTGTGACCCTGGCTGGGAAGGTGAACACTGCGATCGCT-
GCGTGCTCATGCCTGGCTGTGTGCACGGCTCCTGCCAGCAGCCATGGCAGTGCACAT-
GTGAGCCTGGATGGGGGGGGCGATTCTGTGACAAAGATCTTAGCGTGTGCTCAAATCAGCAGC-
CATGCCGGAATGGTGCCACCTGTGCAATGAAGGACAGCGGAGATTTTACTTGTCTGT-
GTCCACAAGGCTATCATGGCCACCTGTGCCAACGAAAGTCGGGGCCATGTCATCAAATCAGGTCTC-
CCTGTAAAAATGGTGGCCTTTGTGAAGACGCTGATGGTTTTGCTGCAGATCTTACCT-
GCCGCTGTCTGGCGGGTTTCACTGGATCGTTTTGCGAGACAGACATAGACGACTGTCT-
GTTGAAGCCATGCGCCAACGACGCCATCTGCCTGGATGGCATCAATCGGTTCTCAT-
GCATCTGTCCCAGTGGCTTCACTGGACGCTTCTGCACCGTCAACCTGGACGACTGT-
GCTAGTCAGCCCTGCCTGAATGGCGGCCGCTGCCTAGACCTTGCGGGGGGCTTTCGCT-
GTATATGTCAGCTGGGTTACATGGGAAACACCTGTGAGATGTCGCTCAGCAGCCCCAACTG-
GACCACAAAGGGGGAGAAGGGAAAAGGCAAAAGAAGCAGCAACATCACTCAACATGGGAACA-
GACTGATGAAGGTGACAGTGAGCGACCGTGGAATAGCCAGCCTCTCGGACATTCAGCT-
TATTGTTGTCGTGGTTCTGGGGGGAGTGACTTTGGTAGCGGTGGCACTAACGAGTG-
GTTTGGTGCTGTGGGGCCGTTGCCAAAACTGTAGTTACACCGCCGGCTGGTCACCGC-
CATGCTCTCAAGGAGCCGAGAGGAGCAGACGGCGAGGACAGAGTGAAACACAGCAAT-
GCCAGATCAGCTTTCTGAACTCGGTAGAACCACAGAAGAAGTTAAATTTGGAGGCT-
GTTTAA
Australian ghost shark Dlk2
ATGAGAGGGATCAGAGACTGGGGACTTCCACTGTGGGGCTTGGCCTGTTTTTTGTGCTCGC-
CCAGCATGGCCGCAGGTGCAGAAGACGTGCAGTGTAATCCTGGTTGTAACCTATTA-
CATGGTCGCTGTGAGTCAAGCGAATGCAGGTGTGATCCCGGCTGGGAGGGGGAGCT-
GTGTGAACGTTGTGTCCGTTCTCCGGGCTGTGTGCACGGCACCTGTCACCAACCCTG-
GCAATGCATCTGTCAGACTGACTGGGCTGGACGATTCTGTGACAAGGACATTCATGCTTG-
CACCCACCAGCAGCCGTGCCAGAATGGTGGGAGCTGCTTCGACACAGGCGAGGGC-
GAGCACTGGTGCTCGTGTCCGGATGGTTTCTATGGGAAGAACTGTGAGCTGCGGGCAGGAC-
CCTGCACTAAGTCCAGGTCTCCCTGTAAGAATGGTGGGACGTGCTTGGACCGGGACG-
GTTTTGCGGACACGCTCACCTGTCGTTGCTTGGCTGGCTTTGTGGGGCCGAGGTGC-
GAAGAGGACGTCGACGACTGCCTGATGCGTCCATGTGCCAATGGTGCCACCTGCCGGGATG-
GAGTGAACCGTTTCTCTTGCATATGCCCACAGGGCTTTGAAGGCCGCTTCTGCACCGT-
CAACTGGGACGATTGTACCAGCGGTCCATGCCAGAATGGTGGTCGGTGCTATGACCGGGTG-
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GCCGACTTTGATTGCGTCTGTCTTAAAGGCTACTCTGGGAAGACCTGCTCTTTACCT-
GTCCCTCAGTGGAGGAAGGAGCGGCCAGCGCTGAGCCGCCGAGATCCTGGGATTAC-
CATTCCTCAGCCAGACCATGCCACTCGGCAGGGATTGGCAGCGTTACCCGCTGCCAGC-
CCCACACAGCCCGTGCGGGAACAGGAGAGGCTGCTGAAGGTGGAGGTGAAGGAGCT-
GCTGTCAGAACCCAGCTCAGCACTAGCCCACAGCCAGATAGTCGGCCTGAGTGTGTTCGGGGC-
CTTGACGGCACTGCTGGTCTCAGTGACGGTCGTTGTGATGCTCTTGTGCCGGCGGCAA-
GAAGAGCCCTCCCGCAAGCCCCCCCGATCGGGAGAGAGGGGCCAAGCTGAGGGGGC-
CATTAGCTTCCTACAACCCCCTGCTCCCGAGAGCAGGAAGGAGCTTTATCTTGATCTAAT-
GTAG
A.1.5 Alignments of DLK1 (close-up view)
A.1.6 Alignments of DLK2 (close-up view)
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A.2 In situ hybridisation sense controls 195
Fig. A.1 Close up of alignments of DLK1 protein sequences across various vertebrates
in section 2.3 part 1
196 Appendix
Fig. A.2 Close up of alignments of DLK1 protein sequences across various vertebrates
in section 2.3 part 2
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Fig. A.3 Close up of alignments of DLK1 protein sequences across various vertebrates
in section 2.3 part 3
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Fig. A.4 Close up of alignments of DLK1 protein sequences across various vertebrates
in section 2.3 part 4
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Fig. A.5 Close up of alignments of DLK2 protein sequences across various vertebrates
in section 2.3 part 1
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Fig. A.6 Close up of alignments of DLK2 protein sequences across various vertebrates
in section 2.3 part 2
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Fig. A.7 Close up of alignments of DLK2 protein sequences across various vertebrates
in section 2.3 part 3
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(a) Antisense (b) Sense
Fig. A.8 Antisense and sense Dlk2 ISH on e12.5 wild-type embryos (N=3)
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(a) Antisense
(b) Sense
Fig. A.9 Antisense and sense Dlk2 ISH on e12.5 wild-type placentae (N=3)
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(a) Antisense
(b) Sense
Fig. A.10 Antisense and sense Dlk1 ISH on e12.5 wild-type embryos (N=2)
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(a) Antisense
(b) Sense
Fig. A.11 Antisense and sense Dlk1 ISH on e12.5 wild-type placentae (N=2)
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(a) Antisense
(b) Sense
Fig. A.12 Antisense and sense Dlk2 ISH on e14.5 wild-type embryos (N=4)
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(a) Antisense
(b) Sense
Fig. A.13 Antisense and sense Dlk2 ISH on e14.5 wild-type placentae (N=2)
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(a) Antisense
(b) Sense
Fig. A.14 Antisense and sense Dlk1 ISH on e14.5 wild-type embryos (N=4)
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(a) Antisense
(b) Sense
Fig. A.15 Antisense and sense Dlk1 ISH on e14.5 wild-type placentae (N=3)
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(a) Antisense
(b) Sense
Fig. A.16 Antisense and sense Dlk2 ISH on e16.5 wild-type embryos (N=1)
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(a) Antisense
(b) Sense
Fig. A.17 Antisense and sense Dlk2 ISH on e16.5 wild-type placentae (N=1)
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A.3 DNA sequences of CRISPR generated Dlk2 mutants
DLK2 exon5 13bp del
ATGCCCAGCGGCTGCCGCTGCCTAAATCTCGTGTGCCTGCTGTGCATCCTGGGGGCAACCAGCCAGC-
CTGCCAGAGCGGATGACTGCAGCTCCCACTGTGACCTGGCCCACGGCTGCTGCGCTC-
CTGACGGCTCCTGCAGGTGTGACCCAGGCTGGGAGGGGCTGCACTGTGAGCGCTGT-
GTGAGGATGCCTGGCTGCCAGCACGGTACCTGCCACCAGCCCTGGCAGTGCATCTGC-
CACAGTGGCTGGGCAGGAAAGTTCTGTGACAAAGATGAGCACATCTGTACCTCACAAT-
CACCCTGCCAGAATGGAGGCCAGGGGGTGGTGAGTACCACTGTGTGTGCCTGCCAGGCTTC-
CATGGACGTGGCTGTGAGCGCAAGGCTGGACCTTGTGAGCAGGCAGGCTTCCCGT-
GCCGGAATGGAGGGCAGTGCCAGGACAACCAGGGTTTTGCCCTCAACTTCACATGC-
CGCTGCTTGGCAGGATTCATGGGTGCCCACTGTGAGGTCAATGTGGACGACTGTCT-
GATGCGGCCTTGCGCCAATGGTGCCACATGCATTGATGGCATAAACCGCTTTTCCTGC-
CTCTGTCCTGAGGGCTTCGCTGGACGCTTCTGCACCATCAACCTGGATGACTGTGCCAGC-
CGCCCATGCCAGAGAGGGGCCCGCTGCAGGGACCGTGTCCATGACTTTGACTGCCT-
GTGCCCCAGTGGCTATGGTGGTAAGACTTGTGAACTTGTCCTACCTGCTCCAGAGC-
CTGCCTCAGTGGGCACCCCACAAATGCCCACCTCAGCTGTAGTTGTACCTGCCACGGGGC-
CGGCCCCTCACAGTGCGGGGGCGGGCCTGCTAAGGATCTCAGTGAAGGAGGTGGTACG-
GAGGCAAGAGTCTGGGCTTGGTGAATCTAGCCTGGTTGCCCTGGTGGTGTTTGGGTCTCT-
CACTGCTGCGCTGGTCCTGGCCACGGTGCTGCTGACCCTGAGGGCATGGCGCCGAG-
GTATATGCCCCACTGGACCCTGCTGCTACCCAGCCCCACACTATGCCCCAGCTCGGCAGGATCAGGAGT-
GCCAGGTTAGCATGCTGCCAGCGGGGTTCCCTCTGTCCCCAGACCTGCCCCCTGAGC-
CTGGTAAGACCACAGCGCTGTGA
DLK2 exon5 2bp del
ATGCCCAGCGGCTGCCGCTGCCTAAATCTCGTGTGCCTGCTGTGCATCCTGGGGGCAACCAGCCAGC-
CTGCCAGAGCGGATGACTGCAGCTCCCACTGTGACCTGGCCCACGGCTGCTGCGCTC-
CTGACGGCTCCTGCAGGTGTGACCCAGGCTGGGAGGGGCTGCACTGTGAGCGCTGT-
GTGAGGATGCCTGGCTGCCAGCACGGTACCTGCCACCAGCCCTGGCAGTGCATCTGC-
CACAGTGGCTGGGCAGGAAAGTTCTGTGACAAAGATGAGCACATCTGTACCTCACAAT-
CACCCTGCCAGAATGGAGGCCAGTGTGTGTATGGGGGGTGGTGAGTACCACTGTGT-
GTGCCTGCCAGGCTTCCATGGACGTGGCTGTGAGCGCAAGGCTGGACCTTGTGAGCAGGCAGGCTTC-
CCGTGCCGGAATGGAGGGCAGTGCCAGGACAACCAGGGTTTTGCCCTCAACTTCA-
CATGCCGCTGCTTGGCAGGATTCATGGGTGCCCACTGTGAGGTCAATGTGGACGACT-
GTCTGATGCGGCCTTGCGCCAATGGTGCCACATGCATTGATGGCATAAACCGCTTTTC-
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(a) Antisense (b) Sense
Fig. A.18 Antisense and sense Dlk1 ISH on e16.5 wild-type embryos (N=1)
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(a) Antisense
(b) Sense
Fig. A.19 Antisense and sense Dlk1 ISH on e16.5 wild-type placentae (N=1)
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(a) Antisense
(b) Sense
Fig. A.20 Antisense and sense Dlk2 ISH on e18.5 wild-type embryos (N=3)
216 Appendix
(a) Antisense
(b) Sense
Fig. A.21 Antisense and sense Dlk2 ISH on e18.5 wild-type placentae (N=3)
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(a) Antisense
(b) Sense
Fig. A.22 Antisense and sense Dlk1 ISH on e18.5 wild-type embryos (N=2)
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(a) Antisense (b) Sense
Fig. A.23 Antisense and sense Dlk1 ISH on e18.5 wild-type placentae (N=2)
A.3 DNA sequences of CRISPR generated Dlk2 mutants 219
CTGCCTCTGTCCTGAGGGCTTCGCTGGACGCTTCTGCACCATCAACCTGGATGACT-
GTGCCAGCCGCCCATGCCAGAGAGGGGCCCGCTGCAGGGACCGTGTCCATGACTTTGACT-
GCCTGTGCCCCAGTGGCTATGGTGGTAAGACTTGTGAACTTGTCCTACCTGCTCCA-
GAGCCTGCCTCAGTGGGCACCCCACAAATGCCCACCTCAGCTGTAGTTGTACCTGC-
CACGGGGCCGGCCCCTCACAGTGCGGGGGCGGGCCTGCTAAGGATCTCAGTGAAG-
GAGGTGGTACGGAGGCAAGAGTCTGGGCTTGGTGAATCTAGCCTGGTTGCCCTGGTG-
GTGTTTGGGTCTCTCACTGCTGCGCTGGTCCTGGCCACGGTGCTGCTGACCCTGAGGGCATG-
GCGCCGAGGTATATGCCCCACTGGACCCTGCTGCTACCCAGCCCCACACTATGCCCCAGCTCG-
GCAGGATCAGGAGTGCCAGGTTAGCATGCTGCCAGCGGGGTTCCCTCTGTCCCCAGAC-
CTGCCCCCTGAGCCTGGTAAGACCACAGCGCTGTGA
DLK2 exon5 INDEL
ATGCCCAGCGGCTGCCGCTGCCTAAATCTCGTGTGCCTGCTGTGCATCCTGGGGGCAACCAGCCAGC-
CTGCCAGAGCGGATGACTGCAGCTCCCACTGTGACCTGGCCCACGGCTGCTGCGCTC-
CTGACGGCTCCTGCAGGTGTGACCCAGGCTGGGAGGGGCTGCACTGTGAGCGCTGT-
GTGAGGATGCCTGGCTGCCAGCACGGTACCTGCCACCAGCCCTGGCAGTGCATCTGC-
CACAGTGGCTGGGCAGGAAAGTTCTGTGACAAAGATGAGCACATCTGTACCTCACAAT-
CACCCTGCCAGAATGGAGGCCAGTGTGTGTATGGGGGGGGGTGAGTACCACTGTGT-
GTGCCTGCCAGGCTTCCATGGACGTGGCTGTGAGCGCAAGGCTGGACCTTGTGAGCAGGCAGGGGCAGGCTTC-
CCGTGCCGGAATGGAGGGCAGTGCCAGGACAACCAGGGTTTTGCCCTCAACTTCA-
CATGCCGCTGCTTGGCAGGATTCATGGGTGCCCACTGTGAGGTCAATGTGGACGACT-
GTCTGATGCGGCCTTGCGCCAATGGTGCCACATGCATTGATGGCATAAACCGCTTTTC-
CTGCCTCTGTCCTGAGGGCTTCGCTGGACGCTTCTGCACCATCAACCTGGATGACT-
GTGCCAGCCGCCCATGCCAGAGAGGGGCCCGCTGCAGGGACCGTGTCCATGACTTTGACT-
GCCTGTGCCCCAGTGGCTATGGTGGTAAGACTTGTGAACTTGTCCTACCTGCTCCA-
GAGCCTGCCTCAGTGGGCACCCCACAAATGCCCACCTCAGCTGTAGTTGTACCTGC-
CACGGGGCCGGCCCCTCACAGTGCGGGGGCGGGCCTGCTAAGGATCTCAGTGAAG-
GAGGTGGTACGGAGGCAAGAGTCTGGGCTTGGTGAATCTAGCCTGGTTGCCCTGGTG-
GTGTTTGGGTCTCTCACTGCTGCGCTGGTCCTGGCCACGGTGCTGCTGACCCTGAGGGCATG-
GCGCCGAGGTATATGCCCCACTGGACCCTGCTGCTACCCAGCCCCACACTATGCCCCAGCTCG-
GCAGGATCAGGAGTGCCAGGTTAGCATGCTGCCAGCGGGGTTCCCTCTGTCCCCAGAC-
CTGCCCCCTGAGCCTGGTAAGACCACAGCGCTGTGA
DLK2 exon5 73bp del
ATGCCCAGCGGCTGCCGCTGCCTAAATCTCGTGTGCCTGCTGTGCATCCTGGGGGCAACCAGCCAGC-
CTGCCAGAGCGGATGACTGCAGCTCCCACTGTGACCTGGCCCACGGCTGCTGCGCTC-
220 Appendix
CTGACGGCTCCTGCAGGTGTGACCCAGGCTGGGAGGGGCTGCACTGTGAGCGCTGT-
GTGAGGATGCCTGGCTGCCAGCACGGTACCTGCCACCAGCCCTGGCAGTGCATCTGC-
CACAGTGGCTGGGCAGGAAAGTTCTGTGACAAAGATGAGCACATCTGTACCTCACAAT-
CACCCTGCCAGAATGGAGGCCAGTGTGTGGACCTTGTGAGCAGGCAGGCTTCCCGT-
GCCGGAATGGAGGGCAGTGCCAGGACAACCAGGGTTTTGCCCTCAACTTCACATGC-
CGCTGCTTGGCAGGATTCATGGGTGCCCACTGTGAGGTCAATGTGGACGACTGTCT-
GATGCGGCCTTGCGCCAATGGTGCCACATGCATTGATGGCATAAACCGCTTTTCCTGC-
CTCTGTCCTGAGGGCTTCGCTGGACGCTTCTGCACCATCAACCTGGATGACTGTGCCAGC-
CGCCCATGCCAGAGAGGGGCCCGCTGCAGGGACCGTGTCCATGACTTTGACTGCCT-
GTGCCCCAGTGGCTATGGTGGTAAGACTTGTGAACTTGTCCTACCTGCTCCAGAGC-
CTGCCTCAGTGGGCACCCCACAAATGCCCACCTCAGCTGTAGTTGTACCTGCCACGGGGC-
CGGCCCCTCACAGTGCGGGGGCGGGCCTGCTAAGGATCTCAGTGAAGGAGGTGGTACG-
GAGGCAAGAGTCTGGGCTTGGTGAATCTAGCCTGGTTGCCCTGGTGGTGTTTGGGTCTCT-
CACTGCTGCGCTGGTCCTGGCCACGGTGCTGCTGACCCTGAGGGCATGGCGCCGAG-
GTATATGCCCCACTGGACCCTGCTGCTACCCAGCCCCACACTATGCCCCAGCTCGGCAGGATCAGGAGT-
GCCAGGTTAGCATGCTGCCAGCGGGGTTCCCTCTGTCCCCAGACCTGCCCCCTGAGC-
CTGGTAAGACCACAGCGCTGTGA
DLK2 exon5 12bp del
ATGCCCAGCGGCTGCCGCTGCCTAAATCTCGTGTGCCTGCTGTGCATCCTGGGGGCAACCAGCCAGC-
CTGCCAGAGCGGATGACTGCAGCTCCCACTGTGACCTGGCCCACGGCTGCTGCGCTC-
CTGACGGCTCCTGCAGGTGTGACCCAGGCTGGGAGGGGCTGCACTGTGAGCGCTGT-
GTGAGGATGCCTGGCTGCCAGCACGGTACCTGCCACCAGCCCTGGCAGTGCATCTGC-
CACAGTGGCTGGGCAGGAAAGTTCTGTGACAAAGATGAGCACATCTGTACCTCACAAT-
CACCCTGCCAGAATGGAGGCCAGTGTGTGTATGAGTACCACTGTGTGTGCCTGCCAGGCTTC-
CATGGACGTGGCTGTGAGCGCAAGGCTGGACCTTGTGAGCAGGCAGGCTTCCCGT-
GCCGGAATGGAGGGCAGTGCCAGGACAACCAGGGTTTTGCCCTCAACTTCACATGC-
CGCTGCTTGGCAGGATTCATGGGTGCCCACTGTGAGGTCAATGTGGACGACTGTCT-
GATGCGGCCTTGCGCCAATGGTGCCACATGCATTGATGGCATAAACCGCTTTTCCTGC-
CTCTGTCCTGAGGGCTTCGCTGGACGCTTCTGCACCATCAACCTGGATGACTGTGCCAGC-
CGCCCATGCCAGAGAGGGGCCCGCTGCAGGGACCGTGTCCATGACTTTGACTGCCT-
GTGCCCCAGTGGCTATGGTGGTAAGACTTGTGAACTTGTCCTACCTGCTCCAGAGC-
CTGCCTCAGTGGGCACCCCACAAATGCCCACCTCAGCTGTAGTTGTACCTGCCACGGGGC-
CGGCCCCTCACAGTGCGGGGGCGGGCCTGCTAAGGATCTCAGTGAAGGAGGTGGTACG-
GAGGCAAGAGTCTGGGCTTGGTGAATCTAGCCTGGTTGCCCTGGTGGTGTTTGGGTCTCT-
CACTGCTGCGCTGGTCCTGGCCACGGTGCTGCTGACCCTGAGGGCATGGCGCCGAG-
A.3 DNA sequences of CRISPR generated Dlk2 mutants 221
GTATATGCCCCACTGGACCCTGCTGCTACCCAGCCCCACACTATGCCCCAGCTCGGCAGGATCAGGAGT-
GCCAGGTTAGCATGCTGCCAGCGGGGTTCCCTCTGTCCCCAGACCTGCCCCCTGAGC-
CTGGTAAGACCACAGCGCTGTGA
DLK2 exon5 84bp del
ATGCCCAGCGGCTGCCGCTGCCTAAATCTCGTGTGCCTGCTGTGCATCCTGGGGGCAACCAGCCAGC-
CTGCCAGAGCGGATGACTGCAGCTCCCACTGTGACCTGGCCCACGGCTGCTGCGCTC-
CTGACGGCTCCTGCAGGTGTGACCCAGGCTGGGAGGGGCTGCACTGTGAGCGCTGT-
GTGAGGATGCCTGGCTGCCAGCACGGTACCTGCCACCAGCCCTGGCAGTGCATCTGC-
CACAGTGGCTGGGCAGGAAAGTTCTGTGACAAAGATGAGCACATCTGTACCTCACAAT-
CACCCTGCCAGAATGGAGGCCAGTGTGTGTAGGCAGGCTTCCCGTGCCGGAATGGAGGGCAGT-
GCCAGGACAACCAGGGTTTTGCCCTCAACTTCACATGCCGCTGCTTGGCAGGATTCATGGGT-
GCCCACTGTGAGGTCAATGTGGACGACTGTCTGATGCGGCCTTGCGCCAATGGTGC-
CACATGCATTGATGGCATAAACCGCTTTTCCTGCCTCTGTCCTGAGGGCTTCGCTGGACGCTTCT-
GCACCATCAACCTGGATGACTGTGCCAGCCGCCCATGCCAGAGAGGGGCCCGCTGCAGGGAC-
CGTGTCCATGACTTTGACTGCCTGTGCCCCAGTGGCTATGGTGGTAAGACTTGTGAACTTGTC-
CTACCTGCTCCAGAGCCTGCCTCAGTGGGCACCCCACAAATGCCCACCTCAGCTGTAGTTG-
TACCTGCCACGGGGCCGGCCCCTCACAGTGCGGGGGCGGGCCTGCTAAGGATCTCAGT-
GAAGGAGGTGGTACGGAGGCAAGAGTCTGGGCTTGGTGAATCTAGCCTGGTTGCC-
CTGGTGGTGTTTGGGTCTCTCACTGCTGCGCTGGTCCTGGCCACGGTGCTGCTGAC-
CCTGAGGGCATGGCGCCGAGGTATATGCCCCACTGGACCCTGCTGCTACCCAGCCC-
CACACTATGCCCCAGCTCGGCAGGATCAGGAGTGCCAGGTTAGCATGCTGCCAGCGGGGTTC-
CCTCTGTCCCCAGACCTGCCCCCTGAGCCTGGTAAGACCACAGCGCTGTGA
DLK2 exon3 1G INS
ATGCCCAGCGGCTGCCGCTGCCTAAATCTCGTGTGCCTGCTGTGCATCCTGGGGGCAACCAGCCAGC-
CTGCCAGAGCGGATGACTGCAGCTCCCACTGTGACCTGGCCCACGGGCTGCTGCGCTC-
CTGACGGCTCCTGCAGGTGTGACCCAGGCTGGGAGGGGCTGCACTGTGAGCGCTGT-
GTGAGGATGCCTGGCTGCCAGCACGGTACCTGCCACCAGCCCTGGCAGTGCATCTGC-
CACAGTGGCTGGGCAGGAAAGTTCTGTGACAAAGATGAGCACATCTGTACCTCACAAT-
CACCCTGCCAGAATGGAGGCCAGTGTGTGTATGACGGGGGTGGTGAGTACCACTGT-
GTGTGCCTGCCAGGCTTCCATGGACGTGGCTGTGAGCGCAAGGCTGGACCTTGTGAGCAGGCAGGCTTC-
CCGTGCCGGAATGGAGGGCAGTGCCAGGACAACCAGGGTTTTGCCCTCAACTTCA-
CATGCCGCTGCTTGGCAGGATTCATGGGTGCCCACTGTGAGGTCAATGTGGACGACT-
GTCTGATGCGGCCTTGCGCCAATGGTGCCACATGCATTGATGGCATAAACCGCTTTTC-
CTGCCTCTGTCCTGAGGGCTTCGCTGGACGCTTCTGCACCATCAACCTGGATGACT-
222 Appendix
GTGCCAGCCGCCCATGCCAGAGAGGGGCCCGCTGCAGGGACCGTGTCCATGACTTTGACT-
GCCTGTGCCCCAGTGGCTATGGTGGTAAGACTTGTGAACTTGTCCTACCTGCTCCA-
GAGCCTGCCTCAGTGGGCACCCCACAAATGCCCACCTCAGCTGTAGTTGTACCTGC-
CACGGGGCCGGCCCCTCACAGTGCGGGGGCGGGCCTGCTAAGGATCTCAGTGAAG-
GAGGTGGTACGGAGGCAAGAGTCTGGGCTTGGTGAATCTAGCCTGGTTGCCCTGGTG-
GTGTTTGGGTCTCTCACTGCTGCGCTGGTCCTGGCCACGGTGCTGCTGACCCTGAGGGCATG-
GCGCCGAGGTATATGCCCCACTGGACCCTGCTGCTACCCAGCCCCACACTATGCCCCAGCTCG-
GCAGGATCAGGAGTGCCAGGTTAGCATGCTGCCAGCGGGGTTCCCTCTGTCCCCAGAC-
CTGCCCCCTGAGCCTGGTAAGACCACAGCGCTGTGA
DLK2 exon3 2G INS
ATGCCCAGCGGCTGCCGCTGCCTAAATCTCGTGTGCCTGCTGTGCATCCTGGGGGCAACCAGCCAGC-
CTGCCAGAGCGGATGACTGCAGCTCCCACTGTGACCTGGCCCACGGGGCTGCTGCGCTC-
CTGACGGCTCCTGCAGGTGTGACCCAGGCTGGGAGGGGCTGCACTGTGAGCGCTGT-
GTGAGGATGCCTGGCTGCCAGCACGGTACCTGCCACCAGCCCTGGCAGTGCATCTGC-
CACAGTGGCTGGGCAGGAAAGTTCTGTGACAAAGATGAGCACATCTGTACCTCACAAT-
CACCCTGCCAGAATGGAGGCCAGTGTGTGTATGACGGGGGTGGTGAGTACCACTGT-
GTGTGCCTGCCAGGCTTCCATGGACGTGGCTGTGAGCGCAAGGCTGGACCTTGTGAGCAGGCAGGCTTC-
CCGTGCCGGAATGGAGGGCAGTGCCAGGACAACCAGGGTTTTGCCCTCAACTTCA-
CATGCCGCTGCTTGGCAGGATTCATGGGTGCCCACTGTGAGGTCAATGTGGACGACT-
GTCTGATGCGGCCTTGCGCCAATGGTGCCACATGCATTGATGGCATAAACCGCTTTTC-
CTGCCTCTGTCCTGAGGGCTTCGCTGGACGCTTCTGCACCATCAACCTGGATGACT-
GTGCCAGCCGCCCATGCCAGAGAGGGGCCCGCTGCAGGGACCGTGTCCATGACTTTGACT-
GCCTGTGCCCCAGTGGCTATGGTGGTAAGACTTGTGAACTTGTCCTACCTGCTCCA-
GAGCCTGCCTCAGTGGGCACCCCACAAATGCCCACCTCAGCTGTAGTTGTACCTGC-
CACGGGGCCGGCCCCTCACAGTGCGGGGGCGGGCCTGCTAAGGATCTCAGTGAAG-
GAGGTGGTACGGAGGCAAGAGTCTGGGCTTGGTGAATCTAGCCTGGTTGCCCTGGTG-
GTGTTTGGGTCTCTCACTGCTGCGCTGGTCCTGGCCACGGTGCTGCTGACCCTGAGGGCATG-
GCGCCGAGGTATATGCCCCACTGGACCCTGCTGCTACCCAGCCCCACACTATGCCCCAGCTCG-
GCAGGATCAGGAGTGCCAGGTTAGCATGCTGCCAGCGGGGTTCCCTCTGTCCCCAGAC-
CTGCCCCCTGAGCCTGGTAAGACCACAGCGCTGTGA
DLK2 exon3 16bp del
ATGCCCAGCGGCTGCCGCTGCCTAAATCTCGTGTGCCTGCTGTGCATCCTGGGGGCAACCAGCCAGC-
CTGCCAGAGCGGATGACTGCAGCTCCCACTGTGACCTGGCCCTGACGGCTCCTGCAGGT-
GTGACCCAGGCTGGGAGGGGCTGCACTGTGAGCGCTGTGTGAGGATGCCTGGCTGCCAGCACG-
A.3 DNA sequences of CRISPR generated Dlk2 mutants 223
GTACCTGCCACCAGCCCTGGCAGTGCATCTGCCACAGTGGCTGGGCAGGAAAGTTCT-
GTGACAAAGATGAGCACATCTGTACCTCACAATCACCCTGCCAGAATGGAGGCCAGT-
GTGTGTATGACGGGGGTGGTGAGTACCACTGTGTGTGCCTGCCAGGCTTCCATGGACGTG-
GCTGTGAGCGCAAGGCTGGACCTTGTGAGCAGGCAGGCTTCCCGTGCCGGAATGGAGGGCAGT-
GCCAGGACAACCAGGGTTTTGCCCTCAACTTCACATGCCGCTGCTTGGCAGGATTCATGGGT-
GCCCACTGTGAGGTCAATGTGGACGACTGTCTGATGCGGCCTTGCGCCAATGGTGC-
CACATGCATTGATGGCATAAACCGCTTTTCCTGCCTCTGTCCTGAGGGCTTCGCTGGACGCTTCT-
GCACCATCAACCTGGATGACTGTGCCAGCCGCCCATGCCAGAGAGGGGCCCGCTGCAGGGAC-
CGTGTCCATGACTTTGACTGCCTGTGCCCCAGTGGCTATGGTGGTAAGACTTGTGAACTTGTC-
CTACCTGCTCCAGAGCCTGCCTCAGTGGGCACCCCACAAATGCCCACCTCAGCTGTAGTTG-
TACCTGCCACGGGGCCGGCCCCTCACAGTGCGGGGGCGGGCCTGCTAAGGATCTCAGT-
GAAGGAGGTGGTACGGAGGCAAGAGTCTGGGCTTGGTGAATCTAGCCTGGTTGCC-
CTGGTGGTGTTTGGGTCTCTCACTGCTGCGCTGGTCCTGGCCACGGTGCTGCTGAC-
CCTGAGGGCATGGCGCCGAGGTATATGCCCCACTGGACCCTGCTGCTACCCAGCCC-
CACACTATGCCCCAGCTCGGCAGGATCAGGAGTGCCAGGTTAGCATGCTGCCAGCGGGGTTC-
CCTCTGTCCCCAGACCTGCCCCCTGAGCCTGGTAAGACCACAGCGCTGTGA
DLK2 exon3 1C INS
ATGCCCAGCGGCTGCCGCTGCCTAAATCTCGTGTGCCTGCTGTGCATCCTGGGGGCAACCAGCCAGC-
CTGCCAGAGCGGATGACTGCAGCTCCCACTGTGACCTGGCCCACGCGCTGCTGCGCTC-
CTGACGGCTCCTGCAGGTGTGACCCAGGCTGGGAGGGGCTGCACTGTGAGCGCTGT-
GTGAGGATGCCTGGCTGCCAGCACGGTACCTGCCACCAGCCCTGGCAGTGCATCTGC-
CACAGTGGCTGGGCAGGAAAGTTCTGTGACAAAGATGAGCACATCTGTACCTCACAAT-
CACCCTGCCAGAATGGAGGCCAGTGTGTGTATGACGGGGGTGGTGAGTACCACTGT-
GTGTGCCTGCCAGGCTTCCATGGACGTGGCTGTGAGCGCAAGGCTGGACCTTGTGAGCAGGCAGGCTTC-
CCGTGCCGGAATGGAGGGCAGTGCCAGGACAACCAGGGTTTTGCCCTCAACTTCA-
CATGCCGCTGCTTGGCAGGATTCATGGGTGCCCACTGTGAGGTCAATGTGGACGACT-
GTCTGATGCGGCCTTGCGCCAATGGTGCCACATGCATTGATGGCATAAACCGCTTTTC-
CTGCCTCTGTCCTGAGGGCTTCGCTGGACGCTTCTGCACCATCAACCTGGATGACT-
GTGCCAGCCGCCCATGCCAGAGAGGGGCCCGCTGCAGGGACCGTGTCCATGACTTTGACT-
GCCTGTGCCCCAGTGGCTATGGTGGTAAGACTTGTGAACTTGTCCTACCTGCTCCA-
GAGCCTGCCTCAGTGGGCACCCCACAAATGCCCACCTCAGCTGTAGTTGTACCTGC-
CACGGGGCCGGCCCCTCACAGTGCGGGGGCGGGCCTGCTAAGGATCTCAGTGAAG-
GAGGTGGTACGGAGGCAAGAGTCTGGGCTTGGTGAATCTAGCCTGGTTGCCCTGGTG-
GTGTTTGGGTCTCTCACTGCTGCGCTGGTCCTGGCCACGGTGCTGCTGACCCTGAGGGCATG-
GCGCCGAGGTATATGCCCCACTGGACCCTGCTGCTACCCAGCCCCACACTATGCCCCAGCTCG-
224 Appendix
GCAGGATCAGGAGTGCCAGGTTAGCATGCTGCCAGCGGGGTTCCCTCTGTCCCCAGAC-
CTGCCCCCTGAGCCTGGTAAGACCACAGCGCTGTGA
DLK2 exon2 INDEL
ATGCCCAGCGGCTGCCtaatttcagtgtggTCCTGGGGGCAACCAGCCAGCCTGCCAGAGCG-
GATGACTGCAGCTCCCACTGTGACCTGGCCCACGGCTGCTGCGCTCCTGACGGCTC-
CTGCAGGTGTGACCCAGGCTGGGAGGGGCTGCACTGTGAGCGCTGTGTGAGGATGC-
CTGGCTGCCAGCACGGTACCTGCCACCAGCCCTGGCAGTGCATCTGCCACAGTGGCTGGGCAGGAAAGTTCT-
GTGACAAAGATGAGCACATCTGTACCTCACAATCACCCTGCCAGAATGGAGGCCAGT-
GTGTGTATGACGGGGGTGGTGAGTACCACTGTGTGTGCCTGCCAGGCTTCCATGGACGTG-
GCTGTGAGCGCAAGGCTGGACCTTGTGAGCAGGCAGGCTTCCCGTGCCGGAATGGAGGGCAGT-
GCCAGGACAACCAGGGTTTTGCCCTCAACTTCACATGCCGCTGCTTGGCAGGATTCATGGGT-
GCCCACTGTGAGGTCAATGTGGACGACTGTCTGATGCGGCCTTGCGCCAATGGTGC-
CACATGCATTGATGGCATAAACCGCTTTTCCTGCCTCTGTCCTGAGGGCTTCGCTGGACGCTTCT-
GCACCATCAACCTGGATGACTGTGCCAGCCGCCCATGCCAGAGAGGGGCCCGCTGCAGGGAC-
CGTGTCCATGACTTTGACTGCCTGTGCCCCAGTGGCTATGGTGGTAAGACTTGTGAACTTGTC-
CTACCTGCTCCAGAGCCTGCCTCAGTGGGCACCCCACAAATGCCCACCTCAGCTGTAGTTG-
TACCTGCCACGGGGCCGGCCCCTCACAGTGCGGGGGCGGGCCTGCTAAGGATCTCAGT-
GAAGGAGGTGGTACGGAGGCAAGAGTCTGGGCTTGGTGAATCTAGCCTGGTTGCC-
CTGGTGGTGTTTGGGTCTCTCACTGCTGCGCTGGTCCTGGCCACGGTGCTGCTGAC-
CCTGAGGGCATGGCGCCGAGGTATATGCCCCACTGGACCCTGCTGCTACCCAGCCC-
CACACTATGCCCCAGCTCGGCAGGATCAGGAGTGCCAGGTTAGCATGCTGCCAGCGGGGTTC-
CCTCTGTCCCCAGACCTGCCCCCTGAGCCTGGTAAGACCACAGCGCTGTGA
DLK2 exon2 70bp del
ATGCCCAGCGGCTGCCCCCAGGGATTGGGTCCCGGCTCTCCTCAGCCGTCCTCGCTG-
GCACGTTGACCTCTGCTGGCTAGAGACGGCACTGCAACCGCTCCGTTCCATAGGGA-
GAGATCTATAAGTGCTCTCTTTGGAATGGGACGCTCGTCCGTGCCCATGAGTCCATCT-
GACTACTGAAACCTCTGCCAAGTCCCGCGCCTGGGAAGTCAGACTCGGACCCAGACT-
CACACCCACTACACCAATCTCTTTCAGCGGATGACTGCAGCTCCCACTGTGACCTG-
GCCCACGGCTGCTGCGCTCCTGACGGCTCCTGCAGGTGTGACCCAGGCTGGGAGGGGCT-
GCACTGTGAGCGCTGTGTGAGGATGCCTGGCTGCCAGCACGGTACCTGCCACCAGC-
CCTGGCAGTGCATCTGCCACAGTGGCTGGGCAGGAAAGTTCTGTGACAAAGATGAG-
CACATCTGTACCTCACAATCACCCTGCCAGAATGGAGGCCAGTGTGTGTATGACGGGGGTG-
GTGAGTACCACTGTGTGTGCCTGCCAGGCTTCCATGGACGTGGCTGTGAGCGCAAG-
GCTGGACCTTGTGAGCAGGCAGGCTTCCCGTGCCGGAATGGAGGGCAGTGCCAGGA-
A.4 Protein sequences of CRISPR generated Dlk2 mutants 225
CAACCAGGGTTTTGCCCTCAACTTCACATGCCGCTGCTTGGCAGGATTCATGGGTGC-
CCACTGTGAGGTCAATGTGGACGACTGTCTGATGCGGCCTTGCGCCAATGGTGCCA-
CATGCATTGATGGCATAAACCGCTTTTCCTGCCTCTGTCCTGAGGGCTTCGCTGGACGCTTCT-
GCACCATCAACCTGGATGACTGTGCCAGCCGCCCATGCCAGAGAGGGGCCCGCTGCAGGGAC-
CGTGTCCATGACTTTGACTGCCTGTGCCCCAGTGGCTATGGTGGTAAGACTTGTGAACTTGTC-
CTACCTGCTCCAGAGCCTGCCTCAGTGGGCACCCCACAAATGCCCACCTCAGCTGTAGTTG-
TACCTGCCACGGGGCCGGCCCCTCACAGTGCGGGGGCGGGCCTGCTAAGGATCTCAGT-
GAAGGAGGTGGTACGGAGGCAAGAGTCTGGGCTTGGTGAATCTAGCCTGGTTGCC-
CTGGTGGTGTTTGGGTCTCTCACTGCTGCGCTGGTCCTGGCCACGGTGCTGCTGAC-
CCTGAGGGCATGGCGCCGAGGTATATGCCCCACTGGACCCTGCTGCTACCCAGCCC-
CACACTATGCCCCAGCTCGGCAGGATCAGGAGTGCCAGGTTAGCATGCTGCCAGCGGGGTTC-
CCTCTGTCCCCAGACCTGCCCCCTGAGCCTGGTAAGACCACAGCGCTGTGA
A.4 Protein sequences of CRISPR generatedDlk2mutants
DLK2 exon5 13bp del
MPSGCRCLNLVCLLCILGATSQPARADDCSSHCDLAHGCCAPDGSCRCDPGWEGLHCER-
CVRMPGCQHGTCHQPWQCICHSGWAGKFCDKDEHICTSQSPCQNGGQGVVSTTVCAC-
QASMDVAVSARLDLVSRQASRAGMEGSARTTRVLPSTSHAAAWQDSWVPTVRSMWTTV
DLK2 exon5 2bp del
MPSGCRCLNLVCLLCILGATSQPARADDCSSHCDLAHGCCAPDGSCRCDPGWEGLHCER-
CVRMPGCQHGTCHQPWQCICHSGWAGKFCDKDEHICTSQSPCQNGGQCVYGGW
DLK2 exon5 INDEL
MPSGCRCLNLVCLLCILGATSQPARADDCSSHCDLAHGCCAPDGSCRCDPGWEGLHCER-
CVRMPGCQHGTCHQPWQCICHSGWAGKFCDKDEHICTSQSPCQNGGQCVYGGG
DLK2 exon5 73bp del
MPSGCRCLNLVCLLCILGATSQPARADDCSSHCDLAHGCCAPDGSCRCDPGWEGLHCER-
CVRMPGCQHGTCHQPWQCICHSGWAGKFCDKDEHICTSQSPCQNGGQCVDLVSRQAS-
RAGMEGSARTTRVLPSTSHAAAWQDSWVPTVRSMWTTV
226 Appendix
DLK2 exon5 12bp del
MPSGCRCLNLVCLLCILGATSQPARADDCSSHCDLAHGCCAPDGSCRCDPGWEGLHCER-
CVRMPGCQHGTCHQPWQCICHSGWAGKFCDKDEHICTSQSPCQNGGQCVYEYHCV-
CLPGFHGRGCERKAGPCEQAGFPCRNGGQCQDNQGFALNFTCRCLAGFMGAHCEVN-
VDDCLMRPCANGATCIDGINRFSCLCPEGFAGRFCTINLDDCASRPCQRGARCRDRVHDFD-
CLCPSGYGGKTCELVLPAPEPASVGTPQMPTSAVVVPATGPAPHSAGAGLLRISVKEVVR-
RQESGLGESSLVALVVFGSLTAALVLATVLLTLRAWRRGICPTGPCCYPAPHYAPARQDQEC-
QVSMLPAGFPLSPDLPPEPGKTTAL
DLK2 exon5 84bp del
MPSGCRCLNLVCLLCILGATSQPARADDCSSHCDLAHGCCAPDGSCRCDPGWEGLHCER-
CVRMPGCQHGTCHQPWQCICHSGWAGKFCDKDEHICTSQSPCQNGGQCV
DLK2 exon3 1G INS
MPSGCRCLNLVCLLCILGATSQPARADDCSSHCDLAHGLLRS
DLK2 exon3 2G INS
MPSGCRCLNLVCLLCILGATSQPARADDCSSHCDLAHGAAALLTAPAGVTQAGRGCTVSAV
DLK2 exon3 16bp del
MPSGCRCLNLVCLLCILGATSQPARADDCSSHCDLALTAPAGVTQAGRGCTVSAV
DLK2 exon3 1C INS
MPSGCRCLNLVCLLCILGATSQPARADDCSSHCDLAHALLRS
Dlk2 exon2 INDEL
MPSGCLISVWSWGQPASLPERMTAAPTVTWPTAAALLTAPAGVTQAGRGCTVSAV
DLK2 exon2 70bp del
MPSGCPQGLGPGSPQPSSLAR
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Postnatal
day
DK73 N1
females
DK73 N1
males
DK73 N2
females
DK73 N2
males
3 0Hm, 3H, 0W 1Hm, 0H, 1W
6 0Hm, 3H, 0W 1Hm, 0H, 2W 1Hm, 1H, 2W 1Hm, 1H, 0W
9 1Hm, 2H, 0W 1Hm, 3H, 3W 1Hm, 1H, 2W 1Hm, 1H, 0W
12 1Hm, 1H, 3W 4Hm, 4H, 1W
15 1Hm, 2H, 0W 1Hm, 3H, 1W 1Hm, 1H, 3W 4Hm, 4H, 1W
18 1Hm, 2H, 0W 1Hm, 3H, 1W 1Hm, 1H, 3W 4Hm, 4H, 1W
21 1Hm, 2H, 1W 1Hm, 1H, 3W 0Hm, 0H, 1W 3Hm, 3H, 1W
24 1Hm, 5H, 0W 1Hm, 3H, 3W 1Hm, 2H, 1W
27 1Hm, 2H, 1W 1Hm, 1H, 3W
30 2Hm, 7H, 1W 2Hm, 4H, 6W 1Hm, 1H, 2W 1Hm, 1H, 0W
33 1Hm, 5H, 1W 1Hm, 1H, 5W 0Hm, 0H, 1W 2Hm, 1H, 0W
36 2Hm, 4H, 1W 2Hm, 4H, 4W 1Hm, 1H, 2W 2Hm, 3H, 1W
39 0Hm, 3H, 0W 0Hm, 0H, 2W 0Hm, 0H, 1W 2Hm, 1H, 1W
42 1Hm, 2H, 0W 1Hm, 3H, 1W
Table A.3 Sample sizes of each genotype (each time point) where postnatal weights were
assessed in figure 6.7
Blank cells — time point not assessed for that genotype or timepoint. Acronyms used: H
— heterozygotes, Hm — homozygotes, W — wild-types
